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Abstract
There is increasing evidence that events early in life may ‘programme’ later body 
composition (BC) and health outcomes. The aim of the work presented in this thesis was 
to test the following hypotheses:(l) birthweight and growth in infancy programme 
specific components of BC in later life and therefore have differential effects on health 
outcomes; (2) infant BC is differentially related to later BC, and is potentially involved 
in the programming process. These hypotheses were investigated in 2 cohorts (1) 
prospective follow-up during adolescence of subjects who had BC measurements during 
infancy (by stable isotope) as part of nutrition intervention studies; (2) healthy children 
who participated in a BC reference study, with retrospective collection of early growth 
records. The main outcome was BC assessed by the four-component model. Secondary 
outcomes were cardiovascular risk factors (blood pressure, lipid profiles, and insulin 
resistance markers).
308 subjects aged 4.22-20.36 years were studied. Birthweight (regarded as a proxy for 
prenatal growth) was positively related to later height in both sexes, and positively 
associated with fat free mass (FFM) in boys. In contrast, postnatal growth during the 
first 6 months of life positively influenced later fat mass (FM) and central fat 
distribution, with a weaker effect on FFM. Whilst FM showed a consistent association 
with most cardiovascular risk factors except HDL-C, FFM showed a strong negative 
association with HDL-C, independent of FM and central fat distribution. In a smaller 
group(n=41), BC at 12 weeks of age showed no significant association with adolescent 
BC; but SF during very early postnatal life (3 and 6 weeks) was related to later FFM and 
central fat distribution. Infant nutrition affected infant body composition, but I was 
unable to detect effects on later BC.
Conclusion: I found differential effects of growth during different periods on later BC, 
measured using the ‘gold standard’ four-component model. The mechanism by which 
early growth ‘programs’ later BC possibly involves both prenatal and postnatal nutrition
3
and warrants further investigation, since it could be useful in terms of designing 
effective early intervention to reduce obesity prevalence in childhood and adolescence. 
BC during adolescence has a differential impact on cardiovascular risk factors. 
Therefore, separate measurements of FM, FFM, and central fat distribution may offer 
more insight into the impact of body composition programming on health outcomes.
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Chapter 1 Introduction
There is a rising trend of childhood overweight and obesity worldwide with increasing 
evidence of short term health consequences and long term morbidity in adulthood (1-8). 
A great deal of research has focused on potential explanations for the obesity epidemic; 
most agree that a western lifestyle consisting of physical inactivity and excessive energy 
intake combined with genetic susceptibility are contributing factors to childhood and
adult overweight (7-9). However, there is also increasing interest in the concept that
#
obesity risk may at least in part be ‘programmed’ by events early in life (11). Early
studies in animal models showed that ovemutrition and excessive weight gain during the 
postnatal period are predisposing factors for obesity (11-14). In humans, the concept that 
events operating in early life influence or ‘programme’ later health has been extensively 
investigated over the past 15 years. Early studies tended to focus on intrauterine life as 
the main critical period for programming effects (15), however, increasing evidence 
points to the importance of growth and nutrition during the postnatal period (16; 17) and 
the possibility that this may interact with subsequent lifestyle factors to cause 
overweight and the metabolic syndrome (16).
The aim of the work presented in this thesis was to investigate the programming of 
specific components of body composition by growth and nutrition during early life, and 
to examine the relationship between body composition outcomes and cardiovascular risk 
factors in healthy children and adolescents, using the most accurate body composition 
techniques currently available.
The organisation of this thesis is as follow: Chapter 2 covers background to my research 
and review of the existing research works; issues that require further research are 
highlighted. Chapter 3 outlines the hypotheses and describes methodology including
The term “programming” refers to the idea that stimuli or insults during critical or sensitive periods in 
early life can have lifetime consequences (10).
18
statistics and details of outcomes measured. The next 5 chapters present results and 
discussion, within each chapter the results are presented and immediately followed by 
relevant discussion about validity of the results and comparison with other studies. 
Chapter 9 provides an overall discussion about potential mechanism of body 
composition programming and broader implication for public health as well as 
recommendation for future research.
19
Chapter 2 
Background
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Chapter 2 Background
This chapter is divided into 3 parts: 1) a general background section giving an overview 
of growth and the basic principles of body composition measurement in children, 2) a 
review of the literature on the programming of body composition, and 3) a review of the 
literature on the relationship between body composition and health outcomes.
2.1 General background■ I I   aCl I
In this general background section, I will briefly summarize the physiology of fetal and 
infant growth (particularly in relation to nutrition). Since my study involves body 
composition data during different stages of development, I also provide a review of the 
body composition changes seen during growth, followed by a discussion of body 
composition measurement techniques available for use in the paediatric population.
2.1.1 Physiology o f growth
“Growth is the maturation process characterized by change, compensation, and 
adaptation; it is genetically predetermined and significantly affected by hormonal, 
nutritional, and environmental factors”(18). For the purpose of this thesis, it is most 
relevant to focus on the influence of hormonal, nutritional, and environmental factors 
that affect prenatal and early postnatal growth.
Prenatal growth
Fetal growth and development are limited both by the intrauterine environment and by 
genetic potential. Many factors influence fetal growth throughout pregnancy; during this 
period nutrition and hormonal regulation may alter the expression of genes and have 
life-long consequences through a process that has been defined as ‘fetal
21
programming’(19). The ability of the maternal-placental system to transfer nutrients to 
the fetus, and the endocrine environment, also determine whether the fetus will achieve 
its growth potential during intrauterine life (see Figure 2-1)
Figure 2-1 Main determinants of fetal nutrition and growth#
Maternal body 
composition
Dietary' intake
Fetal genom e
Ute to-placenta! 
Wood flow
I
Placental transfer
Nutrient dem and - placental supply 
Fetal nutrition
Oxygen 
Blood flow
Nutrient supply 
G lucose 
Amino acids 
Fatty' acids
Endocrine regulation 
IGFs. PGH 
leptin
The three main intrauterine factors that affect fetal growth are briefly summarised 
below:
1) Hormonal regulation (20;21): the most important one are the insulin-like growth 
factors (IGFs—which induce cell proliferation and differentiation together with DNA 
synthesis), insulin (regulating the transport of nutrients across cell membrane and the 
synthesis of the peptide growth factors), placental growth hormone (PGH—which 
controls maternal IGF-1 level), thyroid hormone (critical for neural development), 
glucocorticoids (for maturation of lungs, liver, pancreas, gastrointestinal tract), and
Reproduced from Cetin et al (20)
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leptin. The function of leptin for fetal growth is still under investigation, however, its 
level in cord blood is related to fetal weight and fat mass (22).
2) The nutrient environment; which can modulate the activity of IGF-1 and its binding 
protein (21).
3) Maternal constraints; i.e. maternal-placental factors such as multiple pregnancy, 
maternal nutrition.
Birthweight is a convenient measurement of pregnancy outcome which has been used 
widely in clinical and research settings. It is clearly affected by multiple endogenous and 
environmental factors. Kramer (23) has identified the important factors associated with 
low birthweight in developed countries as follows: cigarette smoking, low maternal 
energy intake during gestation, and low prepregnancy weight, primiparity, female infant 
sex, maternal short stature, non-European ethnicity, and previous history of low 
birthweight. Such knowledge is important for targeting public health interventions aimed 
at improving prenatal growth.
Postnatal growth
Growth is a complex process that is sustained throughout intrauterine life, infancy, 
childhood and puberty until early adult life. During infancy, nutrition is a main 
determinant of growth, whereas in childhood and adolescence, growth hormone and sex 
steroids play a vital role. Indeed, infant growth rate is highly variable and its regulation 
is not well understood. It is likely that early postnatal growth is controlled by nutritional 
intake and by appetite, which might be influenced by feeding practices as well as by 
prenatal growth restraint (24;25). However, although there is increasing evidence from 
animal models that appetite and food preference can be altered by manipulating nutrient 
intakes and growth in the early post-natal period (26;27), this area has not so far 
received much attention in humans. A limited number of studies have suggested that 
during the first weeks of life, infant appetite regulation may not be well developed, so it 
is possible to manipulate infant nutrient intake to a significant degree -  for example 
using formulas with different energy or protein contents. However, beyond 6-8 weeks of
23
age, infants seem better able to adjust their intake and can effectively sabotage attempts 
to manipulate their intake by up or down-regulating the volume taken (28-30)—see later 
review in this chapter. The significance of these observations is poorly understood, 
although likely to be important, particularly in relation to infants who suffer poor early 
growth.
It is well-recognized, for example, that infants bom small for their gestational age are 
likely to show rapid postnatal growth, or ‘catch-up’ growth. Low birthweight may occur 
as a result of poor fetal growth throughout pregnancy or just in the last trimester. The 
underlying causes and outcomes differ in the two situations. The latter scenario, which is 
more common, arises as a result of maternal constraints such as placental failure as 
mentioned previously. An otherwise normal fetus is starved of nutrients and fails to gain 
weight, but grows in length near normally; so-called asymmetrical growth retardation. 
After birth, these infants almost always show complete catch-up growth with rapid 
weight gain within the first 6-12 months (31). Whilst these adaptations certainly benefit 
short-term infant survival there is evidence from epidemiological studies that this pattern 
of growth is associated with an increased risk of adult chronic disease such as type II 
diabetes and cardiovascular disease (32;33); similar effects of rapid postnatal growth 
seen even in non-small for gestational age (SGA) babies (34). Consequently, the 
mechanisms that regulate infancy growth or catch-up growth are under investigation.
2.1.2 Body composition changes during growth5
In general, the body can be divided into fat mass (FM) and fat-free mass (FFM). The FM 
includes all ether-extractable lipids and the FFM consists of 4 major constituents: water, 
protein, glycogen, and minerals (see Figure 2-2 ). The study of body composition allows 
better comprehension of physiologic changes during growth and the effects of factors 
such as hormones, nutrition, and physical activity. Figure 2-3 and Table 2-1 illustrate 
the changes in body composition seen during different periods of growth.
$ ,Adapted from Bechard and Puig (18)
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Figure 2-2 Body composition models.#
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Figure 2-3 Changes in body composition during fetal development and early life.#
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Table 2-1 Body composition of reference children and adolescents#
Length icjk) Differ ik&
Ptoncraiage of Body Wright
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Sins
Birih 51.6 3.5 13.7 12.0 3.2 0.5 69.6 42.5 27.0
0.5 67.0 a o 4 29.1 10.0 2.4 0.5 57.2 32.9 2 4 3
1 76.1 10.03 25.6 1 2 3 2.7 0.5 59.0 31.6 27.4
1.5 62.6 11.43 24.5 12.0 3.0 0.5 59.1 30.1 29.4
2 67.6 12.46 25.4 13.5 3.1 0.5 58.1 26.6 38.7
5 m o m ? 14.6 15.6 3.7 0.5 65.4 30.0 35.4
10 137.5 31.4 13.7 16.8 4.1 0.3 64.8 26.7 38.0
12.5 153.0 4 2 3 l c 3 16.4 4.1 0.6 62.7 26.4 36.4
15.5 171.5 53.5 13.0 17.4 4.5 0.6 64.6 2 5 3 33.6
IS. 5 177.0 « . o 110 17.7 4.6 0.7 64.1 24.7 39.4
CM;!
Btrih 53.5 3 3 14.0 12.6 3.2 0.5 68.6 4 2 0 26.7
0.5 66.5 7.6 32.0 10.4 2 3 0.3 54.0 31.7 23.2
1 7 5 3 9.5 27.6 12.2 2. i 0.5 .56.0 20.7 27.4
1.5 62.0 10.04 26.3 12.7 2.0 0.5 57.6 20.0 28.5
2 67.7 12.02 25.4 13.1 3.0 0.5 57.7 20.0 29.4
5 108.4 17.7 16.7 15.0 3.1 0.5 64.6 31.0 33.6
10 138.3 32.6 19.4 15.0 3.1 0.5 62.0 28.1 33.0
12.5 154.6 43.8 21.5 15.4 4.2 0.5 53.5 25.6 32.0
15.5 162.1 55.0 24.7 14.0 4.5 0.5 55.5 23.7 31.6
1&5 164.0 57.0 25.0 14.0 4.4 0.7 55.2 23.5 31.7
A d ip ted  from Portion S[ ai * H a s d ile  J* « 1; Jnd Butts NF «t j IJ-
ECW -  « tn u r lln l ir  xHtrr; 2CW -  irErmT^s.Tir sntfrr- I W  -  ray’ be&< m i f  t
# Reproduced from Bechard and Puig (18); this table was adapted from Fomon et al (36), Haschke (37;38), and Butte et al (39).
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Changes in the fa t component
Fat is the most variable o f body components. FM increases most rapidly during the 
3rd trimester, and comprises 13.7% of birthweight in healthy full-term boys and 
14.9% in girls (36). From birth, the accumulation of fat progresses rapidly to a peak 
of around 29.1% in boys and 32% in girls at age 6 months (39). After infancy, the fat 
content drops to a minimum at around 6-7 years of age and then increases steadily to 
adolescence. Although gender differences in body composition are present at birth 
(40), they become more obvious during the adolescent years. During puberty, 
adipocyte size and number increase substantially and fat becomes more centrally 
distributed, especially in males (41). The tendency for fat accumulation in the 
abdomen for males and around the hips for females can be attributed to the effects of 
hormonal change; androgens significantly reduce adipocyte volume and number 
around the hips, whereas estrogen and progesterone induce a slight increase (42). 
During and after puberty, the relative amount of fat diverges in boys and girls; the 
former tend to have less fat while the latter demonstrate an increase in fat as a 
proportion of weight.
Changes in body water
Water content is highest during fetal life -  about 88.6% of body weight at 24 weeks 
gestation and around 70% at term (18). After birth, it drops rapidly to around 60% at 
the age of 6 months before stabilizing between 60-65% during childhood and 
adolescence.
Changes in bone mineral content
Bone is constantly being formed and resorbed throughout life; bone modelling 
followed by bone remodelling, takes place continually from birth until late 
adolescence. The skeleton grows through infancy, childhood, and puberty, reaching 
maturity by late adolescence. Mineral accretion is particularly rapid during the third 
trimester and infancy, and again during the pubertal growth spurt. The period of
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maximal mineral accretion during puberty occurs after peak height velocity has been 
reached.
Changes in skeletal muscle mass
Skeletal muscle represents 22-25% of the mass of a newborn infant and 
approximately 40-54% of body weight in adolescence, with a higher figure in males 
than females. The number of muscle fibres in humans is probably set before birth so 
growth afterward occurs by hypertrophy without hyperplasia (43). Total muscle mass 
develops slowly during childhood with a growth spurt in the adolescent years, which 
is more intense and prolonged in boys than in girls. The development of muscle mass 
is influenced by several factors including age, sex, nutrition, hormonal, and physical 
activity.
Changes in visceral mass
In general, the growth and development of the viscera are associated with the same 
changes in chemical composition as those seen in muscle mass: a decrease in the 
proportion of water and an increase in the proportion of protein.
Table 2-2 Contributions of organs and major tissues to body weight#
O rgaeor
Issu e
IVrcentagr <?/ Beaiy Weight
Fetus 
i20 -24  ■**>
Fall-Term
Xewhoni
Ac\iut
Male FcVSilf
Skeletal m usde 2 1 0 2 5 0 40.0 29 3
Skeleton 22.0 L8.0 17.1 17.1
Skin 13.0 15.0 3.7 3.1
U ver 4 .0 5.0 2.6 2.4
Brain B.O 130* 2.0 2.1
Lung? 3 3 1.5 1.4 1.4
Kidney?. 3.1 1.6 0.4 0.5
Heart 0 .6 0.3 0.5 0 .4
Spleen — 0.2 0 3 0 3
A itap u d  from W hile  D i  el a I.*
Reproduced from Bechard and Puig (18); this table was adapted from W hite et al (44)
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Chemical changes in fat-free mass
FFM increases rapidly during the late fetal and neonatal period, followed by a rapid 
deceleration between the 1st and 3rd year o f life until the adolescent growth spurt 
begins (18). There is a slight predominance of FFM in boys compared to girls, which 
becomes apparent during the adolescent period.
The concept of chemical maturity of FFM was introduced by Moulton in 1923 (45); 
he found that the body composition of most species approached that of an adult when 
puberty was reached. The chemical composition of FFM varies greatly during 
growth since the chemical maturity of each component is reached at different stages. 
See Figure 2-4. For example, in children, FFM contains relatively more water than 
adults; the hydration fraction ranges from 80.2% in the newborn to 75% in early 
puberty and 73% in adults (Figure 2-4B). During growth, as the water content 
decreases and protein and mineral content rise, there is an increase in body density 
(Figure 2-4D). As a result, paediatric body composition cannot be correctly 
estimated if adult constants are used.
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Figure 2-4 Changes in FFM composition as a function of age. A Total body
potassium (TBK) in relation to FFM. B Total body water (TBW) in relation to FFM.
#
C Bone mineral content in relation to FFM. D Density o f the FFM.
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2.1.3 Paediatric body com position m easurement techniques
The gold standard for measuring body composition is cadaver analysis; in vivo 
techniques do not measure body composition directly, but rather predict it from 
measurements of body properties. Therefore, methodological error when obtaining 
the raw data and assumption errors when converting raw data to final values need to 
be considered. There are a number of available techniques for measuring body 
composition; however, in this review, I have only addressed the measurement 
techniques used in my study or comparable studies.
Simple measurements
Body mass index (BMI, calculated as weight/height) is widely used as an index of 
relative weight and used in both adult and children populations to categorise 
overweight and obesity. Some studies reported high correlations between BMI and 
FM in children (49); however, BMI cannot distinguish fat and lean masses and 
cannot represent fat distribution. FM or percentage fat (in relation to weight) can 
vary greatly within individual children (50), with ethnicity (51), and within a 
population over time (52). Moreover, in paediatric populations, the predictive value 
o f BMI for clinical outcomes such as cardiovascular risk factors is less clear than in 
adult populations (see later).
Waist circumference (WC) is used as a simple measurement of central fatness, 
which may be more predictive of clinical outcomes than total fatness. Some recent 
studies in children have suggested that WC might be a better predictor of 
cardiovascular risk factors than BMI (53-55).
Skinfold thickness (SF) measurements have traditionally been used as an indicator 
of fatness to rank individuals or to assess the size of specific subcutaneous fat depots 
(56). However, they can also be used to ‘predict’ total body composition as discussed
Adapted from W ells and Fewtrell (48)
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below. SF measurements are fairly quick and simple to obtain, but are subject to 
greater inter- observer errors than WC or BMI.
Predictive techniques 
SF equations
SF measurements can also be used to predict percentage body fat or body density by 
equations based on two-component models (57). However, these equations have 
limited use beyond the population from which they were derived and inevitably 
confound accurate raw values with predictive error. Indeed, it has been suggested 
that for assessment of fatness, it is better to rank people according to raw or SDS 
values of SF (48). Moreover, for assessment of FFM, the use of SF equations is 
particularly inappropriate since no index of this component is directly measured.
Bioelectrical impedance analysis (BIA)
BIA measures the impedance (resistance) of the body to a small electric current. It 
assumes that the body is a single cylinder and the lean tissue contains a high level of 
water and electrolytes and therefore acts as an electrical conductor. Adjustment of 
bioelectrical data for cylinder length (height) then allows estimation of cylinder 
volume (total body water—TBW), by using the appropriate regression equations 
relating the square o f height divided by impedance to TBW. The predicted TBW is 
then converted to FFM. This principle relies on several assumptions which can be 
affected by the age range and characteristics (e.g. ethnicity, disease state) o f the 
population. Published BIA equations are population specific and perform poorly in 
healthy individuals, with errors typically ± 8% fat (58).
Two-component models (2C models)
The 2C model divides the body into FM and FFM; the accuracy mainly depends on 
the assumption of constancy of FFM composition. As previously mentioned, the
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chemical composition of FFM varies with age, sex, and pubertal status; these 
changes are generally accounted for by assuming constant FFM characteristics for a 
given age and sex.
Dual Energy X-ray absorptiometry (DXA)
DXA was introduced as a technique for measuring bone mineral mass from the 
differential absorption of 2 different energy X-rays. The technique only estimates the 
relative proportions of fat and fat-free tissue in pixels without bone. In the limbs, this 
allows the majority of pixels to undergo soft tissue analysis, but in the trunk, where 
the pelvis, spine, ribs obscure significant numbers of pixels, soft tissue composition 
is predicted rather than measured. Due to these limitations, total body FM and FFM 
derived from DXA need to be interpreted with caution. In a recently published study 
(59) evaluating DXA against the 4-component model (see later), the researchers 
reported that the bias of DXA for measuring body composition varies according to 
the sex, size, fatness, and disease state of the subjects.
Densitometry
The densitometric approach uses Archimedes’ principle to distinguish fat and fat-free 
components of weight assuming specific densities of these two tissues. It thus 
requires the measurement o f total body density (mass/volume). FM density is 
relatively constant whereas that of FFM varies, so age and sex specific equations 
(based on FFM density in reference children(36)) are used to convert body density to 
final body composition values (60). Wells et al (58) have shown that these values are 
biased in contemporary children and inter-individual variability is significant even in 
normal healthy children.
There are two available methods for body volume measurements: hydrodensitometry 
and air displacement plethysmography. The latter is the newer method which is 
reported to have a better precision and to be more readily acceptable in children (61) 
(measurement details are shown in Chapter 3).
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Isotope dilution
The deuterium (a non-radio active stable isotope of hydrogen) dilution technique is 
used to measure TBW, allowing the estimation of FFM. A dose of water labelled 
with deuterium (D20 ) is given and, following equilibration, the enrichment of 
deuterium in the body water pool is measured using samples of saliva (in children) or 
urine (preferable in infants). In most children, 4 hours is sufficient for equilibration 
of deuterium in saliva. In infants, who have rapid water turnover, collecting post­
dose samples (urine) over several days and calculating the maximum post-dose 
enrichment through back extrapolation is a better approach (62). For calculating 
TBW, it is assumed that the deuterium dilution space overestimates TBW by a factor 
of 1.044 (63), although in infancy this factor varies in relation to age (64).
An alternative isotope, 18-oxygen (180 ), can also be used and the protocol is 
identical to that for deuterium except the overestimation factor is 1.01 (63).
However, it is substantially more expensive than deuterium.
Estimation of FFM from TBW requires an assumption of the hydration of fat-free 
tissue. Published reference values are relatively consistent with measured values in 
healthy children and infants (65) with relatively low inter-individual variability (58). 
Since deuterium dilution is simple to perform and requires minimal subject 
cooperation, it can easily be used in field studies, particularly in populations where 
the normality of hydration is known or can be assumed.
Magnetic resonance imaging (MRI)
MRI is an imaging technique that estimates the volume rather than the mass of 
adipose tissue. It primarily detects hydrogen nuclei, located either in water or fat, and 
uses these data to discern tissue types in imaging slices which can then be summed to 
calculate regional tissue volumes. The main advantage is that currently it is the only 
accurate and viable approach for the estimation of intra-abdominal adipose tissue, 
despite its relatively high cost and limited availability. An alternative imaging 
technique is computed tomography (CT), based on X-rays, as opposed to
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electromagnetic radiation in MRI. However, the high radiation dose makes it 
essentially unsuitable for routine use in paediatric populations.
Multicomponent models
The greatest advantage of multicomponent models lies in minimizing the 
assumptions made in simpler models. Bone mineral content and TBW are measured 
by techniques specifically designed for that purpose. It therefore provides a greater 
degree of accuracy. The three-component model (3C) divides the body into fat, water 
by measuring TBW (by the isotope dilution), and remaining fat-free dry tissue, and 
thus avoids the need to assume a value for the hydration of fat-free tissue. However, 
it assumes a constant ratio of protein to mineral (66). The four-component model 
(4C) further divides fat-free dry tissue into protein and mineral, by measuring total 
body mineral (by DXA). This avoids the assumption of a constant protein to mineral 
ratio, but still assumes a constant ratio o f bone mineral to total mineral (66). The 
practical measurement details and equations used in my study are shown in Chapter 
3.
Summary:
Growth and body composition vary greatly in paediatric populations, both between 
individuals and in the same individual over time. A basic understanding of the 
physiology of growth and body composition changes during growth is fundamental 
to research in this area. Advances in in vivo techniques for measuring body 
composition allow researchers to explore growth and its outcomes in more detail, and 
to investigate the role of specific components in the development of obesity and 
other diseases.
The next part of this background section is a review of published work on the 
programming of body composition.
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2.2 Body composition programming
Research on the long-term effects o f birthweight and infant growth on later health, 
including obesity and cardiovascular disease, has increased rapidly during the past 
10-15 years, with publications from both developed and developing countries. The 
majority of studies investigating the possible programming of obesity have used BMI 
as the main outcome, since it has been shown to correlate well with morbidity and 
mortality from cardiovascular disease in adults. However, in paediatric populations 
the evidence that any BMI ‘cut-off relates to the outcome of interest (e.g. the 
metabolic syndrome, type II diabetes, or early signs of cardiovascular disease) is less 
strong. More recent studies have included more detailed measurements of the 
components of BMI i.e. FM and FFM, mostly in relation to birthweight. Fewer 
studies have looked into the effects of postnatal growth on later body composition.
Most of the papers cited in this section were published before I proposed my 
hypotheses and started my research, and these formed the background to my work. 
More recent research and work in progress will be included in the discussion sections 
o f the relevant chapters.
Here I will review: 1) the influence of birthweight and early growth in infancy on 
later body composition; 2) the effect of early nutrition (breast vs. formula feeding 
and different infant formulas) on growth and body composition; and 3) the long term 
effect of early body composition on later outcomes.
2.2.1 Long term effects o f early growth on later body composition  
Animal data
Early studies in animals demonstrated that nutrition and growth in the early postnatal 
period have a long term effect on later growth trajectory and also later body fat. 
McCance (67) manipulated litter size in rats, so that rats from larger litters received 
less breast milk than those from smaller litters during the 3-week suckling period, by
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which time rats from larger litters were substantially smaller. These smaller animals 
continued to diverge in body size even though they were fed normally after weaning. 
The same researcher also showed that equivalent dietary manipulation for a 3-week 
period a few weeks later (post-weaning) had no lasting effect: the underfed animals 
showed catch-up growth when they were re-fed. This showed that 3-weeks of 
intervention in a critical period had resulted in a lifetime programming of the growth 
trajectory. Knittle and Hirsch reported that the preweaning nutrition of rats also 
markedly influenced the number of fat cells of these animals during adult life (68).
Lewis et al tested the fat cell number hypothesis in primates by feeding newborn 
baboons with different caloric density formulas (40.5, 67.5, 94.5 kcal/lOOml- 
underfed n=8, normally fed n=12, overfed n=12, respectively) in similar volumes 
until they were weaned at 4 months of age (11-14). In the first experiment (11), 
overfed baboons at 4 months o f age (at weaning) had greater absolute FM and fat cell 
size, but not more fat cells, than baboons that were underfed. The second experiment 
(13) examined the long-term effect of infant ovemutrition by follow up of the 
baboons that were overfed, normally fed, or underfed until 4 months of age and then 
fed an identical diet until they were young adults at 5 years of age. Overfeeding 
during infancy markedly increased FM in the 10 fat depots measured in 5-yr-old 
female baboons and marginally increased FM in 4 of 10 fat depots in 5-yr-old male 
baboons. On the contrary, underfeeding did not affect body weight or adipose mass 
of either sex. The increased FM resulted primarily from an increase in fat cell size 
but not fat cell number.
These studies in baboons thus demonstrated that 1) overfeeding during the early 
postnatal period increased body mass and FM at weaning compared with 
underfeeding; 2) the effect of preweaning diet on body mass disappeared before 1 
year, but the effect of the exposure was ‘remembered’: female baboons overfed as 
infants began to gain weight at a greater rate than those underfed or normally fed 
especially between 3-5 years of age (female baboons enter puberty around 3 years of 
age)(13) and the majority of the excess weight gained was fat (14). These results 
therefore provide evidence in support o f the hypothesis that rapid growth during 
infancy can predispose to obesity in later life, even when the early effects are 
transitory. The findings were confined to females, and the researchers suggested that
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the rapid increase in lean body mass during the pubertal growth spurt in males (age 5 
years) may have masked an effect o f infant overfeeding on FM (13). Consequently 
they might develop obesity at a later age than females. Alternatively, the obesity 
response to infant overfeeding may be sexually dimorphic, at least in the baboon. 
They also found that much of the body fat in overfed male and female baboons was 
located in the intra-abdominal fat region (omentum, perirenal, and mesentery). 
However, it is difficult to determine whether this type of obesity is similar to the 
truncal obesity reported in human, as defined by SF ratios, circumferences, and 
waist-to-hip ratios, which do not differentiate between subcutaneous and intra­
abdominal fat.
Human data
The following is a review of evidence supporting the programming of body 
composition in humans, divided into ‘prenatal’ and ‘postnatal’ periods of growth.
Birthweight or ‘prenatal’ growth
A large number of studies have addressed the relationship between birthweight and 
later BMI. Almost all have found direct positive associations although of differing 
magnitudes- typically 0.5 to 0.7 kg/m2 per 1 kg increase in birthweight (69;70). As 
mentioned previously, although a higher BMI is traditionally interpreted as 
indicating greater ‘fatness’, it is also influenced by lean mass or FFM. Thus for 
instance, a tall athletic individual with high muscle mass and a tall individual with 
excess fat might both have a high BMI but for entirely different reasons and with 
very different implications for health.
I will focus on the limited number of recent studies attempting to look at more 
specific measures of body composition in relation to birthweight. These are 
summarized below:
Allison et al (71) reported a positive association between birthweight and adult 
height but not weight, and Phillips (72) reported a similar association between
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birthweight and later muscle mass (estimated by urinary creatinine excretion) but not 
later weight.
Stettler et al (73) studied 447 African Americans followed to 20 years of age. 
‘Adiposity’ was defined as the sum o f triceps plus subscapular SF >85th centile for 
age and sex. Three predictors for adiposity were identified: being a first-born child, 
female sex, and high maternal BMI. After adjusting for these factors, there was no 
relationship between birthweight and later adiposity.
Hediger et al (74) studied 3192 children at 3-6 years. Those bom small for 
gestational age (SGA) remained shorter and lighter at follow-up. Those bom large 
for gestational age (LGA) remained taller and heavier with a significant increase in 
mid-upper arm circumference (MUAC) SDS with age. The authors suggested that 
they may be at risk for increasing accumulation of fat. However, the same group of 
researchers studied arm fat and muscle mass, calculated from MU AC, in 4431 
children aged 2-47 months and reported that those bom SGA had a deficit in arm 
muscle, but less of a deficit in arm fat, whereas LGA infants showed a greater excess 
of arm muscle than arm fat (75).
Weyer et al (76) studied 272 adult non-diabetic Pima Indians. Underwater weighing 
or DXA was used to measure body composition. Birthweight was positively related 
to adult height and to FFM, but not FM.
Gale et al (77) reported data from 143 women aged 70-75 years from Sheffield. DXA 
was used to measure body composition. Birthweight was positively related to 
weight, lean mass and bone mass. The association with lean mass persisted after 
adjustment for weight and height in adult life. There was no significant association 
between birthweight and adult FM. On the basis of these findings, the authors 
suggested that bone and muscle growth are programmed by intrauterine factors.
Loos et al (78;79) studied 229 male twins pairs and 238 female twins pairs. Twins 
who were heavier at birth were taller and heavier as adults, with more lean body 
mass (from BIA) and less subcutaneous and abdominal fat (measured using waist-hip 
ratio and sum of SF) when adjusted for current body weight.
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Singhal et al (80) used BIA and DXA to assess body FM and FFM in children and 
adolescents aged 8-12 years and 13-16 years old respectively and found that higher 
birthweight was associated with greater FFM, but not with greater FM. Moreover, 
this association was independent of age, sex, pubertal stage, socioeconomic status, 
physical activity and height.
To summarise, data are quite consistent in showing a positive association between 
birthweight and later BMI, although the size of the effect varies. Nevertheless, more 
recent studies that have examined body composition in detail suggest that this 
relationship may predominantly reflect greater height and lean body mass rather than 
excess adiposity.
Postnatal growth
There is increasing evidence from longitudinal studies that a pattern of rapid weight 
gain during early infancy is associated with obesity (defined by BMI) not only in 
childhood but also in adulthood (81-87). For example, Stettler et al (82) reported that 
rate of weight gain during the first 4 months of life was associated with being
tVioverweight (defined by BMI over 95 centile) at age 7 years in 19,397 US children; 
Odds ratio (OR): 1.38 (1.32-1.44). This association was present in each birthweight 
quintile, and remained significant after adjustment for the weight attained at age 1 
year. The same authors (84) presented data from a longitudinally followed cohort of 
300 term-born African Americans from birth to 20 years suggesting that high infancy 
weight gain during the first 4 months of life (defined as an increase of > 1 SD in 
weight-for-age SDS from birth to age 4 months) can help to predict the likelihood of 
developing obesity in early adulthood (defined by BMI; OR 5.22 (1.55-17.6, p 
0.008)).
Ong et al (85) studied 848 healthy term infants from the ALSPAC study (Avon 
Longitudinal Study of Pregnancy and Childhood) and showed that infants who 
gained greater than 0.67 SD in weight SDS between birth and 2 years (30.7 % of the 
cohort), indicating clinically significant catch-up growth, were heavier, taller and
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fatter (by BMI, percentage body fat and total FM which was calculated from SF) at 5 
years than those who showed no change (remained within the same weight percentile 
band between birth and two years - 44.8%) or catch-down growth (lost more than 
0.67 SD - 24.5%). Moreover, they also had larger waist circumference at 5 years 
even after allowing for BMI or FM. Infants showing the ‘catch-up’ pattern o f growth 
were also smaller at birth, more likely to be first-bom, had taller fathers, and their 
mothers had lower birthweight and were more likely to have smoked; all o f these 
factors are thought to result in intrauterine constraint of fetal growth which is then 
followed by post-natal catch-up due to the effect of parental genes on childhood 
growth (e.g. taller fathers). In contrast, catch-down growth in babies of large 
birthweight was related to small size at five years. Even if catch-up growth was 
defined on the basis of gain in SDS for length, those who showed catch-up growth 
also had greater BMI SD scores and total FM. In addition, these results were 
unaffected by feeding mode (breast or bottle feeding).
Parsons et al (86) reported data from 10,683 members of the 1958 birth cohort. The 
risk o f adult obesity was highest in those who had grown to a greater proportion of 
their adult height by 7 years of age. In men, the effect of childhood growth was 
strongest in those with lower birthweight, and, to a lesser extent, those bom to lighter 
mothers.
In addition, central fat distribution may be of greater clinical significance than the 
total amount of fat in terms of its association with the metabolic syndrome (9;55;88- 
90). Several studies (78;91-95) have shown that, after adjusting for current BMI or 
weight, there has been a negative association between birthweight and later central 
fatness as measured either by S:T ratio or waist: hip ratio. This finding suggests that 
there is actually an association between postnatal growth and later central fatness; in 
other words, those who show the greatest change in size between birth and the later 
measurement have the greatest central fatness.
More recently, there have been a limited number of studies that have directly 
measured central fatness using more sophisticated body composition techniques. 
Gamett et al (96) studied 255 healthy children aged 7-8 years using DXA and found 
a significant negative relationship between birthweight SDS and abdominal fat in
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childhood. The greatest abdominal fat was seen in those with lowest birthweight SDS 
who had gained weight centiles, and increased abdominal FM in these children was 
associated with higher total cholesterol, triglycerides and diastolic blood pressure. 
However, conflicting results were reported from a study that used a more direct 
technique for in vivo abdominal fat measurement in a smaller population. Choi et al 
(97) studied the relationship between birthweight, visceral fat area (by computerized 
tomography) and insulin sensitivity in 22 healthy young Korean adults. Without 
adjustment for current BMI or weight, they could not find a significant correlation 
between birthweight and any of the abdominal obesity measurements (waist: hip 
ratio, visceral fat area and visceral: subcutaneous fat ratio).
2.2.2 The long term influence o f early nutrition
Many studies looking at associations between events during early life and later 
outcome have also examined the influence of infant nutrition, particularly the effect 
o f breast versus formula feeding, but there are also some studies examining the 
effects o f infant formulas with different composition. These studies are relevant to 
the study of early growth and later outcomes since the growth pattern in infancy is 
strongly influenced by early nutrition.
Breast versus formula feeding
There are a large number of publications from studies investigating the effect of 
breastfeeding on later obesity risk. Because it is unethical to randomly assign healthy 
term infants to be breast or formula-fed, the large majority of data come from 
observational studies. These may demonstrate associations between breastfeeding 
and later outcome but cannot, individually, prove causation. The odd ratios (OR) for 
the protective effect of breastfeeding against obesity are remarkably similar across 
several studies, ranging from 0.75-0.84 (98;99). For example, Von Kries et al. (99) 
studied 9357 children from Germany and found that the prevalence of obesity 
(defined as BMI above the 97th centile for the population) at age 5-6 years was 4.5% 
in those never breast-fed and fell with increasing duration of exclusive breast-fed (2 
months, 3.8%; 3-5 months, 2.3%; 6-12 months, 1.7% and more than 12 months,
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0.8%). Furthermore, the effect of breastfeeding remained after adjusting for potential 
confounding factors such as social class or lifestyle. After adjustment for 
confounders, the OR for development of obesity in breast-fed children was 0.75 
(95%CI 0.57-0.98), and for being overweight, 0.79 (95%CI 0.68-0.93). It is possible 
that the apparent protective effect of breastfeeding on obesity is related to the lower 
nutrient intakes and slower weight gain of breast-fed infants early in life, and this is 
currently being investigated by a number of groups. Singhal et al (100) reported 
lower plasma leptin concentrations in relation to FM during adolescence in preterm 
infants randomised to receive breast milk when compared with those fed a nutrient- 
enriched preterm formula. These findings might suggest that early diet may program 
leptin physiology with the potential for influencing fatness, although no differences 
in body composition were apparent between diet groups at this follow-up.
In contrast, Li et al. (101) have published data from 2631 offspring of the 1958 
British birth cohort (age 4-18 years) suggesting that there is no supportive evidence
tVifor a protective effect of breast feeding on obesity (defined by BMI above 95 
percentile). Parsons et al. (102) also examined the associations between infant 
feeding and obesity at 33 year follow-up of the 1958 British birth cohort and found 
that breastfeeding and BMI were unrelated in childhood, but breastfeeding was 
protective against increased BMI at 16 and 33 years in women and at 33 years in 
men. However, after adjusting for social class, mother’s BMI and smoking during 
pregnancy, the effects became non-significant. It is difficult to reconcile this finding 
with the fairly consistent results of more recent studies relating infant feeding to 
obesity risk during childhood, and further follow-up of these and other cohorts into 
adult life is clearly required.
Infant formulas with different composition
During the 1970’s and 1980’s, there were several studies looking at the effects on 
growth of different infant formulas, generally with different protein contents or 
protein: energy ratios - only a few studies concentrated specifically on energy 
content.
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Fomon et al found that healthy term infants receiving a more concentrated formula 
(133 vs. 67 kcal/lOOml (29), 100 vs. 54 kcal/lOOml (30)) had a higher caloric intake 
and rate of growth (gain in weight and length) in the interval 8 through 41 days of 
age but similar caloric intake and rate of growth from 42 through 112 days of age. 
This was because during this later period the groups that received lower energy 
formulas consumed a relatively higher volume of milk and considerably greater 
quantity of other foods. Brooke and Kinsey (28) reported similar findings in term 
SGA fed different energy formulas. These studies suggest that it is possible to 
manipulate infant nutrient intake during the first few weeks of post-natal life but that 
at least some degree of appetite regulation becomes apparent by about 8 weeks, as 
demonstrated by the infant’s ability to up or down regulate intake during this period.
A few studies have reported in greater detail on the composition of growth obtained 
using different energy formulas. Fomon et al (103) showed that a high energy intake 
between 8 and 55 days of age led to increased gain in weight but not in length, 
resulting in greater BMI. It was suggested that this represented increased fat 
deposition. Similar and more obvious findings were reported in studies in preterm 
infants (104-106). For example, Van Goudoever et al (106) showed that weight gain 
and percentage body fat (by SF) were significantly lower in very low birthweight 
infants fed with lower energy formula (67 vs. 80 k c a l/100 ml).
Most studies o f formula composition and body composition used basic 
anthropometry as outcome measures. More recently, DXA has been used to assess 
body composition and bone health in preterm infants. These studies found that 
infants fed diets with higher nutrient contents (preterm vs. term formula, formula vs. 
fortified human milk) have greater lean mass, FM and bone mineral mass (107; 108) 
at the time of hospital discharge and age 6 months.
These studies therefore agree that body composition and growth pattern can be 
altered by changing the composition of the formula fed in early infancy. However, 
very few studies have followed the infants for a longer period in order to look into 
longer term outcomes of different early growth patterns resulting from different 
formula composition. Some follow-up studies in these preterm infants showed that 
the effects of diets during the post-discharge period on the growth of preterm infants
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persisted up to 18 months of age, which was beyond the period when the formulas 
were fed (109; 110). In contrast to post-discharge nutrition, studies examining the 
effect of pre-discharge nutrition in preterm infants generally show neither apparent 
persisting effects on growth at 18 months nor long term effects at age 7.5-8 years 
(111) - despite marked dietary effects on growth during the early post-natal period. 
Similarly, Fewtrell et al (112) demonstrated that term SGA infants fed nutrient- 
enriched formula were longer and had greater gains in length and OFC by 9 and 18 
months than those fed a standard term formula, but a 6 year follow-up showed no 
differences in growth parameters. Worryingly however, the enriched formula group 
had higher FM (assessed by BIA) at 6 years of age (Singhal et al., Unpublished data) 
and the researchers suggested that these findings might be explained by the results of 
early rapid growth rather than the effects o f different formula per se. It should be 
noted that there is the possibility of delayed emergence of the long term effects of 
early nutrition and growth on later body composition until a certain age (e.g. around 
puberty) as seen in the baboons (13; 14). Therefore, longer term follow-up in 
adolescents and early adulthood in these cohorts is still required.
2.2.3 Relationship between infant body composition and later health 
outcom es
The data discussed above suggest that early ‘growth’ has significant effects on later 
body composition. However, it is important to emphasize that most studies on the 
later consequences of early growth pattern use only crude indices to assess growth or 
catch-up growth such as weight, height or BMI (absolute value, gain or SDS 
change), mainly because of the limitations of growth records and infant body 
composition measurement techniques.
There are a few longitudinal studies looking at the tracking of BMI from infancy 
through to adolescence and adult life. Rolland-Cachera et al (113) found that only 
42% of 162 subjects followed up from 1 year to 21 years remained in their original 
category o f lean, medium, and fat (defined using the 25th and 75th centiles of BMI as 
cut-offs), and the relative risk of being in the fat group at age 21 was 1 for the lean, 1
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for the medium, and 2 for the infants categorised as fat at 1 year. Gasser (83) showed 
that correlations between BMI and SF measurements at 1 month and in adult life 
were very weak compared to the correlation from childhood to adolescence and from 
adolescence to adulthood. Due to the limitations of BMI mentioned previously, these 
findings cannot provide information on whether infant FM or FFM have any 
differential effect on later BC.
Available techniques for infant body composition measurements such as stable 
isotopes, total body potassium, total body electrical conductivity, DXA, and 
densitometry have been used more recently (39; 114-116) and a few studies have 
followed up these infants to 2-3 years of age. Butte et al (117) found that differences 
in body composition (by multicomponent model; deuterium dilution, total body 
potassium, and DXA) in early infancy (up to 6 months), which were associated with 
infant feeding mode (breast vs. formula), did not persist into the second year of life. 
In contrast, Wells et al.(l 18) reported that infant fatness (by doubly labelled water 
study) showed a strong relationship with childhood fatness at the age 2.5-3.5 years. 
However, there have been no longitudinal follow-up studies o f the effects of 
alterations in infant body composition on later obesity. Follow-up studies of cohorts 
that have detailed anthropometry and body composition measurements in infancy 
would be very useful to examine which components of growth (e.g. lean mass, or 
FM) are important for long term health outcomes. This could in turn provide clues 
about the potential mechanisms behind the programming effects of early growth.
Summary:
Available evidence supports the hypothesis that the growth pattern early in life, 
which can be manipulated by nutrition, affects different components of body 
composition in later life. Collectively, the data suggest that birthweight predicts later 
lean mass whereas postnatal growth may predict FM and possibly the development 
of central fat stores. However, the majority of studies have used proxy measures of 
‘fatness’ such as BMI, and very few have attempted to directly measure specific 
components of body composition. In addition, the effects of body composition 
changes during infancy (which have actually been measured, rather than using crude 
indices as a proxy of fatness) on health outcomes have not been explored and warrant
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further investigation. Such data could be important in determining the direction of 
infant feeding policy, in order to make infants ‘grow’ in a way that might be more 
beneficial for long term health outcome e.g. reducing the risk of obesity.
2.3 Body composition and health outcomes
Although there was no commonly accepted definition of overweight and obesity in 
children until the International Obesity Task Force (IOTF) recently recommended 
using the BMI cut-offs proposed by Cole et al (119), there is a clearly rising trend of 
childhood overweight and obesity worldwide (l;3-5). Moreover, there are a number 
o f studies showing that overweight children and adolescents are likely to become 
overweight adults (8;120-122) and some (123), but not all (124;125), studies suggest 
that childhood obesity is associated with an increased risk o f cardiovascular disease 
even when obesity does not itself persist. Both short and long term health 
consequences of childhood obesity are under extensive investigation.
In adults, WHO criteria for overweight (BMI >25 kg/m2) and obesity (BMI > 30  
kg/m2) are widely accepted and used as health risk markers for cardiovascular 
disease and the metabolic syndrome (consisting of insulin resistance, hypertension, 
dyslipidemia and several abnormalities in clotting and inflammatory markers)
(89; 126; 127). In adults, studies comparing the relative value of BMI and percentage 
fat (relative to weight) in the prediction of metabolic risk are contradictory, with 
some reporting that BMI has similar, or even better correlation, with cardiovascular 
risk factors (128), and others reporting that the value of %FM exceeds that o f BMI 
(129).
Although BMI has been shown to be associated with cardiovascular risk factors in 
children to a certain extent (130-132), the use o f BMI as a ‘proxy’ for adiposity in 
children and adolescents might have limitations due to variation in growth rates and 
maturity. For example, it has been reported that annual increases in BMI during 
childhood are generally attributable to the lean rather than the fat component of BMI 
until late adolescence (133; 134). Furthermore, there is evidence that in obese 
children, FFM increases as well as FM (135). The mechanism by which FM 
regulates a host of physiological processes related to the development of insulin
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resistance and cardiovascular disease has been extensively investigated (136-138). In 
contrast, the impact of increased FFM on health outcomes has rarely been explored. 
Differential effects of these two components of BMI on cardiovascular health risks 
warrant further exploration.
There is increasing evidence that enlarged adipocytes in the visceral fat depot 
synthesize and release biologically active molecules that may affect cardiovascular 
risk factors such as circulating free fatty acid molecules, inflammatory cytokines 
(TNF-a, IL-6), adiponectin, resistin and leptin (9;89;90). Therefore, central fat 
distribution may be of greater clinical significance than the total amount of fat in 
terms of its association with the metabolic syndrome (88;96;97; 139). Since MRI or 
CT, which are considered to be the ‘gold standard’ for visceral adipose tissue 
assessment, are not always practical in clinical and research settings, WC has been 
proposed as a better marker for cardiovascular disease and insulin resistance than 
BMI (53-55) in children as well as adults. For example, Maffeis et al (55) studied 
818 prepubertal children aged 3-11 years and showed that ApoAl: ApoB, HDL 
cholesterol, total cholesterol: HDL cholesterol, and systolic as well as diastolic BP 
were significantly associated with WC, triceps and subscapular SF, independently of 
age, gender, and BMI. Moreover, WC had a higher correlation with systolic and 
diastolic BP than triceps, subscapular SF and relative body weight.
Although designed to measure bone mineral content, DXA has also recently been 
used to assess soft tissue composition. Increasing number of studies investigating the 
programming of body composition have used trunk FM from DXA as an index for 
central fat distribution (140; 141). Therefore, its relationship with cardiovascular risk 
factors is relevant in my study. As previously mentioned, DXA has some limitations 
in soft tissue assessment since it predicts rather than measures soft tissue 
composition in pixels that contain bone; thus, trunk soft tissue measurements (which 
include the thoracic cage) are likely to be predicted to a greater extent than limb 
measurements (which only include the long bones). For this reason, a DXA manual 
region o f interest (excluding the thoracic cage and defining the abdominal area from 
L1-L4) has been introduced and validated against CT in an adult population (142). 
The same researchers reported that abdominal FM by this method provided a sex- 
independent predictor of insulin sensitivity index in a group of older adults (143).
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Therefore, its relationship with cardiovascular markers in children and adolescents, 
especially in comparison with other body composition variables, deserves further 
investigation.
Summary:
In children, BMI is not a good index of body fat, which may be the component that is 
most associated with health risks. Separate measurements of FM and FFM would be 
desirable in further defining the health effects of increasing body weight. Simple 
techniques for assessing central fat distribution in paediatric populations warrant 
further investigation.
The next chapter is an outline of my hypotheses and research plan, beginning with a 
description of the study populations and followed by details of the measurement 
techniques used for the main outcomes and potential confounding factors.
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Chapter 3
Hypotheses, Study plan and Outcome measures
50
Chapter 3 Hypotheses, Study plan and Outcome 
measures
3.1 Hypotheses
Base on the findings discussed in Chapter 2 ,1 proposed 2 main hypotheses which have 
been tested in this dissertation:
(I) Early growth patterns program later specific component of body composition in 
adolescence and early adulthood, and could thereby influence the development of 
obesity and cardiovascular health risks.
This first hypothesis can then be divided as follows:
1-1 Different periods of growth, i.e. ‘prenatal’ (represented by birthweight) and 
‘postnatal’, have differential influences on later body composition.
1-2 Different components of body composition in adolescence and early adulthood 
have differential effects on cardiovascular health risks.
The research and specific analyses addressing this hypothesis are shown in Chapter 4, 
Chapter 5, and Chapter 6.
(II) Specific components of body composition (e.g. lean body mass or FM) during 
infancy are differentially related to later body composition and cardiovascular risk 
factors; and are, therefore, potentially involved in the programming process. Infant 
nutrition may have long-term consequences for later body composition and health that 
are mediated by effects on infant body composition.
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Research and specific analyses addressing this hypothesis are shown in Chapter 7 and 
Chapter 8.
The remaining part of this chapter will provide an overview of the research project and 
outcome measures which apply broadly to all of the subsequent chapters. Additional 
measurements or details of more specific statistical analyses will be discussed in greater 
detail in the relevant chapters.
3.2 Study populations
The hypotheses were tested using 4 cohorts of healthy UK children and adolescents. 
Three cohorts had body composition measurements during infancy and were 
prospectively followed-up during adolescence. The fourth cohort consisted of healthy 
children and adolescents who are a part of body composition reference study; 
birthweight and growth records were retrieved retrospectively from infant records and 
maternal recall in this group.
3.2.1 Prospective follow-up of healthy term infants
A follow-up study was carried out in three different cohorts of healthy term infants who 
had early growth and body composition measurements using the doubly-labelled water 
technique (144-147). A summary of each of these three cohorts is given below:
Cohort A: Randomised controlled trial o f different energy infant 
formulas
Based on the observation that formula-fed infants might effectively be overfed compared 
to breast-fed infants when consuming current infant formulas, a randomised controlled 
trial was set up in 1990 to test the hypothesis that the use of a formula with an energy 
content similar to that in breast milk (metabolisable energy density around 60
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kcals/lOOml, as determined by doubly-labelled water measurements) would result in the 
pattern of growth, body composition and energy metabolism seen in breast-fed babies. 
Between 1990 and 1992, 107 healthy term infants with birthweight >10th centile by local 
growth standards were recruited from the maternity hospital in Cambridge. Infants were 
eligible if their mother intended to formula feed. After informed parental consent was 
obtained, the infants were randomly assigned to receive a standard (67kcal/100ml) or a 
low energy (60kcal/100ml), lower fat formula (both manufactured by Ross Products, 
Ohio, US; detailed composition shown in Appendix A). The formulas were otherwise 
identical. Formulas were fed as sole diet until 12 weeks and as a supplement to weaning 
foods thereafter. Anthropometry was performed at recruitment (age 2-3 days), 3, 6 
weeks, and at 3, 6, 9, and 12 months of age. Energy expenditure, milk volume intake 
and body composition were measured using the doubly-labelled water technique at 3 
months.
Results (unpublished data, further details of the study are shown in Appendix A and 
discussed in Chapter 8)
Infants who received the reduced energy (RE) formula showed similar weight and length 
gains to those fed standard formula. However, at 6 weeks and 3 months they had 
evidence of reduced adiposity with lower SF, lower FM and higher FFM. From 3 to 12 
months of age, when both groups were receiving solids as well as trial formulas, there 
were no differences between the groups. Milk intake at 3 months was greater in infants 
receiving the RE formula, indicating some attempt to ‘up regulate’ intake, consistent 
with previous studies (28;30). However, their fat intakes were still significantly lower 
than those of the standard formula group, whilst their protein intakes per kg body weight 
were higher. This finding corresponded with the difference in body composition at 3 
months. No differences were detected in energy expenditure between the two groups at 
the age of 3 months.
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Cohort B: Study o f energy metabolism in infancy
50 healthy full-term infants (25 breast-fed and 25 formula-fed) were recruited from the 
Maternity Hospital in Cambridge in 1992-1993 for a comprehensive study of energy 
metabolism in infancy. Anthropometry, doubly-labelled water study and indirect 
calorimetry were performed at 3 months of age and part of the cohort was followed up at
2-3.5 years.
Results
The detailed description and results from this cohort are published elsewhere (118; 148- 
153). Briefly, there were no significant differences in anthropometry (weight, length,
SF) and body composition (FM and FFM) between breast-fed and formula-fed infants in 
this cohort, although FFM was slightly greater in the formula-fed group. Sleeping 
metabolic rate was higher in the formula-fed group, which was accounted for by the 
difference in body composition (149). The researchers found no relationship between 
energy expenditure and energy intake at 3 months and fatness at 2-3.5 years (152). 
However, infant fatness at 3 months of age influenced both later fatness and activity 
pattern at 2-3.5 years (118).
Cohort C: Infant feeding study
52 healthy full-term infants (21 breast-fed and 31 formula-fed) were recruited from the 
Maternity Hospital in Cambridge in 1985-1987 for a study of energy requirements and 
expenditure in healthy term infants. Anthropometry was performed at 5 and 11 weeks, 6 
and 9 months and at 2 years of age. Total energy expenditure and body composition was 
measured at 1.5, 3 and 6 months of age using doubly-labelled water technique. Part of 
this cohort was followed up at 2-3.5 years of age.
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Results
The detailed description and results from this cohort are published elsewhere (154-158). 
Briefly, the researchers presented the centiles for total energy expenditure in early 
infancy and suggested the most appropriate method of expressing energy expenditure 
relative to body weight (expressed as KJ/square root of body weight)(154;155). In terms 
of infant body composition, the researchers showed that BMI (weight/height2) and SF 
were poorly predictive of body fatness in young infants (156; 157). Moreover, the 
follow-up study at 2-3.5 years of age showed no relationship between the level of energy 
expenditure at age 12 weeks and later indices of body fatness (by BMI, SF, and FM 
from stable isotope measurements)(158).
These 3 cohorts provide the opportunity to test the hypothesis (I), concerning the 
programming of body composition by early growth, and hypothesis (II), concerning the 
relationship between body composition in infancy and later outcomes, in normally- 
grown term infants with prospective early growth and body composition measurements. 
They also provide the opportunity to investigate the relationship between different 
feeding modes (breast vs. formula or different infant formulas) in early infancy and later 
body composition and cardiovascular risk factors (hypothesis II).
3.2.2 Retrospective study of infant growth data (Cohort D)
Healthy term-born children aged 4-19 years were recruited for a body composition 
reference study using the 4 component model of body composition, at the same study 
centre. The subjects were eligible for the study if they were bom full-term and had no 
condition that might affect growth and body composition. This study started in February 
2002 and data collection is ongoing. The aim was to recmit a minimum of 320 healthy 
children and adolescents to form a reference for body composition data. Initially, 
recmitment was done through advertisements in schools and sport clubs and by word of 
mouth, followed by advertisement on the intranet within the Institute of Child Health, 
University College London, and Great Ormond Street Hospital. From March 2005,
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recruitment was also via local newspapers. The studied population were based in Greater 
London and Cambridgeshire (some of the baseline characteristics are shown in Table 
3-1).
Collection of the retrospective growth records was started in March 2004. Birthweight 
and early growth data were collected by parental recall and from parent-held baby record 
books. The families were asked to bring their child’s baby record book on the study day. 
Subjects who took part in the study before this time (85 subjects) were contacted and 
asked for a copy of growth records to be sent by post. Overall, around 58 % of subjects 
provided baby record books that could be analysed. This cohort provides the opportunity 
to test hypothesis (I), concerning the relationship between early growth and later body 
composition in healthy children at different ages.
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Table 3-1 Characteristics of subjects from cohort D++
Boys (n=125) Girls (n=131) P
A ge (y) 11.1 ± 3 .9 11.0 ±  3.8 0.9
Birthweight (kg) 3.57 ± 0 .5 3 3.42 ± 0 .5 2 0,03
Gestation (wk) 40.1 ±  1.3 40.0  ±  1.5 0.6
Birthweight SDS -0.02 ± 1.06 0.04 ± 1.06 0.7
Height (cm) 145.2 ± 2 2 .5 142.9 ±  18.6 0.4
Height SDS 0.22 ±  0.96 0.22 ±  0.96 1.0
BMI (kg/m2) 18.6 ± 4 .2 19.0 ± 3 .5 0.4
BMI SDS 0.28 ±  1.28 0.37 ± 1 .1 5 0.6
Maternal BMI (kg/m2) 25.1 ± 4 .8 24.6 ±  4.9 0.5
Paternal BMI (kg/m2) 26.5 ± 3 .8 25.4 ± 3 .6 0.02
Pubertal status (n, %) 
Prepubertal 
Early pubertal 
Late pubertal
65, 52.8%  
30, 24.4%  
28, 22.8%
69, 52.7%  
27, 20.6%  
35, 26.7%
0.7
Social class (n, %) 
Class 1 
Class 2 
Class 3
Class 4 or more
29, 23.8%  
54, 44.3%  
7, 5.7% 
32, 26.2%
26, 19.8% 
61,46.6%  
14, 10.7% 
30, 22.9%
0.4
Ethnicity (n, %) 
White
African-Caribbean
Asian
Chinese
Other
89, 72.4%  
29, 23.6%  
3, 2.4%  
1,0.8%  
1,0.8%
92, 70.8%  
27, 20.7%  
3, 2.3%  
3, 2.3%  
5, 3.8%
0.7
++ Continuous variables were expressed as mean ± SD. Independent sample t-test was used to test 
differences between genders. Categorical variables were expressed as n (%). Chi-square test was used to 
test differences between genders.
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3.3 Outcome measures
3.3.1 Primary outcome: Body composition measurements
Detailed body composition measurements in children and adolescents are important for 
two main reasons. Firstly, they enable more specific testing of the programming of body 
composition, using measured components rather than proxies of fatness such as BMI or 
SF. Secondly, although it is widely accepted that BMI in adults predicts cardiovascular 
health risks (89; 126; 127), in children and adolescents there is less available evidence 
relating BMI, or indeed other measures of body composition to clinical outcome. Hence, 
one important aspect of research using body composition measurements in children and 
adolescents might be to help identify which elements of body composition are most 
related to obesity-related health risk (e.g. whilst most interest is focused on FM, it is also 
interesting to determine whether FFM shows any association with cardiovascular risk 
factors). It would also be possible to determine if body composition measurements 
obtained from the ‘gold standard’ method (four-component model) are better predictors 
of the risk of cardiovascular disease than simple methods such as BMI, WC or SF which 
would have practical implications for research and clinical practice.
The next section is a brief explanation of the body composition measurement procedures 
used, which are standardized in all of the populations previously mentioned.
3.3.1.1 The four-component model
The four-component model of body composition (4C model) divides the body into fat, 
water, protein, and mineral (see Figure 3-1). As described in Chapter 2, it minimises 
the assumptions made in the 2C model by directly evaluating several presumed constant 
relations (e.g. hydration, density, and BMC of FFM) that is fundamental to the 2C 
model. It has been accepted to be the most robust technique to detect inter-individual
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variability in the composition of FFM, as well as showing consistent accuracy across a 
range of body fat (159).
Figure 3-1 Picture illustration of 2-component and 4-component models of body 
composition measurement
The minimal assumptions for density of fat, water, protein, and mineral are used to 
calculate FM from the basic measurements.
FM (kg) = 2.747BV-0.710TBW+1.460BMC-2.050BW
BV = actual body volume in litres (from Air-displacement plethysmography)
TBW = total body water in litres (from Deuterium dilution)
BMC = total body bone mineral content in kg (from DXA)
BW = body weight in kg
This calculation is based on the equation of Keys and Brozek (161) and is described in 
detail elsewhere (58;66). In order to calculate the 4C model, measurements were 
obtained using the following methods:
#
From Brozek et al (160): density o f  body fat = 0.9007 kg/1, density o f water at 36°C = 0.99371 kg/1, 
density o f  protein = 1.34 kg/1, density o f  total body mineral =  3.0375 kg/1 (assumed constant ratio 
(0.8191:0.1809) o f  osseous to non-osseous mineral)
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A. A ir displacem ent plethysmography
Whole body air displacement plethysmography was performed using the Bodpod body 
composition system (Life measurement Instruments, Concord, California, USA), with 
the subject wearing a tight fitting swimming costume and a swimming cap (see Figure 
3-2).
Figure 3-2 Air displacement plethysmography (Bodpod) body composition
##system
R eference
cham ber
Electronics
Lung Volume 
Measurement
Scale
Photograph presented with consent from the subject and parents
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The procedure (61) involved a volume calibration with and without a 50 litre metal 
cylinder. The subject entered the Bodpod and sat inside the anterior chamber (450 litres), 
which was connected to a rear measuring chamber (300 litres) via oscillation 
diaphragms (used to induce pressure change in anterior chamber), and breathed normally 
(relaxed tidal breathing). The recommended procedure, consisting of two measurements 
of body volume (50 seconds each), was adopted and when, occasionally, body volume 
differed by more than 150 ml, the system required that a third measurement be 
performed. To improve precision, the procedure was repeated until 2 values for raw 
density of within 0.007 kg/L were obtained (162).
The principle is to measure the volume of air in the anterior chamber, using pressure 
changes induced by the oscillating diaphragm according to Boyle’s laws of the relations 
between the volume, pressure and temperature of gases (see Figure 3-2). The machine 
provides raw body volume (in litres) for each subject, from the difference between the 
volumes of air in this chamber, with and without the subject present. Actual body 
volume can be obtained after correction for the thoracic gas volume and surface area 
artefact by using appropriate prediction equations for children from age, sex, weight, and 
height (61; 163). This fairly new method has been shown to be more acceptable than 
hydrodensitometry in children, and to have better precision (61; 164).
B. Deuterium dilution
TBW was determined by deuterium oxide (D2 O) dilution with a dose equivalent to 0.05 
gm of D2 O (99.9%) per kg body weight. Doses were made up with water to around 100 
mL for young children and to 150 mL for older children and adolescents. Saliva samples 
were obtained pre-dose and 4-hours post-dose using an absorbent salivette (Sarstedt, 
Rommelsdorf, Germany) at least 30 minutes after the last food or drink. The samples 
were frozen at -30°C and then analyzed in duplicate by I so-Analytical Ltd (Sandbach, 
UK) using the equilibration method (165) and continuous-flow isotope ratio mass 
spectrometry (Geo20-20; Europa Scientific, Crewe, UK). The accuracy of the analyses 
was checked by measuring an intermediate water standard within each batch of samples. 
The coefficient of variation of deuterium analyses by this technique in the laboratory is
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< 2.5%. For calculating TBW, it was assumed that the D20  dilution space overestimates 
TBW by a factor of 1.044 (63;64). Correction was made for dilution of the dose by 
water intake during the 4-hour equilibration period (166).
C. Dual-energy X-ray absorptiometry (DXA)
Bone mineral content (BMC), FM and lean soft tissue mass was determined using a GE 
Lunar Prodigy whole-body scanner (GE Medical Systems, Madison, Wisconsin, USA) 
in conjunction with Encore 2002 software. All DXA scan and analyses, including the 
manual ROI, were performed by a single operator. The instrument automatically alters 
scan depth depending on the thickness of the subject, as estimated from age, height, and 
weight. A whole body scan was performed while the subject was wearing light indoor 
clothing and no metal objects. The typical scan duration was 5-10 minutes, depending on 
the subject’s height. The radiation exposure per whole body scan is estimated to be 2.2 
pSv, which is lower than the daily background radiation in the UK (around 7pSv). The 
coefficient of variation (CV, %) for a Lunar DPX-L instrument (regarded by the 
manufacturers to be similar to the Lunar Prodigy) has been reported as 1.10, 2.0, 1.11 % 
for total body BMC, FM, and lean mass, respectively(167). Regional measurements 
(arm, leg, and trunk) were less precise than total body measurements, with CVs in the 
range of 1% to 3%.
Due to its limitations in measuring soft tissue composition (59; 168; 169) as mentioned 
previously, only total body BMC was used in the analysis (as a part of the 4-component 
model). However, for regional body composition, DXA is still a practical tool when 
compared to gold standards such as MRI and CT which are more complicated, 
expensive, and, in the case of CT, involve more radiation exposure. Therefore, in this 
dissertation, DXA-derived trunk and limb composition were also used in some analyses. 
In addition, abdominal FM by manual ROI between L1-L4 was analyzed. A validation 
study in adults showed good agreement between this method and CT for abdominal total 
tissue mass and FM (142). Examples of a DXA scan and the manual ROI L1-L4 are 
shown in Figure 3-3.
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Figure 3-3 Examples of DXA scans
a) Whole body scan
b) Manual region of interest L1-L4
m : v  -
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3,3,1,2 Anthropometry
Body weight was measured as an integral part of the Bodpod procedure to within 0.01 
kg. Accuracy was confirmed by the use of 2 solid weights of known mass. Height was 
measured to the nearest 0.1 cm with a wall-mounted stadiometer (Holtain, Dyfed, United 
Kingdom). SF was measured at the biceps, triceps, subscapular, and suprailiac sites with 
Holtain callipers in triplicate, and the average of the 3 measurements was used. All 
measurements were done on the left hand side of the body, with the subject standing. 
Waist circumference was measured at the natural waist site (170) with a non-stretchable 
fibre glass insertion tape, to the nearest 0.1 cm.
3.3.2 Secondary outcomes
Cardiovascular risk markers were assessed in cohorts A, B, and C only.
33,2,1 Lipid and insulin profiles
A blood sample was obtained after overnight fasting for plasma glucose, insulin (total, 
proinsulin and 32-33 split proinsulin), total cholesterol, high density lipoprotein 
cholesterol (HDL-C), and triglycerides. Venepuncture was performed at an antecubital 
vein after local anaesthetic cream was applied. Blood was kept cool, separated within 40 
minutes (to prevent proteolytic degradation of the insulin peptide) and plasma stored at - 
80°c prior to analysis. Plasma glucose, total cholesterol, HDL-C and triglycerides were 
measured using standard enzymatic method at the Biochemical and Nutrition 
Department, Institute of Child Health (London, UK). Plasma insulin, intact proinsulin 
and 32-33 split proinsulin were analysed by using the monoclonal antibody-based two- 
site immunoradiometric assay method (171) at the Department of Clinical Biochemistry,
Addenbrooke’s Hospital (Cambridge, UK). Low density lipoprotein cholesterol (LDL-
#
C) was calculated using Friedewald’s formula (172). HOMA (Homeostasis model
LDL-C = total cholesterol -  HDL-C -  0.456x Triglycerides (mmol/L)
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assessment) was calculated by the HOMA Calculator ®The University of Oxford 2004 
(173; 174) from fasting glucose and insulin.
Surrogate markers of insulin resistance, rather than a direct measure (the glucose clamp 
(175)), were used because of technical difficulties of the latter method in children. The 
HOMA index has been reported to be strongly correlated with the glucose clamp, and 
proposed to be suitable for assessing insulin sensitivity in situations where only a fasting 
blood sample is available (176). Proinsulin and split-proinsulin have been shown to be 
strongly related to the development of insulin resistance, and the latter has been reported 
to predict progression to type II diabetes more strongly than total insulin concentrations 
(177).
33.2.2 Blood pressure
Systolic, diastolic and mean arterial pressure were recorded in triplicate using an 
automated oscillometric device with appropriate cuff size (Accutorr, Datascope Corp., 
New Jersey, USA) (178). The subject rested on a couch for at least 15 minute before the 
measurement was made.
3.3.3 Assessment of confounders
Questionnaires (Appendix B) were used to determine socioeconomic status, previous 
medical history, physical activity, family history of cardiovascular disease, and parental 
body size. Pubertal stage, which has a significant effect on body composition, was 
evaluated using a pubertal status self assessment form (line drawings of the different 
Tanner pubertal stages with written explanation) for subjects to complete by themselves 
in private and return in a sealed envelope to avoid the need for undressing. This method 
has been shown to have a good agreement with physician’s assessment (179). Social 
class was assessed using the Standard Occupational Classification (180), according to 
primary earner of the family (either mother or father or both). For older subjects, social
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class was still based on parents’ occupation since it provides information on family 
background and environment they were brought up. A simple assessment of subjects’ 
physical activity level was made by asking parents to rate their child (or asking young 
adults to rate themselves) compared with his or her peers on a 5-point scale ranging from 
“much less active” to “much more active”. This simple method has been shown to 
correlate well with physical fitness and BMI in children (181).
3.4 Statistical methods
3.4.1 Sample size
In published studies, birthweight explained between 2.7% (182) and 5.4% (79) of the 
variance in BMI and FFM; therefore, to test hypothesis I, I estimated that the sample 
size required to detect a similar correlation (r=0.16-0.23) would be 143-300 subjects (at
5% significance with 80% power (183)). For early infancy growth, the results from a
similar study showed that weight gain from birth to 3 months explained around 4.9% of 
the variance in BMI SDS at age 19 years (182); therefore, I estimated that the sample 
size required to detect a similar correlation (r=0.22) would be around 157 subjects.
There were no published studies from which to calculate sample size for the relationship 
between infant BC and adolescent BC (hypothesis II). The study by Wells et al (118) 
showed that the correlation between infant FM at 3 months and childhood FM at 3 years 
(n=30) was around 0.55 (p 0.006); however, I appreciate that the correlation at follow-up 
10 years later during adolescence could be much weaker and require a bigger sample 
size. For example, if half of the original cohort who completed the isotope study at 3
#
From Cole TJ (183) n =  (Z ,.a/2+ Z ,.p)2 + 5
d2/( l-d 2)
when d=correlation, (Z j.^  + Zj_p)2 = 7.85 for a = 0.05 and 1-P = 0.8
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months (n=75) agreed to take part, I would be able to detect a correlation of around 0.31 
with 80% power and 5% significance.
For the comparison between groups in the randomised trial of different energy formulas,
40 subjects per randomised group would allow detection of 0.63 SD difference in body
$composition outcomes (80% power, 5% significance) . It was recognized that there
might be a limitation of the sample size since the follow-up study took place around 12 
years after the last contact had been made with these families, and a significant loss to 
follow-up might therefore be anticipated. However, the main reason for following up 
this cohort in my thesis was not to examine the effect of early diet but to combine the 
subjects with those from cohort B and C to examine the effects of infant growth and 
body composition.
Combining the 3 infant cohorts (A, B, and C), the number of potential research 
participants was 199 (excluding 10 early drop-outs from cohort A), which was 
considered a reasonable number for a follow-up study to look at the association between 
early growth (hypothesis I) and infant body composition (hypothesis II) in relation to 
later outcomes. Moreover, these cohorts are unique in that they all had detailed 
anthropometric measurements at different periods in infancy, and 150 of them also 
completed the body composition measurement using stable isotopes at 3 months. In fact, 
it is inevitable that in a study with such detailed measurements of infant body 
composition the sample size cannot be comparable with a study using only weight or 
length as a proxy of growth. A further consideration here is that the primary outcome 
measure for the follow-up study is body composition using the 4C model which also 
cannot be achieved in a very large population. These issues are discussed further in the 
relevant chapters and in the general discussion (Chapter 9).
$
From van Belle (184) n = 16 for a = 0.05 and 1-P = 0.8, 
sd2
when sd = standardized difference (the difference to be detected in the unit o f  standard deviation)
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Since a relatively large (although unknown) loss to follow-up was expected from cohorts 
A, B, and C, and the sample size from these 3 cohorts alone might not be sufficient to 
test hypothesis I, retrospective growth data were collected from cohort D at the same 
time as the follow-up study.
3.4.2 General
Standard deviation scores (SDS) were derived for weight, height, and BMI using the 
1990 British reference (185; 186) and calculated by the lmsGrowth program© (Copyright 
2002-2005, Medical Research Council, UK). Triceps, and subscapular SF SDS were 
derived using Tanner-Whitehouse reference data and calculated manually using age and 
sex-specific L, M, and S values (187). Waist circumference was converted to SDS using 
a nationally representative sample of UK children in 1988 (170) and calculated by the 
lmsGrowth program© (Copyright 2002-2005, Medical Research Council, UK). One 
sample t-test was used to compare the SDS of the study population with reference data.
To describe the characteristics of study subjects, continuous variables were compared 
between genders using independent sample t-test. Categorical variables were compared 
using Chi-square or Fisher’s exact test as appropriate.
To test the association between birthweight, early growth, and early body composition 
and later outcomes (Chapter 4, Chapter 5, and Chapter 7), multiple linear regression 
analysis was used to adjust for potential confounders (pubertal staging, physical activity, 
socioeconomic status, ethnicity, and parental size). Continuous variables which were not 
normally distributed were transformed to natural logarithms and the data were 
interpreted in the form of sympercents described in details by Cole et al (188).
“A difference of natural logs corresponds to a fractional difference on the 
original scale. The agreement is exact if the fractional difference is based on the 
logarithmic mean. The transform y = 100 log(e)x leads to differences, standard 
deviations and regression coefficients of y that are equivalent to symmetric 
percentage differences, standard deviations and regression coefficients of x. The
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100 log(e) scale is the natural scale on which to express percentage differences.
The term sympercent or s% is proposed for them.”
Specific details of the analyses are given in the relevant results chapters. General linear 
model (GLM) was use to test the interaction between gender and birthweight or early 
growth in predicting later body composition. Partial correlation was used to 1) test the 
relationship between different confounders and body composition outcomes (Chapter 
4), and 2) compare the correlation between different body composition variables and 
cardiovascular risk factors (Chapter 6). Continuous variables which were not normally 
distributed were transformed to natural logarithms. To test the mean difference between 
diet groups (Chapter 8), one way ANOVA and GLM were used where appropriate.
All statistical analyses were performed using SPSS version 13 (SPSS Inc, Chicago, 
USA).
3.4.3 Expression of body composition data
Since paediatric populations vary in body size much more than adult populations, 
meaningful interpretation of body composition data depends greatly on size adjustment. 
In this dissertation, body composition data (e.g. FM, FFM, trunk FM) were adjusted for 
body size using height or height2 (189;190). Alternative adjustments by weight or BMI 
are discussed in Chapter 4.
Due to the wide age range of the subjects, internal SDS for body composition variables 
(FMI, FFMI, trunk FMI) were calculated using the LMS method (191) by 
lmsChartMaker program© (Copyright 1997-2005, Medical Research Council, UK). A 
detailed description and discussion is included in Chapter 5 and curve fits for each 
variable are shown in Appendix C.
Different indices for central fat distribution (e.g. waist circumference, triceps and 
subscapular SF, trunk FM, abdominal FM) were used in the analyses for the purpose of
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comparison since the gold standard for visceral fat measurement (MRI) was not 
available. The magnitude of association between different body composition variables 
and cardiovascular risk factors is analyzed and discussed in Chapter 6.
3.4.4 Longitudinal growth data
I considered several options for analyzing longitudinal growth data, with statistician 
input. Multiple linear regression analysis of body composition outcomes on change in 
weight SDS during different periods in infancy was adopted (Cole TJ, personal 
communication). Because the early growth measurements in the retrospective study 
(Cohort D) were not all made at standardised ages, imputation of the missing data points 
was also considered. Specific details are discussed in Chapter 5.
3.5 Ethical and practical considerations for cohorts A, B, C
The protocol was approved by Research Ethic Committee at the Institute of Child 
Health. Informed consents and assents were obtained from parents and study subjects 
accordingly before the study. The important ethical and practical issues are highlighted 
below. Examples of the information sheets and consent forms are shown in Appendix
D.
3.5.1 Recruitment
The procedure was as follows:
a) Research participants were identified using existing information from the original 
study (addresses and GP names from that time were kept by the research team). The 
parents of subjects who participated in the study expected to be contacted for further 
follow-up after the trial finished, although written consent for this was not obtained (this
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was not standard practice at the time); if any parent requested that they were not 
contacted again, this was recorded at the time.
b) Parent and subject information sheets were sent to the subject’s l#st known address. If 
this was unsuccessful, the family was traced via the GP. If the potential research 
participants had moved, the GP (or new GP if appropriate) was asked to forward an 
information sheet to the new address.
c) Subjects and parents who wished to participate or find out more ^bout the study were 
invited to return a reply slip to me. I then telephoned them to discuss the project, and, if 
they wished to participate, I arranged an appointment. All consenting participants who 
were clinically well at the time of the study were recruited.
3.5.2 Informed consent
Both written consent and assent from the subject and his/her parents was obtained on the 
day of the study visit after I had explained the procedures, shown all the equipments to 
the subjects and their parents, and answered any question. Separate Written consent was 
obtained from the parent (or subject if over 16 years) for the blood test, before taking the 
blood sample and after the subject and their parents had been informed of how the 
samples were to be used and stored.
3.5.3 Data protection
All procedures and data storage were compliant with the Data Protection Act.
Individuals were identified on computer databases by their code number; this was also 
used on blood and saliva samples. The papers files containing data were kept in a 
locked cabinet at the Childhood Nutrition Research Centre with the personal information 
section kept separately. Computerised data were kept password protected on my 
computer at the Childhood Nutrition Research Centre. Master copies of computer data
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files will be kept locked in the fire-proof safe within the department for at least the next 
15 years.
3.5.4 Overview of the study day at the MRC Childhood Nutrition 
Research Centre (half-day visit)
The study took place at Great Ormond Street Hospital and the Childhood Nutrition 
Research Centre, Institute of Child Health, London, UK. The subject was asked to arrive 
at 9am, having fasted overnight. Informed consent was obtained as described above. 
Breakfast was provided after the blood test had been performed and further refreshments 
throughout the day as required.
The following investigations were performed:
1. A blood sample was taken for plasma insulin and lipid profiles. Local anaesthetic 
cream was used to minimize discomfort.
2. Blood pressure was measured using an automated device while the subject was resting 
on a couch for at least 15 minutes.
3. Body composition was measured in the Radiology Department in Great Ormond 
Street Hospital as follows:
a) TBW was measured by deuterium kinetics. The subject was asked to drink some 
water containing a known amount of deuterium. A saliva sample was collected before 
(early on the study day) and 4 hours after dosing (before the study day finished) using a 
chewable cotton swab after the subject had cleared their mouth 30 minutes before the 
sample collection. The volume of drinks consumed between the two saliva samples was 
recorded.
b) DXA was used to measure whole-body bone mineral mass.
c) Air-displacement plethysmography (Bodpod) was used to measure body volume
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4. Anthropometric measurements were performed.
5. Questionnaires were used to determine general health, life style, physical activity, 
socioeconomic status of the family and pubertal status (the latter was self-rated in 
private using line drawings of the different Tanner stages and given back in a sealed 
envelope).
The study took approximately 4 hours on the day of the visit to London (a single 
occasion). Travelling expenses were reimbursed for both subjects and parents to come 
from Cambridge to London. The subject was given a £10 gift token after completing the 
study day as a thank you for their time, together with picture of their skeleton (from 
whole body DXA).
Subjects will, in due course, receive a description of the results in lay terms, and they 
can also contact me by telephone to discuss particular research results. In the event of an 
abnormal test result (such as lipid profiles, blood pressure, bone density), both the 
family and GP was informed so that further investigation could be arranged if necessary.
3.5.5 Recruitment and follow-up rates for cohorts A, B, and C
The research proposal was written and the research ethics committee application 
submitted in March 2004. After minor changes to the protocol and information sheets, 
the research project was approved in May 2004. Information sheets and invitation letters 
were sent out to Cohort A in June 2004 and the study started in August 2004. The 
follow-up rate from Cohort A (subjects were around 12-14 years of age) was about 30%. 
This was possibly due to the requirement to travel to the study centre in London, and the 
long time period between the original study and the follow-up. I considered several 
possible ways of improving the follow-up rate: 1) sending a second invitation letter, in 
case the first letter did not get through to the potential participants and their parents; 2) 
instead of asking the GP to forward the information sheet and invitation letter to
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potential research participants who had moved from the last known address, I obtained 
permission from the Research Ethics Committee to access their new address and send 
the invitation to them directly; 3) I offered a home visit in Cambridge for some parts of 
body composition measurements, if the subject was unwilling to travel to London 
(deuterium dilution and anthropometry—the home visit protocol is shown below).
Cohorts C and B were sent the information sheets and invitation letters (which offered a 
home visit if they could or would not travel to the study centre in London) in February 
and September 2005, respectively.
3.5.6 Overview of the home visit
The study took place at the subject’s home in the Cambridge area. Informed consent was 
obtained as described above. The following investigations were performed:
1. Blood pressure was measured using an automated device while the subject was resting 
on a couch for at least 15 minutes.
2. TBW was measured by deuterium kinetics with the same standard procedures as the 
centre visit. Both saliva samples and the sheet record the amount of drinks were posted 
back to the researcher by prepaid envelope.
3. Anthropometric measurements were performed with the same standard procedures as 
the centre visit. Height was measured by a portable stadiometer.
4. The same questionnaires were used to determine general health, life style, physical 
activity, socioeconomic status of the family and pubertal status.
The follow-up study finished in May 2006. In total, 54 subjects out of 199 potential 
participants agreed to come to the study centre in London and completed all the
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measurements. 5 subjects agreed to take part in the study by home visit only (see Figure
3-4). Therefore, the overall follow-up rate was around 30%, which is comparable to 
other similar cohorts that have been followed-up at the same centre over the past two 
years.
Figure 3-4 Recruitment and follow-up rate of the prospective cohorts#
Cohort A 
53 RE, 54 TF
Cohort B 
25 B, 25 F
Cohort C 
21 B ,31 F
97 invitations*
▼
31 YES 
15 NO
15 untraceable 
36 no response**
50 invitations 
1
17 YES 
6 NO
5 untraceable 
22 no response**
52 invitations 
▼
11 YES 
8 NO
6 untraceable 
27 no response
J I I
28 came to the centre 15 came to the centre 11 came to the centre
3 home visits 2 home visits
(15 RE, 16 TF) (10 B, 7 F) (7 B, 4 F)
3.6 Key study design features
Since there were a substantive number of subjects who were not successfully followed- 
up in cohorts A, B, and C, comparison of baseline characteristics of these cohorts for 
those seen or not seen is presented here (Table 3-2a, b, c). For cohort A, those who 
agreed to come for the follow-up study were lighter at birth (mean difference 0.15 kg; 
95%CI 0.01-0.29) and had lower FMI at the age of 12 weeks (mean difference 0.84
RE = reduced energy formula, TF = standard term formula, B = breast-fed, F = formula-fed
*
5 early drop-out (before 3 wks visit) in each group
* *
at least 3 letters were sent to the last known address
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kg/m2; 95%CI 0.16-1.52). For cohort B and C, there was no significant difference in 
baseline characteristics between the subjects who were followed-up and those were not. 
When all three cohorts were analysed together, there was no statistically significant 
difference in any of these baseline characteristics between those who were successfully 
followed-up and those who were not (data not shown).
Table 3-2 Comparison of baseline characteristics between the subjects who were 
and were not followed-up.++
a) Cohort A _____________________________
Follow-up
(n=31)
Lost to follow-up 
(n= 66)
P
Boys (n, %) 11,35.5% 39,51.3% 0.2
First-born (n, %)# 11,37.9% 20, 29.0% 0.5
Reduced energy formula (n, %) 15,48.4% 38, 50% 1.0
#
Mothers with A level/higher qualification (n, %) 3, 18.8% 7, 19.4% 1.0
Maternal BMI (kg/m2) 24.3 ± 4 .1 24.5 ± 5 .5 0.9
Paternal BMI (kg/m2) 24.7 ± 3 .0 24.6 ± 3 .2 0.9
Birthweight (kg) 3.42 ± 0 .3 3 3.57 ± 0 .3 2 0.03
Gestation (wk) 40.1 ±  1.3 40.0 ±  1.3 0.7
Birthweight SDS -0.11 ± 0 .5 8 0.22 ± 0 .6 8 0.02
*
FMI at 12 weeks (kg/m2) 3.4 ±  1.1 4.3 ±  1.2 0.02
FFMI at 12 weeks (kg/m2)* 12.0 ±  1.1 12.0 ± 1.1 1.0
++ Continuous variables were expressed as mean ±  SD. Independent sample t-test was used to test 
differences between those who were and were not followed-up. Categorical variables were expressed as n 
(%). Chi-square test was used to test differences between the two groups.
#
parity data was m issing in 9 subjects, maternal education was missing in 55 subjects
*
n=16 for follow-up and 42 for lost to follow-up subjects
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b) Cohort B
Follow-up
(n=17)
Loss follow-up 
(n= 33)
P
Boys (n, %) 8, 47.1% 15,45.5% 0.6
First-born (n, %) 9, 52.9% 15,45.5% 0.8
Breast-fed (n, %) 10, 58.8% 15,45.5% 0.6
Social class 1 or 2 (n, %) 8,47.1% 23, 69.7% 0.14
Maternal BMI (kg/m2) 23.1 ± 3 .7 23.1 ± 3 .1 0.9
Paternal BMI (kg/m2) 24.6 ± 4 .1 24.3 ± 3 .5 0.8
Birthweight (kg) 3.54 ± 0 .3 5 3.55 ± 0 .3 7 1.0
Gestation (wk) 40.1 ±  1.5 40.2 ±  1.2 0.9
Birthweight SDS 0.04 ± 0.34 0.04 ± 0.56 1.0
FMI at 12 weeks (kg/m ) 4.0 ± 1.5 4.1 ±  1.2 0.7
FFMI at 12 weeks (kg/m2)** 12.1 ±  1.0 11.8 ±  0.9 0.3
c) Cohort C
Follow-up
(n = ll)
Loss follow-up 
(n= 41)
P
Boys (n, %) 4, 36.4% 18, 43.9% 0.7
First-born (n, %) 5, 45.5% 16, 39.0% 0.7
Breast-fed (n, %) 7, 63.6% 14, 34.1% 0.10
Social class 1 or 2 (n, %) 5, 45.5% 24, 58.5% 0.5
Birthweight (kg) 3.48 ± 0 .3 0 3.40 ± 0 .4 8 0.6
Gestation (wk) 40.5 ± 0 .9 39.7 ±  1.4 0.09
Birthweight SDS -0.13 ±  0.86 0.01 ± 0.97 0.7
FMI at 12 weeks (kg/m2) 3.5 ± 1.4 3.7 ± 0 .9 0.5
FFMI at 12 weeks (kg/m2)*** 12.8 ± 1.4 12.9 ±  1.1 0.8
* *
n=15 for follow-up and 27 for loss follow-up subjects 
n=10 for follow-up and 40 for loss follow-up subjects
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Comparison of the key design features for all 4 cohorts are summarised in Table 3-3. 
Selected baseline and BC outcomes of the 4 cohorts are shown in Table 3-4. There were 
no significant differences between birthweight and gestation between the 4 cohorts. 
Infant FMI and FFMI did not differ among those followed-up in cohorts A, B, and C. 
There were no significant differences in the SDS of BC outcomes between cohorts. 
Therefore, in the subsequent chapters, all relevant cohorts were pooled together for the 
analyses of the association between early growth or BC and later outcomes.
The next 5 chapters contain the results of my study; each provides a short introduction 
and description of methods specific to the chapter, followed by the main analyses and 
discussion. A general discussion on the programming of body composition and the 
broader implication of my findings is then presented in Chapter 9.
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Table 3-3 Key design features of the 4 cohorts.
Cohort A Cohort B Cohort C
Rationale for setting up original study Randomised controlled trial 
o f  reduced energy and 
standard term formulas 
(details in Appendix A )
To study energy m etabolism  
o f  breast-fed and formula-fed 
infants
To study energy rec 
o f  breast-fed and fo  
infants
Source of cohort Cambridge, all Caucasian Cambridge, all Caucasian Cambridge, all Cau
Eligibility criteria Full-term, healthy, 
birthweight between 10th and 
90th centile.
Full-term, healthy, breast-fed 
or formula-fed until 12 w eeks 
old.
Full-term, healthy, 
or formula-fed unti 
old.
Period of original study 1990-1992 1992-1993 1985-1987
Time period of current BC 
measurements at the study centre
August 2004-February 2005 October 2005-April 2006 March 2005-N oven
Time period of home visit M ay 2006 M ay 2006 N /A
Time period of lipid and insulin essays May-June 2006 May-June 2006 May-June 2006
Source of growth data: 
Birthweight Hospital records Parental recall in infancy Parental recall in in
Post natal growth Collected prospectively from  
the original study
Collected prospectively from 
the original study
Collected prospecti 
the original study
Age at which prospective post natal 
growth data were available
3, 6, 12 weeks, 6 and 12 
months
12 w eeks only 6, 12 w eeks, 6, 12 r
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Table 3-4 Comparison of some baseline characteristics and BC outcomes among the subjects who w 
up in cohort A, B, C and the subjects who were from cohort D.
Cohort A (n=31) Cohort B (n=17) Cohort C (n = ll)
Mean ± SD range Mean ± SD range Mean ± SD range
Birthweight (kg) 3.42 ± 0.33 2 .8 7 - 4 .0 2 3.54 ± 0 .3 5 2 .8 9 - 4 .1 7 3.48 ± 0 .3 0 2 .9 0 - 3
Gestation (weeks) 40.1 ±  1.3 3 8 .0 - 4 2 .0 40.1 ± 1.5 3 8 .0 - 4 2 .0 40.5 ± 0.9 3 9 .0 - 4 .
Birthweight SDS -0.11 ± 0 .5 8 -1 .0 5 - 0 .9 8 0.04 ±  0.34 -0.57 -  0.56 -0.13 ± 0 .8 6 - 2 .1 4 - 0
Infant FMI (kg/m2) 3.4 ± 1 .1 1 .4 - 6 .0 3.9 ±  1.5 2 .3 - 7 .1 3.5 ±  1.4 1 . 6 - 6
Infant FFMI (kg/m2) 12.0 ± 1 .1 9 .5 - 1 3 .7 12.1 ±  1.0 1 1 .0 -  14.0 12.8 ±  1.4 11.4 -  1
Age at follow-up (yr) 13.2 ± 0 .8 1 2 .0 -  14.8 13.3 ± 0 .4 1 2 .7 -1 3 .9 19.6 ± 0 .6 1 8 .2 -2 1
Boys (n, %) 11,35.5% 8,47 .1% 4, 36.4%
Height (cm) 157.3 ± 7 .5 142.1 - 175 158.7 ± 6 .6 146.1 -  174.9 173.8 ± 9 .0 1 6 1 .5 - 1
BMI (kg/m2) 20 .0  ± 2 .9 1 4 .4 - 2 5 .0 19.6 ± 4 .4 1 4 .7 - 3 2 .9 23.1 ± 2 .9 1 8 .7 - 2
FMI (kg/m2) 5.5 ± 2 .3 1 .4 - 1 0 .8 4.6 ± 2 .7 1 .8 - 1 3 .5 6.7 ± 2 .8 2 .3 - 1 2
FFMI (kg/m2) 14.6 ±  1.2 1 2 .2 - 1 6 .9 15.0 ± 2 .2 1 2 .0 - 1 9 .9 16.4 ± 2 .1 6 1 3 .5 - 1
Height SDS 0.24 ±  0.93 - 1 .4 4 - 1 .8 3 0.28 ± 0 .8 1 - 1 .1 6 - 2 .2 8 0.82 ±  1.07 -0.35 -  2
BMI SDS 0.38 ±  1.07 - 2 .3 3 - 1 .9 8 0.03 ±  1.39 - 2 .0 1 - 3 .0 5 0.34  ±  1.08 - 1 .6 4 - 1
FMI SDS 0.19 ± 0 .8 3 - 1 .5 7 - 1 .7 6 -0.14 ± 0 .9 1 - 1 .1 7 - 2 .3 0 0.31 ± 0 .8 1 - 0 .8 9 - 1
FFMI SDS -0.02 ±  0.80 -1 .5 0 - 1 .5 5 -0.01 ±  1.38 - 2 .3 1 - 2 .7 3 -0 .30 ±  1.01 -1.61 -  1
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Chapter 4
The Influence of Birthweight 
on Later Body Composition
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Chapter 4 The Influence of Birthweight on Later 
Body Composition
4.1 Introduction
Studies of birthweight and later body composition to date suggest that birthweight 
might influence FFM rather than FM (see Chapter 2). Nevertheless, there has been 
no study using the 4- component model to test this hypothesis.
4.2 Methods
4.2.1 Subjects
All children who completed the four-component model and had birthweight data 
were included in this analysis. 52 children were from the prospective follow-up study 
(cohort A, B, C) and 256 children were from the body composition reference study 
(cohort D) (description in Chapter 3). All were full-term bom, singleton and did not 
have any disease that might affect growth or body composition.
4.2.2 Birthweight data
In cohorts A, B, and C, birthweight and gestation were documented from the hospital 
record. In cohort D, birthweight and gestational age data were collected from 
parental recall and verified with parent-held baby book where available (58.44%). 
There was no significant difference between parental recall and baby book record for 
birthweight (mean difference 0.004 kg; 95% Cl -0.008, 0.017). Birthweight SDS 
was calculated according to gestation and sex using the British 1990 reference.
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4.2.3 M easurement o f body composition
Body composition variables derived from the 4C model were used in this analysis 
together with the anthropometry data and regional DXA FM to assess central fat 
distribution. For more details see Chapter 3. In addition, total FM and FFM derived 
from 2C model (DXA and SF equations (57)) were used for the purpose of 
comparison with other published data.
4.2.4 Confounding variables
Factors that might confound the relationship between birthweight and body 
composition were assessed using the structured questionnaire as mentioned in 
Chapter 3 and Appendix B. Pubertal status was self-assessed using pictures of the 
Tanner stages (179) and recoded as prepubertal (stage 1), early pubertal (stage 2,3) 
and late pubertal (stage 4,5). A simple assessment of subjects’ physical activity level 
was made by a 5-point scale ranging from ‘much less active’, ‘less active’, ‘same as 
peers’, ‘more active’, and ‘much more active’. Social class was assessed using the 
Standard Occupational Classification (180) and classified as class 1 (high), 2, 3 and 
>4. Ethnicity was coded as white and non-white since in this dataset there were too 
few subjects for each of the other ethnicities to analyse separately. Reported parental 
height and weight was used in this analysis.
4.2.5 Statistical methods
Body size data were converted to SDS using the British 1990 reference where 
possible since relative body size i.e. BMI changes substantially with age. Multiple 
linear regression was used to assess associations between birthweight SDS and later 
body size and composition adjusting for age and potential confounders. This 
association was also explored after correction for variation in body size by adjusting 
for current height. Variables which were not normally distributed were Loge 
transformed to reduce skewness in distribution. In this case, the degree of association 
was interpreted as sympercents change in body composition variables per SDS 
change in birthweight (188).
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General linear models were used to test the interaction between gender or pubertal 
status and birthweight SDS in predicting later body composition.
4.3 Results
4.3.1 Characteristics o f study subjects
Descriptive statistics of the subjects (age range 4.22-20.36 years) are summarized in 
Table 4-1. Boys and girls in this analysis were heavier, taller, and had higher BMI 
than the British 1990 reference. Compared with reference data (in the form of SDS), 
both boys and girls had higher waist circumference and triceps SF while girls also 
had higher subscapular SF.
Not surprisingly, boys were heavier than girls at birth, but there was no difference in 
gestation and birthweight SDS which was comparable to the British 1990 reference. 
In general, boys had higher FFM and lower FM compared to girls; however, both 
sexes had the same BMC. Girls also had higher waist circumference and SF than 
boys even after difference between sexes were adjusted by SDS. In subgroup 
analysis (data not shown), this difference was significant only in late pubertal 
subjects. Since body composition was significantly different in boys and girls, and 
there was a significant interaction between birthweight and gender in predicting 
some of the body composition variables (see later), all the analyses were performed 
separately for boys and girls.
There was no difference in any o f the potential confounders (parental height, pubertal 
status, physical activity, social class, and ethnicity) between boys and girls except for 
higher paternal BMI in boys (mean difference 0.98 kg/m2; 95%CI 0.11, 1.84).
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Table 4-1 Characteristics of study subjects**
B oys (n=145) G irls (n=163) P
A ge (y) 11.5 ± 3.9 11.7 ±  3.9 0.65
Birthweight (kg) 3.55 ± 0 .5 1 3.43 ±  0.49 0.03
Gestation (wk) 40.1 ±  1.3 40 .0  ±  1.4 0.55
Birthweight SDS -0.06  ±  1.02 0.04 ±  0.99 0.38
H eight (cm ) 147.4 ± 2 2 .1 146.3 ± 18.4 0.65
W eight (kg) 42.8  ±  19.7 43 .4  ±  15.9 0.71
BM I (kg/m 2) 18.7 ± 4 .1 19.5 ±3.6 0.05
Height SDS 0.21 ± 0 .9 4 0.26  ± 0 .9 6 0.66
W eight SD S 0.31 ± 1.17 0.45 ±  1.08 0.29
BM I SDS 0.23 ± 1.29 0.40 ± 1.13 0.20
FM from 4C  (kg) 8.8 ± 7 .1 12.5 ± 7 .2 <0.001
FFM from  4C  (kg) 34.0  ±  15.2 31.0  ±  9.9 0.04
Trunk FM from D X A  (kg) 3.8 ± 4 .0 5.8 ± 4 .0 <0.001
D X A  lean soft tissue (kg) 32.5 ±  13.9 28.6  ± 8 .6 0.003
D X A  BM C (kg) 1.62 ± 0 .7 8 1.62 ± 0 .7 8 0.99
W aist circumference (cm) 65.5 ±  11.4 65.2 ± 9 .2 0.81
Triceps SF (mm) 10.8 ± 5 .0 15.3 ± 5 .1 <0.001
Subscapular SF (mm) 8.2 ± 5 .5 11.2 ± 6 .4 <0.001
WC SDS* 0.49 ± 1.06 0.95 ±  1.06 <0.001
Triceps SD S 0.20 ±  1.01 0.56 ± 0 .8 9 0.001
Subscapular SD S -0.02 ±  1.05 0.23 ±  1.01 0.04
Maternal height (cm ) 164.1 ± 6 .6 163.8 ± 6 .0 0.62
Paternal height (cm ) 178.3 ± 7 .3 178.9 ± 7 .6 0.51
Maternal BM I (kg/m 2) 25.1±4.6 25.0±5.2 0.82
Paternal BM I (kg/m 2) 26.6±3.8 25 .6± 3 .6 0.027
Pubertal status (n, %) 
Prepubertal 
Early pubertal 
Late pubertal
67 (46.2% ) 
39 (26.9% ) 
37 (25.5% )
70 (42.9% ) 
42 (25.8% ) 
51 (31.3% )
0.58
++ Continuous variables were expressed as mean ±  SD. Independent sam ple t-test was used to test 
differences betw een genders. Categorical variables were expressed as n (%). Chi-square test was used  
to test differences between genders.
#
n=130 in boys and 147 in girls since the database for w aist SDS was available only up to the age o f  
17
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Table 4-1 (cont.) Characteristics of study subjects
B oys (n=145) G irls (n=163) P
Physical activity (n, %)
M uch less or less active 
Same as peers 
More active than peers 
M uch more active than peers
13 (9%) 
60 (41.4% ) 
54 (37.2% ) 
15 (10.3% )
17 (10.4% ) 
76 (46.6% ) 
54 (33.1% ) 
12 (7.4% )
0.62
Social class (n, %) 
Class 1 
Class 2 
Class 3
Class 4 or more
33 (22.8% ) 
60 (41.4% ) 
12 (8.3%) 
37 (25.5% )
29 (17.8% ) 
74 (45.4% ) 
20 (12.3% ) 
40  (24.5% )
0.49
Ethnicity (n, %) 
W hite 
N on-w hite
109 (75.2% ) 
34 (23.4% )
124 (76.1% ) 
38 (23.3% )
0.95
Numbers o f  m issing data are as fo llow  (boys, girls): WC (2, 0), Triceps SF (4, 3), Subscapular SF 
(4, 2), Maternal height (2, 4), Paternal height (3, 5), Maternal BM I (6, 6), Paternal BM I (10, 11), 
Pubertal status (2, 0), Physical activity (3, 4), Social class (3, 0), Ethnicity (2, 1)
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4.3.2 Relationship o f potential confounding factors with birthweight 
and body composition
After controlling for age, the effect of potential confounders was assessed (Table 
4-2). Puberty showed a significant positive correlation with birthweight SDS in boys 
i.e. at the same age, boys with higher birthweight SDS were at a more advanced 
pubertal stage. Pubertal status had a significant positive relationship with FFM in 
both sexes but correlated in an opposite direction with FM (weak positive in girls and 
negative in boys). A higher level of physical activity had a significant negative 
association with nearly all indices of fatness in both sexes and had a positive 
association with FFM in girls. The other environmental factor, social class, also 
showed a significant association with the indices of fatness in boys (tendency for 
greater fatness with lower social class). Parental height had a significant positive 
relationship with birthweight SDS and later height in both sexes; taller parents were 
associated with higher birthweight and taller offspring. Maternal height was 
positively related to a higher amount of FFM in both sexes. Only maternal BMI had 
a significant positive association with her offspring’s birthweight SDS. Parental BMI 
was significantly correlated with most of the later body composition variables.
4.3.3 Relationship between current body size and body composition
Partial correlation coefficients (controlled for age) are shown in Table 4-2. As 
expected, height had a strong positive correlation with all body composition 
variables (except SF) and correlated with FFM more strongly than FM. BMI showed 
a stronger relationship with all indices of fatness than with FFM. Therefore, in the 
subsequent regression analysis, body composition variables were adjusted for body 
size by adjusting for height and, alternatively, for BMI. FM explains a high 
proportion of variability (90-92%) in trunk fat; therefore, regression models with 
height and non-trunk FM are shown for the analysis of trunk FM, to demonstrate any 
effect of birthweight on central fat that is beyond its association with total FM.
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Table 4-2 Partial correlation coefficients (r) controlled for age
Boys
BirthWT
SDS
Height FM FFM w c Triceps SF Subsc SF TrunkFM
Puberty o . i r 0.2? -0.1? o.3tr -0.08 -0.2? -0 .16 -o.i r
Physical activity -0.12 0.07 - i0.2? 0.10 -0.15 -0.2? -0.3? -0.2?
Social class 0.02 -0.01 0.2? 0.01 0.1? 0.1? 0.1? 0.2?
Maternal height 0.1? 0.2? -0.04 0.1? 0.09 -0.07 -0.03 -0 .04
Paternal height 0.2? 0.33c -0 .06 0.14 0.00 -0.03 -0 .10 -0.05
Maternal BM I 0.21a -0.001 0.3T 0.13 0.3? 0.21 0.3? 0.3?
Paternal BMI 0.05 0.09 0.3? 0.2? 0.2? 0.3? 0.3? 0.3?
Height 0.2? - 0.2? 0.8? 0.3? 0.05 0.09 0.2?
BMI o.2? 0.20? 0.8? 0.5? 0.9? 0.7? 0.84° 0.8?
FM 0.11 0.2? - 0.3? 0.8? 0.9? 0.8? 0.9?
G irls
BirthWT
SDS
Height FM FFM w c Triceps SF Subsc SF TrunkFM
Puberty -0.14 0.2? 0.15 o.3r 0.15 0.05 0.09 0.1?
Physical activity -0.07 0.23b -0.2? 0.2? -0 .10 -0.3? -0.2? -0.1?
Social class -0.14 -0.01 0.01 0.11 0.08 <0.001 0.02 0.02
Maternal height 0.1? 0.3? 0.07 0.2? 0.09 -0.14 -0.08 0.10
Paternal height 0.2? 0.1? 0.02 -0.01 -0.04 -0.03 -0.04 -0.02
Maternal BM I o .ir 0.08 0.3? 0.2? 0.2? 0.3? 0.2? 0.2?
Paternal BMI -0.04 0.16 0.2? 0.23b 0.2? 0.15 0.10 0.2?
Height 0.11 - 0.3? 0.8? 0.4? 0.04 0.13 0.4 l c
BM I 0.03 0.2? 0.8? 0.5? 0.9? 0.7? 0.81e 0.8?
FM 0.12 0.3? - 0.5l c 0.8? 0. 7? 0.8? 0.9?
@ap <  0.05, bp <0.01, cp<0.001
A ll variables w hich were not norm ally distributed (FM, FFM, BM I, W C, Triceps SF, Subscapular SF, 
Trunk FM, Maternal BM I, Paternal BM I) were natural log transformed before analysis.
Puberty was coded as: 1 = prepubertal, 2 =  early pubertal, 3 = late pubertal
Physical activity was coded as: 2=  much less or less active than peers, 3=  same as peers, 4=  more
active than peers, 5= much more active than peers
Social class ranged from 1 w hich is the highest to > 4 w hich is the lower social class
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4.3.4 Birthweight and later body size
The results of regression analyses are shown in Table 4-3. Birthweight was 
positively associated with later height in both sexes; at any given age, a 1 SDS 
increase in birthweight corresponded to a 0.24 and 0.17 SDS increase (95%CI: 0.09- 
0.38 for boys; 0.02-0.32 for girls) in height in boys and girls respectively. However, 
this association was attenuated substantially and became statistically non-significant 
after adjusting for parental height. Birthweight SDS positively predicted later weight 
and BMI SDS only in boys; a 1 SDS increase in birthweight predicted a 0.30 SDS 
increase (95%CI: 0.09-0.50) in later BMI at any given age. The association remained 
in the same direction after adjusting for potential confounders.
Table 4-3 Regression of body size on birthweight SDS&
Adjusted for age
Adjusted for age, 
puberty, physical activity, 
social class, ethnicity, 
parental height
Adjusted for age, puberty, 
physical activity, social 
class, ethnicity, 
parental BMI
Boys B SE P B SE P B SE P
W eight SDS 0.325 0.09 0.001 0.312 0.102 0.003 0.245 0.093 0.010
H eight SD S 0.237 0.075 0.002 0.116 0.073 0.115 0.215 0.081 0.009
BM I SDS 0.297 0.104 0.005 0.366 0.109 0.001 0.191 0.100 0.058
Girls
W eight SDS 0.125 0.086 0.149 0.117 0.090 0.193 0.092 0.089 0.303
H eight SDS 0.167 0.076 0.031 0.07 0.071 0.320 0.167 0.083 0.045
BMI SDS 0.056 0.091 0.541 0.108 0.095 0.254 0.009 0.092 0 .926
& From multiple regression analysis, each row represents a different m odel with body size in the left 
hand colum n as a dependent variable; birthweight SD S was an independent variable; age, puberty, 
physical activity, social class, ethnicity, and parental height or BMI were covariates.
B = the coefficient o f  birthweight SD S i.e. the change in body size or body com position per SDS  
increase in birthweight, SE = standard error, highlighted p value indicate significant at p<0.05
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4.3.5 Birthweight and body composition (FFM and FM)
The results of the regression analyses are shown in Table 4-4. Birthweight had a 
strong positive association with FFM in boys. This association was equivalent to 
around a 5.2% increase (95%CI: 2.8-7.6%) in FFM per 1 SDS increase in 
birthweight. The relationship was attenuated slightly after adjusting for current 
height and parental BMI but unaffected by adjustment for other confounders. In girls, 
there was no association between birthweight and FFM. The associations between 
birthweight and FFM differed between boys and girls (p for interaction =0.02). In a 
subgroup analysis according to puberty; this interaction was nearly significant 
(p=0.07) in prepubertal children only. There was no evidence that the associations 
for FM differed between boys and girls (p for interaction = 0.96). Birthweight was 
not significantly related to FM in either sex.
Table 4-4 Regression of body composition on birthweight SDS&
Adjusted for age
Adjusted for age, 
puberty, physical activity, 
social class, ethnicity, 
parental height
Adjusted for age, puberty, 
physical activity, social 
class, ethnicity, 
parental BMI
Boys B SE P B SE P B SE P
FM 0.065 0.048 0.179 0.081 0.049 0.101 0.026 0.045 0.564
FM # 0.034 0.049 0.485 0.052 0.046 0.26 -0.012 0.044 0.787
FFM 0.052 0.012 <0.001 0.042 0.012 0.001 0.043 0.012 0.001
FFM# 0.021 0.008 0.008 0.027 0.008 0.001 0.017 0.008 0.036
Girls
FM 0.056 0.036 0.125 0.054 0.038 0.159 0.028 0.037 0.451
FM # 0.037 0.034 0.285 0.037 0.035 0.289 <0.001 0.034 0.994
FFM 0.009 0.013 0.504 0.016 0.013 0.200 0.016 0.013 0.222
FFM# -0.007 0.008 0.379 0.006 0.008 0.458 -0.003 0.008 0.746
& From multiple regression analysis, each row represents a different m odel with body com position in 
the left hand colum n as a dependent variable; birthweight SD S was an independent variable; age, 
puberty, physical activity, social class, ethnicity, and parental height or BM I were covariates. FM and 
FFM were natural log transformed and presented in logescale.
# Adjusted for current height (m)
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4.3.6 Birthweight and fat distribution
Regression analyses of different proxies for fat distribution on birthweight SDS are 
shown in Table 4-5. In boys, there was a strong positive association between 
birthweight and waist circumference; equivalent to around a 2.8% increase (95%CI: 
1- 4.6%) in waist circumference per SDS increase in birthweight. This association 
was generally unaffected after adjusting for potential confounders. There was also a 
weak positive association between birthweight and trunk FM which was slightly 
stronger after adjusting for non-trunk FM; however, the association was attenuated 
after adjusting for parental BMI. There was a weak interaction between gender and 
birthweight SDS in predicting WC and subscapular SF SDS (p for interaction = 0.07 
and 0.06, respectively).
Among girls, birthweight was not associated with fat distribution indices in any of 
the models.
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Table 4-5 Regression of fat distribution indices on birthweight SDS &
Adjusted for age
Adjusted for age, puberty, 
physical activity, social 
class, ethnicity, 
parental height
Adjusted for age, puberty, 
physical activity, social 
class, ethnicity, 
parental BMI
Boys B SE P B SE P B SE P
Triceps SDS 0.139 0.085 0.103 0.172 0.088 0.052 0.096 0.085 0.261
Subscapular SDS 0.09 0.089 0.299 0.115 0.091 0.205 0.006 0.085 0.945
WC SDS 0.268 0.089 0.003 0.301 0.096 0.002 0.207 0.089 0.022
WC* 0.028 0.009 0.025 0.024 0.009 0.009 0.015 0.009 0.104
wc0 0.015 0.005 0.004 0.016 0.005 0.005 0.016 0.006 0.004
Trunk FM 0.112 0.057 0.052 0.142 0.06 0.019 r 0.067 0.054 0 .216
Trunk FM# 0.075 0.059 0.203 0.107 0.056 0.06 0.023 0.053 0.672
Trunk FM0000 0.067 0.032 0.036 0.090 0.033 0.008 0.060 0.034 0.079
Girls
Triceps SDS 0.083 0.072 0.249 0.079 0.073 0.279 -0.005 0.071 0.939
Subscapular SDS -0.007 0.081 0.932 -0.019 0.083 0.82 -0.108 0.082 0.191
WC SD S 0.01 0.089 0.913 0.023 0.095 0.805 -0.033 0.096 0.729
WC* -0.001 0.008 0.875 0.001 0.008 0.919 -0.006 0.008 0.480
wc* -0 .008 0.004 0.058 -0.006 0.005 0.159 -0.006 0.005 0.210
Trunk FM 0.051 0.044 0.251 0.05 0.046 0.285 0.022 0.045 0.622
Trunk FM* 0.025 0.041 0.537 0.029 0.042 0.494 -0.012 0.042 0.783
Trunk FM0000 -0.018 0.034 0.593 -0.007 0.036 0.842 -0.029 -0 .036 0.430
& From multiple regression analysis, each row represents a different m odel with fat distribution 
indices in the left hand colum n as a dependent variable; birthweight SD S was an independent variable; 
age, puberty, physical activity, social class, ethnicity, and parental height or BMI were covariates.
WC and Trunk FM were natural log transformed and presented in loge scale 
#
Adjusted for current height (m)
“ Adjusted for both current height (m) and total FM (loge scale)
oooo
Adjusted for both current height (m) and non-trunk FM (loge scale)
92
4.3.7 Interaction between pubertal status and birthweight SDS
There was no evidence that the associations between birthweight and FFM differed 
between pubertal groups; however, the association between birthweight and FM did 
differ between pubertal groups (p for interaction =0.03). This interaction was not 
significant in a subgroup analysis according to gender. There was also a significant 
interaction between puberty and birthweight SDS in predicting triceps SF SDS, and 
waist circumference SDS (p for interaction =0.02, 0.05, respectively). Since there 
was a significant interaction between pubertal status and birthweight SDS in 
predicting some of the later body composition variables, sub-group analysis was 
performed according to pubertal group.
Boys: Birthweight SDS was positively associated with FFM and central fat, 
persisting after adjusting for current size in the prepubertal group (n=67). The 
relationship was weaker (although in the same direction) in early pubertal boys 
(n=39). None of the associations were significant in late pubertal boys (n=37). 
Pubertal stage was missing in 2 boys.
Girls: There was a weak positive association between birthweight SDS and FFM 
(p=0.064), which was largely attenuated after adjusting for current height in 
prepubertal girls (n=70). None of the associations between birth SDS and FFM, FM, 
and fat distribution were significant in the other 2 groups (early pubertal, n=42; late 
pubertal, n=51).
4.3.8 Effects of using different body composition techniques
Most published studies use 2C techniques to determine body composition in later 
life. The two most commonly used are different SF equations and DXA. Therefore, 
for the purpose o f comparison, the same analyses were repeated within the same 
dataset using FM and FFM derived from DXA and from the SF equation of 
Slaughter et al.(57;192). The results are shown in Table 4-6 and Table 4-7. There 
was a significant positive association between birthweight and FFM in boys, which
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was slightly weaker after adjusting for confounders. Interestingly, if  FFM in the 
analysis was derived from the SF equation, a weak positive association was also seen 
in girls. However, it became statistically non-significant after adjusting for height. 
From these 2 methods, there was a trend for a positive relationship between 
birthweight and FM in boys which was also substantially attenuated after adjusting 
for height.
&
Table 4-6 Regression of body composition by DXA on birthweight SDS
Adjusted for age
Adjusted for age, puberty, 
physical activity, social class, 
ethnicity, parental BMI
Boys B SE P B SE P
FM 0.097 0.051 0.059 0.058 0.048 0.233
FM # 0.061 0.052 0.245 0.016 0.047 0.740
FFM 0.047 0.012 <0.001 0.037 0.012 0.002
FFM # 0.016 0.007 0.027 0.011 0.007 0.129
Girls
FM 0.058 0.038 0.132 0.032 0.039 0.413
FM # 0.035 0.035 0.320 0.001 0.035 0.970
FFM 0.009 0.013 0.504 0.016 0.012 0.194
FFM# -0.007 0.008 0.379 -0.002 0.007 0.794
& From multiple regression analysis, each row represents a different m odel with body com position in 
the left hand colum n as a dependent variable; birthweight SDS was independent variable; age, 
puberty, physical activity, social class, ethnicity, and parental BMI were covariates.
FM and FFM were natural log transformed and presented in loge scale 
D X A  FFM = Fat free soft tissue+ BM C
#
Adjusted for current height (m)
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Table 4-7 Regression of body composition calculated by SF equations 
(Slaughter’s) on birthweight SDS &
Adjusted for age Adjusted for age, puberty, 
physical activity, social class, 
ethnicity, parental BMI
Boys B SE P B SE P
FM 0.112 0.047 0.019 0.080 0.046 0.087
FM # 0.079 0.048 0.105 0.042 0.046 0.355
FFM 0.051 0.012 <0.001 0.044 0.012 <0.001
FFM # 0.022 0.007 0.003 0.020 0.008 0.012
Girls
FM 0.035 0.036 0.324 0.008 0.036 0.813
FM # 0.016 0.033 0.634 -0.017 0.033 0.601
FFM 0.022 0.013 0.097 0.027 0.013 0.034
FFM# 0.006 0.007 0.391 0.008 0.007 0.240
& From multiple regression analysis, each row represents a different m odel with body com position in 
the left hand colum n as a dependent variable; birthweight SDS was independent variable; age, 
puberty, physical activity, social class, ethnicity, and parental BM I were covariates.
FM and FFM were natural log transformed and presented in loge scale 
#
Adjusted for current height (m)
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4.3.9 Effects o f using different methods for size adjustment and 
expression o f BC
To be comparable to other studies, the results of my analysis using alternative body 
size adjustment by BMI are shown in Table 4-8 and Table 4-9. The association 
between birthweight and FFM remained the same in this analysis; yet, there was a 
negative association between birthweight and fat percentage (in relation to body 
weight) in boys which was apparent only after adjusting for BMI (see later 
discussion). There was a significant negative association between birthweight SDS 
and subscapular SF in girls and a trend in the same direction in boys which was 
slightly stronger after adjusting for BMI. The association remained in the same 
direction in girls if  the ratio of subscapular and triceps SF was used. Indeed, S:T ratio 
showed a significant negative association ‘before’ BMI adjustment but the 
relationship was stronger ‘after’ the adjustment.
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Table 4-8 Regression of body composition on birthweight SDS (Alternative size
adjustment by BMI) &
Adjusted for age Adjusted for age, puberty, 
physical activity, social class, 
ethnicity, parental height
Boys B SE P B SE P
FM S -0.049 0.027 0.069 -0.043 0.027 0.115
%Fat 0.478 0.724 0.510 -0.007 0.655 0.992
%Fats -1.105 0.471 0.020 -0 .936 0.448 0.039
FFM$ 0.033 0.01 0.002 0.029 0.010 0.004
Girls
FM $ 0.045 0.017 0.011 0.028 0.019 0.135
%Fat 0.739 0.597 0.217 0.083 0.595 0.889
%Fats 0.573 0.367 0.120 0.092 0.364 0.800
FFMS 0.009 0.013 0.504 0.016 0.011 0.133
& From multiple regression analysis, each row represents a different m odel with body com position in 
the left hand colum n as a dependent variable; birthweight SD S w as independent variable; age, 
puberty, physical activity, social class, ethnicity, and parental BMI were covariates.
FM, FFM were natural log transformed and presented in loge scale 
$
Adjusted for BMI (logescale)
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Table 4-9 Regression of fat distribution indices on birthweight SDS (Alternative
size adjustment by B M I)&
Adjusted for age
Adjusted for age, puberty, 
physical activity, social class, 
ethnicity, parental BMI
Boys B SE P B SE P
w c s 0.005 0.004 0.186 0.007 0.004 0.071
Triceps SFs -0.023 0.023 0.331 -0.011 0.023 0.638
Subscapular SF$ -0 .037 0.021 0.088 -0.037 0.021 0.073
S:T 0.004 0.022 0.871 -0.018 0.023 0.438
SiT* -0.015 0.021 0.486 -0.027 0.023 0.236
Trunk FM$ -0.03 0.028 0.278 -0.022 0.028 0.438
Girls
w c $ 0.001 0.004 0.799 0.001 0.004 0.883
Triceps SF$ 0.025 0.016 0.126 0.005 0.017 0.765
Subscapular SFs -0 .036 0.021 0.085 -0.061 0.021 0.005
S:T -0.053 0.024 0.026 -0.063 0.026 0.017
S:T* -0 .056 0.022 0.011 -0.063 0.024 0.010
Trunk FM$ 0.037 0.02 0.065 0.023 0.022 0.283
& From multiple regression analysis, each row represents a different m odel with central fat distribution 
indices in the left hand colum n as a dependent variable; birthweight SDS was independent variable; 
age, puberty, physical activity, social class, ethnicity, and parental BM I were covariates.
WC, Triceps, Subsc, S:T, TrunkFM were natural log transformed and presented in loge scale 
$
Adjusted for BMI (logescale)
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4.4 Discussion
This study shows the association between birthweight and later body size and 
composition using the 4-component model which is the best available in vivo body 
composition technique to date. It confirms that higher birthweight is associated with 
higher later height in both sexes, and with higher weight and BMI in boys.
Gender differences in the programming effect of birthweight on body composition 
were demonstrated. In boys, the data showed that a higher birthweight was 
associated with higher FFM and central fat distribution. These associations were 
independent of current body size, age, pubertal stage, physical activity, social class, 
ethnicity, and parental size. In girls, there was no association between birthweight 
and later body composition except for a negative association with subscapular SF 
that became statistically significant after adjusting for current BMI.
Comparison between published studies exploring the relationship between 
birthweight and later body composition is difficult because they have used different 
body composition techniques and different methods of expression of body 
composition data. Although the sample size of my study was not comparable to the 
large-scale epidemiologic studies, the use of the 4-component model can give a more 
accurate answer regarding the programming of body composition and demonstrate 
some critical points of body composition data interpretation. In this discussion, I will 
focus on 1) comparison o f my main findings with other studies; a summary is shown 
in Table 4-10, 2) effects o f the use of different body composition techniques on the 
apparent relationship between birthweight and later body composition, 3) effects of 
the use of different methods for size adjustment and expression of body composition 
data on this relationship, and 4) criticisms of my study. The potential mechanism of 
body composition programming and broader implication of my findings will be 
discussed in more detail later in Chapter 9.
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Table 4-10 Summary of studies examining the association between birthweight and later body composition in children, adolescents and
young adults
Reference Population Age n BC technique Gender Statistics Birth variables Outcomes Covariates Results
Hediger et 
al, 1998 
(75)
US infants&
children,
Mixed
term/preterm
2-47 m 4431 Anthropometry
Both sexes 
included
Regression
Birthweight 
categories -  
SGA (CIO'"0/!,), 
AGA, LGA 
(>90lh%)
SDS o f 
Weight, 
MUAC, 
AMA, AFA, 
AFI (%arm 
fat), TSF, 
SSSF, sumSF
6 current age 
cohorts, race, 
sex, birth order, 
maternal 
smoking, 
gestation in 
SGA vs. LGA
- SGA smaller size (W t., MUAC)
- SGA deficit in muscularity (MUAC, AMA) 
approximately -0.5 SDS, less deficit in fat
- SGA had higher AFI in 1st yr than AGA
- LGA surfeit in muscularity (0.45 SDS) but less surfeit in 
fat
- NS for SF
Mulligan et 
al, 2005 
(193)
UK children 6.6-9. ly 85
DXA, Bodpod 
(n=63)
Both sexes 
included
Regression Birthweight
SDS
% Fat BMI, age, sex, 
SES, activity
- Negative association (p=0.046, 0.006 for DXA, Bodpod), 
weaken (p=0.038, 0.022) after adjustment for covariates
Gamett et 
al,
2001(96)
Australian 
children, term 
bom
7-8 y 255
Anthropometry, 
DXA abdominal 
fat by ROI (lower 
ribs-supra iliac 
crest)
Both sexes 
included
ANOVA,
Regression,
Partial
correlation
for CVD
risks
Birthweight 
(gm) 3 
categories 
(<3000, 3000- 
4000, >4000); 
Birthweight 
SDS
Weight SDS at 
7-8y,
%Abdominal 
fat (from total 
fat), % total fat 
(from weight); 
CVD risks 
(Total 
chokHDL,
TG, Insulin, 
Insulin: 
Glucose, BP)
age, gender, 
%fat (for partial 
correlation with 
CVD risks)
W eight SDS 
at7-8y
- Lowest birthweight (<3000gm) and highest current 
weight SDS group (>0.67SDS) had significantly higher 
%abdominal fat (6.53±1.3%, p<0.001); similar results if  
birthweight SDS used
- Birthweight SDS was negatively associated with 
%abdominal Fat (p=0.009), stronger if adjusted for current 
weight SDS (p<0.001); negatively associated with %fat 
only after adjusting for current weight SDS (p=0.007)
- NS interaction between birth and current weight SDS in 
predicting %abdominal fat or %fat
- NS birthweight SDS and CVD risks
- Insulin, SBP associated with % fat; Total chol: HDL 
ratio, TG associated with % abdominal fat
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Table 4-10 (cont.) Summary of studies examining the association between birthweight and later body composition in children,
adolescents and young adults
Reference Population Age n BC technique Gender Statistics Birth variables Outcomes Covariates Results
Duran- 
Tauleria et 
al,1995 
(194)
UK children
(various
ethnicity)
5-1 ly 8374 Anthropometry
Both sexes 
included
Regression Birthweight
Weight for 
height, TSF, 
SSSF, sumSF
Age, sex, SES, 
parental BMI, 
ethnic
- Positive association with all indices
Okosun et 
al, 2000 
(195)
US children 
(Black, White, 
Hispanic)
5-1 ly 2488 Anthropometry
Both sexes 
included
Regression,
Partial
correlation
Birthweight
TSF,SSSF, 
SISF, Thigh 
SF, S:T,
Age, sex, BMI
- NS for TSF/sumSF
- Positive association for thigh SF
- Negative association for SSSF, SISF, S:T
Bavdekar et 
al, 1999 
(94)
Indian children 8y 477 Anthropometry
Both sexes 
included
Regression Birthweight
BMI, SF, 
S:T, WHR
Age, sex, weight
- Positive association (j-shape) with BMI
- Positive association with TSF, NS with SSSF
- Negative association with S:T after adjusting for weight
Wells et al, 
2005(196)
Brazilian boys 9-10.ly 172
BIA,
Anthropometry
Boys
ANOVA,
Regression
Birthweight/PI 
SDS quartile
Height, BMI, 
LMI
(heighf),
FMI,
FM/LM"
SES, maternal 
BMI
- Positive association with Height, BMI, LMI
Rogers I,
2006
((141))
UK children 9-10y 6086 DXA
Separate
sex
Regression
Birthweight/leng 
th/PI SDS
LM, FM, 
FLR
(FM /LM11), 
truncal fat, 
BMI, WHR
GA, age, height, 
height2, SES, 
stage o f puberty 
(girls),FM 
(trunk fat), LM 
(trunk fat)
- Birthweight positive association with LM both sexes/ 
positive association with FM (not with FLR) only in girls
- PI positive association with LM, FM, FLR in both sexes
- NS birth size with central adiposity except PI positive 
association with trunk fat (NS after adjusted for total FM)
- Weak sex-birthweight SDS interaction in predicting LM 
(p=0.097)
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Table 4-10 (cont.) Summary o f studies examining the association between birthweight and later body composition in children,
adolescents and young adults
Reference Population Age n BC technique Gender Statistics Birth variables Outcomes Covariates Results
Walker et 
al, 2002 
(197)
Jamaican
children
7 and 11
y
116
stunted,
190
non­
stunted
Anthropometry 
(SF equation for 
black children)
Both sexes 
included
Regression Birthweight
BMI, SF, 
S:T, %Fat
Age, sex, 
pubertal status, 
stunted groups 
(chronic/ 
previously/ non­
stunted)
BMI
- Positive association BMI
- Negative association S:T ratio at 1 ly , change from 7-11 
y (not with S:T at 7y)
- BMI NS with S:T, not change negative association after 
adjustment
Malina et 
al,
1996(92)
White US 
adolescents
7-12y 237 Anthropometry
Separate
sex
Partial
correlation
Birthweight
BMI, sum 
SF, S:T
age
- Negative association with S:T only after adjusting for 
BMI or sumSF; stronger in girls than boys
Fewtrell et 
al, 2004 
(198)
UK children 
(preterm bom )
UK Children 
(term bom)
8.8- 
12.7y
8-12y
497
95
DXA
Both sexes 
included
Term vs. 
Preterm
Regression
T-test to 
compare term 
vs. preterm
Birthweight 
SDS (with GA)
% Fat, FM, 
FFM, FMI 
(height2or 
height"), 
FFMI, SF, 
WC, AFA, 
AMA
Age, sex, 
puberty, activity
- NS with FMI, FFMI (preterm group)
- Preterm had lower FM, FFM, FMI, SF, WC, Weight., 
BMI than term
- FMI lower in boys/ higher activity level
Singhal et 
al, 2003 
(80)
UK adolescents 
UK children
13-16y 
7.4±1.9y
78
86
BIA, DXA, 
Anthropometry 
(SF equations)
Both sexes 
included
Regression Birthweight 
SDS (with GA)
FM, FFM, 
BMI
Not mention 
fat
distribution
Age, sex, SES, 
Tanner stage, 
physical 
activity, height2
- Positive association FFM, weaken after adjusting for 
height2 in adolescents; only positive association FFM after 
adjustment in children.
- Weak positive association BMI in children
- NS with FM
- FFM in adolescent higher in top half o f birthweight SDS
- No significant sex-birthweight SDS in predicting FFM
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Table 4-10 (cont.) Summary of studies examining the association between birthweight and later body composition in children,
adolescents and young adults
Reference Population Age n BC technique Gender Statistics Birth variables Outcomes Covariates Results
Barker et 
al, 1997 
(93)
Southampton
girls
14-16y 216 Anthropometry Girls Regression
Birthweight 
(kg), divide to 3 
g ro u p s(<=3000, 
3001-3500, 
>3500)
BMI (divided 
to
>,<median), 
WHR, S:T, 
SSSF, TSF
BMI, social 
class
BMI, SF adj. to 
age 15y
- Weak positive association BMI (p=0.08)
- Negative association SSSF (p=0.02), S:T ratio (p=0.05) 
only after adjusting for BMI
- Include GA in regression weaken relationship
Matthes et 
al, 1996 
(199)
UK adolescents
mean 
15.7y
165
pairs
Anthropometry
Both sexes 
included
Case-control
(low
birthweight 
vs. normal)
LBW
(<2500gm, 
term) vs. normal 
(3000-3800)
BMI, TSF, 
SSSF, T:S
Matches for sex, 
parity, gestation, 
DOB
- LBW had lower BMI
- NS different in SF
Labayen et 
al, 2006 
(200)
Spanish
adolescents
13-18y 234
DXA,
Anthropometry 
(SF equation)
Separate
sex
Regression,
Compare
geometric
means in
different
group
Birthweight
SDS
FM, FFM by 
DXA/SF, 
BMC, %fat, 
S:T
Age, gestation, 
Tanner stage, 
SES, physical 
activity, height2,
- Significant sex-birthweight SDS interaction
- Positive association height, BM C/ Negative association 
S:T (before height2 adjustment), with %FM (after height2 
adjustment) for both sexes combine
- Negative association with S:T after adjusting for height2 
in boys
- Positive association with FFM, BMC (persist after 
adjusting for height2) in girls
Frisancho 
et al, 2000 
(201)
White US 
adolescents
15-17y 1993 Anthropometry
Separate
sex
ANOVA
compare
between
group,
Regression
Birthweight 
(SGA, AGA, 
LGA)
BMI (high, 
low), 
TSF(high, 
low)
Maternal BMI, 
GA, sex, family 
income
- NS different between SGA, AGA, LGA
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Table 4-10 (cont.) Summary of studies examining for the association between birthweight and later body composition in children,
adolescents and young adults
Reference Population Age n BC technique Gender Statistics Birth variables Outcomes Covariates Results
Kahn et al, 
2000 (202)
US black/white 
men
17-22y 192 Anthropometry
Men
(military
recruits)
Regression Birthweight (kg)
BMI, height, 
midthigh circ, 
thigh muscle 
area (TMA), 
thigh fat area 
(TFA), WC, 
sagittal 
abdominal 
diameter 
(SAD)
Race, height
- Positive association with BMI, TMA, WC, SAD
- BMI-birth association reduce more (68%) with 
adjustment for TMA than TFA (30%) -> larger BMI 
associate with high birthweight reflect increase lean > fat
Euser et al, 
2005(182)
Dutch adult 
Preterm bom  
<32 wk, 
BW <1500 gm
19y 403
Anthropometry 
(SF equation)
Both sexes 
included
Regression, 
compare R2, 
R2 change
Birthweight 
SDS (with GA)
W eight/ 
Height/ BMI/ 
W C/SumSF 
SDS, WHR, 
S:T,%Fat, 
FM, FFM
Height SDS, 
sex, race, SES, 
activity
- Positive association with HTSDS, WTSDS, BMISDS, 
WC SDS, FM, FFM
- Weak positive association with FFM, NS with WC 
SDS,FM after adj. for Height SDS
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4.4.1 Comparison with other studies
4.4.1.1 Birthweight and body composition (FFM and FM)
The finding that birthweight has a positive association with FFM in later life is 
supported by several studies. The majority of them used anthropometric calculations 
to determine proxies for FFM; for example, arm or thigh muscle area (75;202) and 
FFM calculated by subtracting FM (from SF equation) from weight (182;203-205). 
Recently, there have been an increasing number o f studies trying to measure FFM 
with different body composition techniques. More of them were done in adults and 
elderly populations (76-79; 140) but a few studies in children and adolescents also 
found the same positive relationship (80;141;196;200). My study confirmed that this 
association persists from childhood to young adulthood but was more prominent in 
prepubertal boys. Indeed, in the subgroup analysis there was no significant 
association in the late pubertal group; although this may arguably reflect the smaller 
sample size. However, my study demonstrated this association only in boys, which 
has not been generally reported in other studies (see later discussion).
In contrast, the relationship reported between birthweight and FM is less consistent 
in all age groups. A few studies using anthropometry found a weak positive 
association of birthweight with FM (141;182;203;204). These associations seemed to 
be more prominent in females(141;203;204). Interestingly, a number of studies found 
a negative association of birthweight and proxies of fatness only after adjusting for 
current body size (in the form of weight, height, or BMI) (77;96;140). Therefore, it is 
not surprising that in my dataset, there was no significant relationship of birthweight 
and FM without adjustment for later weight or BMI.
4.4.1.2 Birthweight and fa t distribution
Most studies looking at the relationship of birthweight and central fat distribution 
defined by subscapular SF, subscapular:triceps (S:T) ratio, waist circumference, or 
waist: hip ratio reported a negative association after adjusting for current weight or
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BMI in prepubertal children (92;94;141;195), adolescents (93;200), and adults 
(78;204;206) although a few studies found this negative association without size 
adjustment in children and adolescents (197;200). In my study, after adjusting for 
current BMI, a negative relationship between birthweight SDS and subscapular SF 
and subscapular: triceps ratio in girls was also found. This finding has generally been 
interpreted as the programming of later central adiposity by low birthweight. 
However, an alternative explanation for this is either that postnatal growth actually 
plays an important role in the programming of body fat and central fat, or the 
prenatal constraint o f growth (represented by low birthweight) interacts with rapid 
post natal growth to predict later central fatness. A similar interpretation of data 
regarding low birthweight and coronary heart disease risk in later life was discussed 
by Cole et al (207).
There are few studies that have attempted to directly measure central fatness, and the 
results are not consistent. Garnett et al. studied 255 healthy children aged 7-8 year 
using a DXA region of interest (from lower rib cage to upper iliac crest) to determine 
central fatness, and confirmed a negative association with birthweight either with or 
without considering current weight SDS. On the other hand, the ALSPAC study 
(141) which had a very large sample size of 3006 boys and 3080 girls aged 9-10 
years reported a positive association of ponderal index at birth and trunk FM (by 
DXA), which seems to correspond with my study; however, in their study the 
association depended on total FM. In a small study that assessed visceral fat area by 
computerized tomography (CT), Choi et al (97) reported no relationship between 
birthweight and visceral fat area in 22 healthy young Korean adults.
The other interesting point in my dataset is that higher birthweight SDS was related 
to higher trunk FM in boys both with and without ‘current size’ adjustment; this 
might imply that there is a genuine relationship between prenatal growth and later 
risk of central adiposity in boys, which would be difficult to reconcile with the 
widely-accepted low birthweight and increased later cardiovascular risk hypothesis. 
Alternatively, the ‘trunk FM’ measured by DXA may not be a good proxy for central 
adiposity and metabolic risk. Yet, the relationship of birthweight SDS and WC 
(which is a good indicator of metabolic risk in adults(208) and children(55) was in 
the same direction. It could be argued that both trunk FM and WC are in fact not an
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‘actual’ measurement of visceral adipose tissue, which is important in predicting the 
metabolic syndrome. In other words, among adolescent boys with the same height 
and total FM, those who have higher birthweight tend to have bigger WC or ‘trunk 
FM’ -  both of which have a ‘lean’ component, and do not simply represent fat; i.e. 
they could be bigger around the central area just because they have more FFM which 
may track from birth. This issue is difficult to resolve unless we have a valid method 
for measuring ‘central fat distribution’ in a large sample size.
4.4.1.3 Gender difference in the relationship between birthweight and 
body composition
Differences in body composition between males and females are well-known. 
However, interactions between gender and birthweight in predicting later body 
composition are not well established. Most studies of birthweight and later body 
composition in children were done in prepubertal children where gender difference in 
body composition is less prominent. A few studies have been conducted in 
adolescents when pubertal status is the main confounder. Singhal et al. (80) found a 
positive association between birthweight and FFM in 78 adolescents aged 13-16 
(using BIA and SF). In a younger age group (age 7.4±1.9 year) from the same study 
(using DXA and SF), birthweight was only positively related to FFM after adjusting 
for age, sex, puberty and physical activity. However, there was no interaction 
between gender and birth SDS in predicting FFM in either adolescents or children. 
This finding seems to support the relationship of birthweight and FFM seen in my 
dataset; however, it does not support the gender difference. Barker et al.(93) found a 
negative association (weakened if gestation was included in the model) between 
birthweight and subscapular SF only after adjusting for BMI in 216 adolescent girls 
aged 14-16. This finding also corresponds with my data in that a similar association 
occurred in girls. In this study the authors did not mention the association with FFM 
so it is uncertain whether or not there is any association or gender difference in the 
association. There is one published study that showed a gender difference in the 
association of birthweight and later body composition in an adolescent population. 
Labayen et al (200) reported a significant interaction between sex and birth SDS in 
predicting FM, FFM (by DXA) and S:T in 234 Spanish adolescents (age 13-18
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years). However, the association of birthweight and FFM appeared in the opposite 
sex compared to my data. They demonstrated that birthweight was inversely 
associated with the S:T ratio in boys and directly associated with FFM in girls. One 
possible explanation might be that their subjects are older and the ‘noise’ of puberty 
that might interfere with the results is more obvious in boys, while in my dataset 
more of the subjects were younger (mean age 11.6 years) and the ‘noise’ o f puberty 
might be more prominent in girls.
In my opinion, it is not surprising that we found a gender difference in the 
relationship at this age range. My study showed that at a given age, greater pubertal 
maturity positively predicted more FFM and less FM in boys while it was positively 
associated with both FFM and FM in girls. This can probably be explained by 
hormonal changes during pubertal maturation where the estrogen surge in girls could 
result in more FM accumulation, whereas testosterone predominantly affects FFM in 
boys. That is probably one explanation why the association with FFM was different 
between sexes in this dataset when more than half of the subjects had already entered 
puberty. One could argue that if this is the only explanation, the subset of 
prepubertal girls should show the same association with FFM as boys. Nevertheless, 
there was only a weak positive association of birthweight and FFM in prepubertal 
girls, which depended on height.
In my subgroup analyses, the gender and birthweight interaction was only significant 
in the prepubertal group which may seem inconsistent with the above explanation. 
However, I think it is probably due to the smaller sample size in the pubertal and late 
pubertal groups. Most studies of birthweight and later body composition in the 
prepubertal age group included both sexes in the same analysis and adjusted for sex 
as a confounder. However, among the studies that analysed boys and girls separately, 
it is not clear whether there is a gender difference in the prepubertal age group. 
Malina et al (92) reported the same negative association of birthweight and SF in 
both sexes. In the study of Garnett et al (96) where a negative association between 
birthweight and abdominal fat (by DXA) was found they did not mention FFM or 
any sex and birthweight interaction. The other published study in 172 Brazilian boys 
aged 9-10.1 years by Wells et al (using BIA) showed a similar association of 
birthweight and FFM in prepubertal boys (196), but unfortunately no data in girls
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was shown. In the ALSPAC study (141) which has an exceptionally large sample 
size, there was no evidence that the association between birthweight and FM or trunk 
FM differed between the sexes. However, they reported a weak interaction o f sex and 
birthweight for the association with FFM (p-0.097). The significance of the 
interaction was stronger if  ponderal index was used as a proxy for birth size 
(p=0.04). The effect size on lean mass was larger in boys (350 and 280 gm increase 
in LM per SDS increase in birthweight in boys and girls). This may support my 
finding that the association was only significant in boys in a smaller sample size.
4.4.2 Effects o f using different body composition techniques
In the large scale published studies, anthropometry has been used to derive body fat 
from SF measurements. More recently, DXA has been used widely to assess body 
composition in children. Both methods are not ideal and involve several assumptions 
in calculating body composition (see C hapter 2). My finding of an association 
between birthweight and FFM in boys did not change with the use of different body 
composition techniques. However, there was a height-dependent positive association 
of birthweight and FFM in girls when the SF equation was used. Moreover, my data 
showed that if DXA or SF equation derived FM was used in the analysis; one could 
see a weak positive association of birthweight and FM which was not statistically 
significant if  4C model FM was used. This is a good example of the need for more 
caution in the interpretation and comparison of different studies that use different 
body composition techniques, since they can give us different answers.
4.4.3 Effects o f using different methods for size adjustment and 
expression o f BC
The interpretation of body composition data in children and adolescents in whom 
body size varies greatly is difficult without appropriate adjustment for individual 
body size. In the regression analysis of later body composition parameters where 
SDS were not available, I chose to adjust these body composition variables by height 
to look at the effect of birthweight on different body composition parameters having 
taken out the effect on body size. In my opinion, adjusting for body size using height
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is a more appropriate option than using weight (e.g. using percentage of body fat) 
which precludes individual consideration of fat and lean mass since one is the inverse 
of the other. This issue has recently been discussed elsewhere (189; 190). For 
instance, a child with high percentage fat could either have high FM or low lean 
body mass in relation to total weight. Therefore, the use of percentage fat might not 
be an ideal way of expressing body composition data. However, to be comparable to 
other studies and to evaluate the importance of size adjustment method to the 
interpretation of results, I have also shown the results of the alternative analyses 
using fat percentage and body size adjustment by BMI. Interestingly, a negative 
association between birthweight and FM (in the form of fat percentage) appeared in 
boys after adjusting for BMI. This was also reported by other studies (96;193;200). 
The challenge here is how to interpret such findings. Some authors would interpret 
this as indicating that a small size at birth was associated with higher fatness in a 
person with the same BMI. Conversely, another approach would be to interpret it as 
indicating that a greater increase in body size from birth is related to higher fatness, 
as mentioned previously. A third interpretation could be that a lower birthweight was 
associated with lower FFM in later life (since lower FFM with same FM could result 
in higher percentage fat). This is an important issue, since it can change the 
conclusions drawn from the same findings.
Another consideration when using size adjustment is the interpretation of the 
relationship between birthweight and later fat distribution. Most studies (including 
my dataset) only found a negative association after ‘current size’ adjustment, which 
may imply that this association depends on postnatal growth. The issue of which 
‘body size’ parameter should be used to adjust for central fat distribution depends on 
the research question. For example, birthweight SDS was positively associated with 
trunk FM in boys (Table 4-5). Without adjustment, it would mean that higher 
birthweight is related to a higher absolute trunk FM, but after adjustment for total 
FM, the interpretation would be that a higher birthweight is related to a tendency to 
accumulate central fat despite the same total amount of fat in the body - which 
possibly has different consequences in terms of cardiovascular health outcomes. In 
my opinion, there is no ‘right’ or ‘wrong’ in this matter provided that we understand 
these different meanings and justify the preference according to the question we are 
interested in.
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4.4.4 Criticisms o f the study
4.4.4.1 Characteristics o f  the dataset
I used the British 1990 reference data to calculate SDS. My subjects tend to be 
bigger compared to 1990 reference data (which was constructed using growth data 
from an ‘earlier’ period). I presume that this might result from changes in life style 
and environmental factors (e.g. more sedentary life style, higher caloric density diet) 
over time. In general, girls usually have more FM and less FFM than boys especially 
when they reach puberty, but this group of girls had higher waist circumference and 
SF ‘SDS’ than boys, suggesting that their higher ‘fatness’ is probably beyond the 
typical gender difference. In subgroup analysis, this difference was only significant 
in late pubertal subjects (data not shown). One possible explanation might be that 
both boys and girls in my study entered puberty earlier than the children that formed 
the 1990 reference, but the difference over time is probably larger in girls than boys. 
This might partly contribute to gender differences in the association between 
birthweight and body composition found in this study.
4.4.4.2 Reliability o f  birthweight data
Since this dataset came partly from retrospective records of birthweight, the accuracy 
of the findings depends greatly on the reliability of the information recorded. I have 
tried to verify parental recall and records in baby books; the result seems to be 
satisfactory for birthweight in that there was no difference between the two sources. 
However, gestational age from parental recall was different (mean difference 0.13 
week, 95% Cl 0.02, 0.23) from what was recorded in baby books (45.5% available). 
This probably contributes to some inaccuracy in SDS calculation.
4.4.4.3 Potential confounders
In theory, there are several confounders that influence both birthweight and later 
body composition; for example, parental size, social class, and ethnicity. However, in
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this study, I only found a significant relationship between parental size and offspring 
birthweight. The lack of an apparent association of ethnicity and birthweight is 
probably due to small sample size for non-white ethnicity (23%). In addition, I do 
not have data on some factors that have been shown to affect birthweight such as 
parity or maternal smoking; therefore, I cannot exclude these confounding effects in 
my results.
In some analyses I have shown that parental height and BMI have differential effects 
on the relationship between birthweight and later body size. For instance, the positive 
association between birthweight and later height disappeared after adjusting for 
parental height but persisted with the adjustment for parental BMI. Given that 
parental height influences both the birth size of offspring and later height, which may 
be tracked from birth, it is not surprising that association between birthweight and 
later height disappears after adjusting for parental height. This finding suggests that 
later height is more inheritable (partly mediated through birthweight) whereas for 
later body composition e.g. fatness, the mechanism is less obvious since its 
association with parental BMI could be interpreted as either ‘family lifestyle’ or an 
‘inheritable factor’. However, the correlation table (Table 4-2) shows that parental 
BMI has more influence on later BC than parental height (except for offspring 
height); therefore, in the subsequent analysis I have only shown the results from 
models with parental BMI adjustment.
After adjusting for age, boys who were bigger at birth were in a more advanced 
pubertal stage at the outcome measurement so it might be plausible that the positive 
association between birthweight and FFM in boys is mediated through earlier 
puberty (e.g. higher IGF-1). Nevertheless, the association remained in the same 
direction after adjusting for pubertal staging and was even stronger in prepubertal 
boys which supports an alternative explanation.
From the correlation table (Table 4-2) the strongest predictor for higher indices of 
fatness is a lower physical activity level. However, the data did not show any trend 
for an association between birthweight and physical activity, and the relationship of 
birthweight and later BC did not change after adjusting for physical activity. 
Therefore, my data do not support physical activity as a mediator of the association
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between birthweight and body composition programming. Although, I accept that the 
physical activity rating used in my analysis is relatively crude and my sample size is 
not large, a bigger study recently published by Hallall et al (209) also did not find 
any relationship between birthweight and physical activity in 4453 Brazilian 
adolescents.
4.4.4.4 Wide age range and inclusion o f children with different 
pubertal stages
Due to the wide age range of my study population, that covers pubertal maturation, it 
is inevitable that the results may be confounded by changes of body composition 
during this period. The ideal method would be to separate the analyses according to 
different pubertal stages; unfortunately, the sample size is not big enough. However, 
this study can at least show the different associations of birthweight and later body 
composition (by the same ‘gold standard’ technique) in different pubertal groups 
(more obvious results in prepubertal).
Another way to overcome this problem would be to use body composition SDS 
calculated from a bigger sample size of normal children, which (to the best of my 
knowledge) is not available yet. However, in order to confirm the consistency o f the 
findings, I have created age and sex-specific internal SDS for body composition 
variables using the LMS method which allows adjustment for the non-linear 
relationship o f these variables with age (details in Appendix C). FMI (FM/Height2) 
and FFMI (FFM/Height2) were used to create the SDS in order to take body size into 
account and to be comparable with BMI. The results (Table 4-11) confirmed the 
findings discussed previously. Nevertheless, I still think that it is important to present 
the other methods of body composition data expression, in order to compare with 
other studies and to illustrate that they can make a difference to the study results. 
Having established this point, for the following results chapters (covering the 
relationship between growth and body composition in infancy and later body 
composition), most of the results are shown using body composition SDS where 
possible to simplify the expression of body composition variables and to address the 
issue of the wide age range over which body composition outcomes were measured.
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Table 4-11 Regression o f body composition variables expressed in SDS on
birthweight SDS &
No adjustment
Adjusted for age, puberty, physical 
activity, social class, ethnicity, 
parental BMI
Boys B SE P r2 B SE P r2
BM I SDS 0.295 0.103 0.005 0.055 0.191 0.100 0.058
FMI SDS 0.076 0.082 0.357 -0.013 0.075 0.861
FFMI SDS 0.270 0.080 0.001 0.075 0.218 0.083 0.010 0.052
Trunk FMI SD S 0.140 0.082 0.088 0.074 0.078 0.349
Trunk FMI SD S00 0.110 0.049 0.026 0.034 0.033 0.035 0.350
Girls
BM I SDS 0.043 0.081 0.593 0.009 0.092 0.926
FMI SD S 0.095 0.080 0.239 0.009 0.079 0.914
FFMI SDS -0.033 0.081 0.685 -0 .026 0.085 0.762
Trunk FMI SDS 0.060 0.080 0.452 -0.011 0.081 0.890
Trunk FMI SD S00 0.026 0.059 0.662 -0.019 0.029 0.516
& From multiple regression analysis, each row represents a different m odel with body size or 
com position in the left hand colum n as a dependent variable; birthweight SDS was independent 
variable; age, puberty, physical activity, social class, ethnicity, and parental BM I were covariates. 
r2 = coefficient o f  determination (calculated from partial r o f  birthweight SD S)
00 Adjusted for total FM (loge scale)
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4.5 Summary
- My analysis confirmed that higher birthweight is associated with higher later height 
in both sexes, and with higher weight and BMI in boys.
- A gender difference in the influence of birthweight on later body composition was 
shown. In boys, higher birthweight was associated with higher FFM which was more 
prominent in the prepubertal group.
- Although the sample size of my study was not comparable to the large-scale 
epidemiologic studies, the use of the 4-component model can give a more accurate 
answer regarding the programming of body composition and demonstrates some 
interesting points about the interpretation of body composition data.
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Chapter 5
The Influence of Infant Growth 
on Later Body Composition
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Chapter 5 The Influence of Infant Growth on Later 
Body Composition
5.1 Introduction
Most of the earlier publications investigating postnatal growth and later outcome used 
BMI as a proxy for obesity. They demonstrated a positive relationship between rapid 
infancy and childhood weight gain and higher BMI in childhood and adult life. See 
Chapter 2. However, a limited number of recent publications that have attempted to 
measure FM and FFM separately have reported different associations between postnatal 
growth and these individual components (see the discussion section of this chapter). 
There has been no study using the 4C model of body composition to explore the longer 
term effects of growth during different periods of infancy.
5.2 Methods
5.2.1 Subjects
Children included in this analysis were those (as in Chapter 4) who completed four- 
component model measurements and had early growth records available from their baby 
books for at least one time point at 3, 6,12 weeks, 6 and 12 months. 54% (139 out of 
256) of the BC reference study research participants provided growth records (from 
parent-held baby books) in the first year of life that could be analyzed. 52 children from 
the prospective follow-up study (cohorts A, B, C) were also included. All were bom full- 
term, singletons and did not have any disease that might affect growth or body 
composition.
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5.2.2 Early growth data
In the prospective follow-up study, growth measurements were performed prospectively 
at specific ages (3, 6, 12 weeks, 6 and 12 months). In the retrospective study using 
weights obtained from parent-held baby record books, weight measurements performed 
as close as possible to these ages were selected. A description of the age distributions is 
shown in Appendix E, Table 10-6. Weight SDS at different ages were calculated (for 
gestation, sex and exact age) using the British 1990 reference.
5.2.3 M easurement of body composition
Body composition variables derived from the 4C model were used in this analysis 
together with anthropometry and DXA regional FM to assess central fat distribution. For 
more details see Chapter 3.
5.2.4 Confounding variables
Factors that might confound the relationship between early growth and body 
composition were assessed using the structured questionnaire as mentioned in the 
previous chapter and in Chapter 3 and Appendix B.
5.2.5 Statistical methods 
Early growth data
Changes in weight SDS (AweightSDS) between two time points were calculated by 
subtracting the earlier weight SDS from the later measurement. The association between 
early growth and later body composition was explored using multiple regression models.
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Body composition outcomes were regressed on AweightSDS with adjustment for 
birthweight SDS (Cole TJ, personal communication).
Body composition outcomes
The importance of body size adjustment in the interpretation of body composition data 
was addressed in the previous chapter. In this chapter, dealing with early growth data 
which is complicated to analyze and interpret, I chose to simplify the body composition 
outcome variables by using the SDS which provides body composition measurements 
adjusted for age and gender. In the SDS calculation using the LMS method (details
■y
shown in Appendix C), FMI, FFMI, and trunk FMI (kg/m ) were chosen in order to 
adjust for height in a comparable way to BMI. In the previous chapter, the main findings 
from analyses using body composition SDS were similar to those from analyses 
adjusting for height in regression models. A second reason is that this method allows 
direct comparison of the effect size of early growth on later FM or FFM since they both 
are in SDS, avoiding the problem of unequal variance between different body 
composition variables. Lastly, using body composition SDS has another advantage in 
this chapter since it reduces the number of variables for body composition adjustment in 
the regression model and, therefore, allows for more ‘early growth’ and confounding 
variables to be included in the model. This is even more relevant for analyses presented 
in the subsequent chapters, which had smaller sample sizes.
5.3 Results
5.3.1 Characteristics of study subjects
5.3.1.1 Early growth parameters
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Weight SDS at different periods in infancy are shown in Figure 5-1. In general, mean 
weight SDS in this dataset was not different from zero apart from at the age of 3 weeks 
when there was a drop in weight SDS. The mean difference was significant for boys 
only (mean difference -0.32; 95%CI -0.56, -0.09). Boys were heavier than girls at birth 
but had the same birth SDS. Boys also had higher absolute weight than girls throughout 
infancy (data not shown) but gender differences were no longer apparent when SDS 
were used. AweightSDS was different between boys and girls only during the period 6- 
12 weeks (mean difference 0.15; 95%CI 0.006, 0.295).
From the GLM, there was a significant interaction between gender and AweightSDS 
from 6-12 weeks and 3-6 months in predicting later FM (p for interaction 0.06 and 0.04, 
respectively). However, when FMI SDS, FFMI SDS, and trunk FMI SDS were used as 
outcomes, no interaction was seen. Therefore, the analyses were performed without 
separating the sexes. This is also preferable since separating the sexes in the analysis 
might further reduce statistical power in detecting associations. However, I included sex 
in the multiple regression models since there was a difference in AweightSDS from 6-12 
weeks between boys and girls, and to adjust for differences in body composition that are 
beyond normal gender differences (e.g. waist SDS, triceps SDS were significantly 
different between boys and girls as discussed in the previous chapter).
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Figure 5-1 Mean and 95% confidence interval for weight SDS at different ages# 
a) All subjects
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Since weight SDS during infancy are likely to be strongly related, partial correlations 
(adjusting for gender) between the measurements periods are shown in Table 5-la. As 
expected, weight SDS for the different periods between birth and 12 months were 
strongly correlated with each other and the two nearest measurements showed the 
highest correlation. Lower birthweight SDS correlated with later upward AweightSDS 
up to 6 months of age (Table 5-lb). Low AweightSDS during the first 3 weeks 
correlated with higher AweightSDS during 6-12 weeks of age. AWeightSDS from 6-12 
weeks was positively related to the change in the next period, 3-6 months, but negatively 
related to the change in the second 6 months of life.
Additional analyses showed that there was no significant interaction between birth SDS 
and AweightSDS over the 5 periods in predicting FM or FFM (data not shown). 
Therefore, I did not separate birthweight SDS categories in this analysis but added 
birthweight SDS as a covariate in the multiple regression analyses. In each regression 
analysis, AweightSDS for particular periods that were significantly correlated with the 
period of interest were adjusted for in some models (see later results).
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Table 5-1 Partial correlation coefficients (r) controlled for gender
#
a) Between weight SDS at different ages
Birth SDS WT3wk SDS WT6wk SDS WT12wk SDS WT6mo SDS WT12mo SDS
Birth SDS 1
WT 3 wk SDS 0.80 1
WT 6 wk SDS 0.70 0.93 1
WT 12 wk SDS 0.62 0.77 0.88 1
WT 6 mo SDS 0.46 0.54 0.63 0.82 1
WT 12 mo SDS 0.48 0.49 0.55 0.66 0.85 1
##
b) Between Aweight SDS at different ages
Birth SDS ASDS0-3wk ASDS3-6wk ASDS6-12wk ASDS 3-6mo ASDS6-12mo
Birth SDS 1
ASDS 0-3wk -0.32° 1
ASDS 3-6wk -0.19? 0.11 1
ASDS 6-12wk -0.13 -0 .3 f 0.12 1
ASDS 3-6mo -0.17a -0.16 -0.11 0.2/ 1
ASDS 6-12mo 0.005 -0.07 -0.04 -0.19? 0.13 1
All correlation coefficients were significant at p<0.001
ffff
ap < 0.05, bp < 0 .0 1 ,cp<0.001
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53,1,2 Current body composition outcomes
Descriptive statistics of 191 subjects (age range 4.2 to 20.4 years) are summarized in 
Table 5-2. Boys were comparable to the British 1990 reference in terms of height, 
weight, and BMI whereas girls in this dataset were heavier, taller and had higher BMI 
than the reference children. Both boys and girls had significantly higher WC compared 
to the British 1990 reference while girls also had higher triceps and subscapular SF.
Gender differences in body composition in this dataset were in the same direction as 
described previously in the previous chapter except that boys did not show significantly 
higher FFM compared to girls. Using age and sex specific internal SDS for body 
composition outcomes, no gender differences were apparent.
There was no difference in other potential confounders between boys and girls.
5.3.2 Potential confounders
Partial correlation (controlling for age and sex) was used to test the influence of the 
potential confounders on early growth variables (Appendix E, Table 10-7). Lower 
social class was associated with higher A weight SDS between 3-6 months. This could 
either be explained by a tendency toward earlier weaning or a higher rate of formula 
feeding in lower social class groups. Maternal height and paternal BMI were positively 
associated with AweightSDS between 3-6 wk and 3-6 months, respectively.
124
Table 5-2 Characteristics of study subjects*
All (n=191) Boys (n=88) Girls(n=103) P
A ge (y) 11.8 ±  3.8 11.3 ±  3.7 12.2 ± 3 .9 0.13
Height (cm) 147.5 ± 19.2 146.1 ± 2 0 .1 148.8 ± 18.5 0.34
Weight (kg) 42.8 ±  16.2 40.2 ±  16.0 44.9 ±  16.1 0.04
BMI (kg/m2) 18.9 ± 3 .5 18.1 ± 3 .2 19.5 ± 3 .6 0.004
Height SDS 0.24 ± 0.94 0.17 ± 0 .9 4 0.30 ± 0.94 0.35
W eight SDS 0.31 ± 1 .0 9 0.20 ±  1.16 0.40 ±  1.03 0.20
BMI SDS 0.21 ±  1.21 0.10 ±  1.32 0.31 ±  1.11 0.23
FMI (kg/m2) 4.6 ± 2 .5 3.6 ± 2 .2 5.5 ± 2 .3 <0.001
FFMI (kg/m2) 14.2 ± 1.9 14.4 ±  2.1 14.0 ± 1.7 0.15
Trunk FMI (kg/m2) 2.0 ±  1.3 1.5 ±  1.1 2.5 ±  1.4 <0.001
FMI SDS -0.05 ± 0.98 -0.05 ± 1.03 -0.05 ± 0 .9 3 0.96
FFMI SDS -0.08 ±  1.00 -0.09 ± 1.02 -0.07 ±  0.99 0.90
Trunk FMI SDS -0.04 ±  0.98 -0.04 ±  1.04 -0.03 ±  0.94 0.91
WC(cm) 65.2 ± 9 .2 64.3 ±  9.0 65.9 ± 9 .3 0.23
Triceps SF (mm) 13.3 ± 5 .3 10.8 ± 4 .7 15.4 ± 4 .9 <0.001
Subscapular SF (mm) 10.0 ± 6 .3 7.9 ± 5 .0 11.8 ±  6.8 <0.001
W CSDS# 0.70 ±  1.07 0.45 ±  1.09 0.91 ±  1.02 0.004
Triceps SDS 0.40 ± 0.95 0.22 ±  1.03 0.56 ± 0 .8 5 0.01
Subscapular SDS 0.12 ±  1.06 -0.04 ± 1 .1 1 0.26 ±  1.00 0.05
& Continuous variables were expressed as mean ±  SD and independent sample t-test was used to test the 
difference between gender; categorical variables were expressed as n (%) and Chi-square test was used to 
test the difference between gender.
u n= 80 in boys and 93 in girls since the database for waist SDS was available only up to the age o f  17
125
(a)
Table 5-2 Characteristics of study subjects (cont.)
All (n=191) Boys (n=88) Girls(n=103) P
Maternal height (cm) 163.9 ± 6 .6 164.8 ± 6 .9 163.1 ± 6 .2 0.06
Paternal height (cm) 178.6 ± 7 .0 178.1 ± 7 .1 179.0 ± 6 .9 0.37
Maternal BMI (kg/m2) 24.8 ± 4 .8 25.0 ± 4 .6 24.7 ± 4 .9 0.66
Paternal BMI (kg/m2) 26.5 ± 3 .9 27.1 ± 4 .0 26.1 ± 3 .7 0.08
Pubertal status (n, %) 
Prepubertal 
Early pubertal 
Late pubertal
81,42.6%  
5 1 ,2 6 .8 %  
58, 30.5 %
44, 50% 
22, 25% 
21,23.9%
37, 35.9 % 
29, 28.2 % 
37, 35.9 %
0.10
Physical activity (n, %) 
Much less or less 
Same as peers 
More
Much more
15,8.0%  
86, 45.7 % 
68, 36.2 % 
19, 10.1%
8, 9.0% 
38, 43.2%  
32, 36.4%  
10, 11.4%
7, 6.8%  
48, 46.6%  
36, 35.0%  
9, 8.7%
0.86
Social class (n, %) 
Class 1 
Class 2 
Class 3
Class 4 or more
36, 18.9%  
90, 47.4 % 
22, 11.6% 
42, 22.1 %
20, 22.7%  
38, 43.2%  
8, 9.0% 
2 1 ,2 9 .3 %
16, 15.5% 
52, 50.5%  
14, 13.6% 
21,20.4%
0.40
Ethnicity (n, %) 
White 
Non-white
172, 90.5%  
18, 9.5%
80, 90.9%  
8 ,9 .1  %
92, 89.3%  
10,9.7%
0.87
Numbers o f  missing data (boys, girls) are as follow: Maternal height (1 ,2 ) , Paternal height (2, 2), 
Maternal BMI (2, 3), Paternal BMI (8, 6), Pubertal status (1, 0), Physical activity (0, 3), Social class (1, 0), 
Ethnicity (0, 1).
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5.3.3 Early growth and later body size
Regression analyses of later body size and composition on AweightSDS during different 
periods of infancy are shown in Table 5-3. In the first model (Table 5-3a), only 
birthweight SDS and gender were adjusted for. AWeightSDS from birth to 3 weeks and 
3 to 6 weeks showed a positive association with height SDS, but not weight or BMI, in 
childhood and adolescence. A 1 AweightSDS increase during these respective periods 
was associated with a 0.37 SDS (95%CI 0.09, 0.64) and 0.55 SDS (95%CI 0.10, 1.01) 
increase in later height. The association remained significant in the same direction after 
adjusting for confounding factors, except for parental height (data shown in Appendix 
E, Table 10-8).
AWeightSDS during later infancy tended to be positively associated with later weight 
SDS and BMI SDS. The association was most prominent for the period 3-6 months; a 1 
AweightSDS increase in early growth corresponded to a 0.68 SDS increase (95%CI: 
0.38, 0.98) in later weight and a 0.60 SDS increase (95%CI: 0.26, 0.95) in later BMI. 
AWeightSDS during this period explained around 11.8% and 7.4% of variability in 
weight SDS and BMI SDS respectively. This association was robust to the adjustment 
for potential confounders (Table 5-3b). These results did not change considerably after 
adjusting for AweightSDS during other periods that were significantly correlated with 
the period of interest (data not shown).
There was no significant association between AweightSDS in the second half of infancy 
and later body size.
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Table 5-3 Regression of current body size and composition on A weight SDS during different infancy periods& 
a) Adjusted for birthweight SDS and gender
Aweight SDS 0-3wk 
(n=149)
Aweight SDS 3-6wk 
(n=139)
Aweight SDS 6-12wk 
(n=157)
Aweight SDS 3-6mo 
(n=150)
Aweight SDS 6-12mo 
(n=125)
Later BC B SE P r2 B SE P r2 B SE P r2 B SE P r2 B SE P r2
Wt SDS 0.22 0.17 0.18 0.57 0.27 0.04 0.032 0.55 0.20 0.006 0.048 0.68 0.15 <0.001 0.118 0.20 0.17 0.26
Ht SDS 0.37 0.14 0.01 0.045 0.55 0.23 0.02 0.041 0.25 0.17 0.15 0.44 0.14 0.001 0.067 0.17 0.15 0.26
BMI SDS 0.03 0.19 0.88 0.38 0.30 0.21 0.58 0.22 0.01 0.043 0.60 0.18 0.001 0.074 0.14 0.19 0.47
FMI SDS 0.05 0.15 0.73 0.33 0.25 0.18 0.45 0.18 0.01 0.039 0.48 0.14 0.001 0.071 0.11 0.16 0.47
FFMI SDS 0.08 0.15 0.62 0.07 0.25 0.77 0.17 0.19 0.36 0.29 0.15 0.06 0.11 0.16 0.47
Triceps SDS 0.04 0.15 0.77 0.56 0.23 0.02 0.041 0.45 0.17 0.01 0.043 0.40 0.14 0.005 0.052 -.05 0.15 0.73
Subscapular SDS 0.01 0.16 0.95 0.45 0.26 0.09 0.37 0.20 0.06 0.37 0.16 0.02 0.036 0.18 0.17 0.28
WC SDS* 0.21 0.16 0.20 0.48 0.27 0.07 0.30 0.21 0.15 0.52 0.16 0.002 0.072 -.004 0.18 0.98
WCS 0.01 0.02 0.47 0.02 0.02 0.47 0.02 0.02 0.22 0.04 0.01 0.006 0.051 0.002 0.02 0.88
WC® 0.01 0.01 0.29 -.01 0.02 0.62 -.02 0.01 0.15 0.004 0.01 0.69 0.001 0.01 0.92
TrunkFMISDS 0.06 0.15 0.69 0.49 0.25 0.05 0.028 0.48 0.18 0.009 0.044 0.51 0.14 0.001 0.080 0.12 0.16 0.46
TrunkFMISDS' 0.04 0.06 0.56 0.21 0.10 0.04 0.031 0.06 0.08 0.46 0.12 0.06 0.06 0.10 0.06 0.13
& From m ultiple regression analysis, each row represents a different m odel with body size  or BC variables in the left hand colum n as a dependent variable; 
Aweight SD S was an independent variable; birthweight SD S and gender were covariates; B = the coefficient o f  Aweight SD S i.e. the change in current body size  
or body com position per early Aweight SD S (w eight SD S change between 2 tim e points), SE = standard error, highlighted p value indicate significant at p<0.05, 
r2 = coefficient o f  determination (calculated from partial r o f  Aweight SD S)
# n=144, 134, 142, 136, and 116 for Aweight SD S 0 -3 wk, Aweight SD S 3-6wk, Aweight SD S 6-12w k, Aweight SD S 3-6m o, and Aweight SD S 6 -1 2m o,
respectively since the database for waist SD S was available only up to the age o f  17.
$ Adjusted for current height (m ) WC was natural log transformed and presented in loge scale. For the m odel with WC, current age was also adjusted for.
00 Adjusted for both current height (m ) and total FM (loge scale)
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b) Adjusted for birthweight SDS, gender, puberty, physical activity, social class, ethnicity, and parental BM I&
Aweight SDS 0-3wk Aweight SDS 3-6wk Aweight SDS 6-12wk Aweight SDS 3-6mo Aweight SDS 6-12mo
Later BC B SE P r2 B SE P r2 B SE P r2 B SE P r2 B SE P r2
Wt SDS 0.17 0.16 0.29 0.54 0.25 0.03 0.036 0.44 0.19 0.02 0.038 0.55 0.15 <0.001 0.090 0.13 0.17 0.45
Ht SDS 0.31 0.15 0.04 0.032 0.53 0.24 0.03 0.039 0.23 0.18 0.20 0.47 0.15 0.001 0.075 0.20 0.16 0.20
BMI SDS -.01 0.17 0.96 0.36 0.27 0.19 0.45 0.20 0.03 0.034 0.41 0.17 0.02 0.042 0.02 0.18 0.93
FMI SDS 0.04 0.14 0.77 0.32 0.22 0.16 0.33 0.17 0.05 0.028 0.32 0.14 0.02 0.038 -.01 0.15 0.93
FFMI SDS 0.03 0.15 0.85 0.07 0.24 0.77 0.13 0.18 0.46 0.21 0.15 0.16 0.07 0.16 0.64
Triceps SDS 0.03 0.14 0.84 0.53 0.22 0.02 0.045 0.34 0.17 0.04 0.029 0.28 0.14 0.05 0.029 -.17 0.15 0.24
Subscapular SDS 0.002 0.15 0.99 0.43 0.25 0.08 0.25 0.18 0.17 0.22 0.15 0.16 0.04 0.16 0.82
WC SDS 0.19 0.16 0.24 0.46 0.25 0.07 0.19 0.20 0.33 0.39 0.16 0.02 0.046 -.10 0.17 0.57
WCS 0.01 0.02 0.53 0.02 0.02 0.48 0.01 0.02 0.43 0.03 0.01 0.07 -.01 0.02 0.65
WC® 0.01 0.01 0.28 -.01 0.02 0.71 -.02 0.01 0.15 0.003 0.01 0.78 0.001 0.01 0.89
TrunkFMISDS 0.04 0.14 0.80 0.47 0.23 0.04 0.034 0.36 0.17 0.03 0.032 0.36 0.14 0.01 0.047 0.001 0.15 0.99
TrunkFMISDS® 0.04 0.07 0.57 0.23 0.11 0.03 0.038 0.05 0.08 0.58 0.11 0.07 0.09 0.10 0.07 0.13
& From m ultiple regression analysis, each row represents a different m odel with body size and BC in the left hand colum n as a dependent variable; Aweight SD S  
was an independent variable; birthweight SD S, gender, puberty, physical activity, social class, ethnicity, and parental BMI were covariates. See footnote to 
previous table.
s Adjusted for current height (m ) WC was natural log transformed and presented in loge scale. For the m odel with WC, current age was also adjusted for.
00 Adjusted for both current height (m ) and total FM (loge scale)
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5.3.4 Early growth and later body composition
Regression analyses results are shown in Table 5-3a and b. AWeightSDS 6-12 weeks and 
3-6 months showed a positive relationship with FMI SDS (1 AweightSDS increase in early 
growth was associated with 0.45 SDS (95% Cl 0.09, 0.80) and 0.48 SDS (95% Cl 0.20, 
0.76) increases in later FMI. AWeightSDS 3-6 months explained more of the variability in 
FMI SDS than AweightSDS 6-12 weeks (7.1% vs. 3.9%). The association remained 
significant but the magnitude was decreased after adjusting for potential confounders 
(Table 5-3b). The results for other indices of fatness such as triceps and subscapular SF 
were similar.
There was a weak trend toward a positive association between AweightSDS at 3-6 months 
and later FFMI SDS; however, it was diminished after adjusting for potential confounders. 
Interestingly, this trend strengthened slightly after adjusting for parental height (Appedix 
E, Table 10-8) instead of parental BMI in the model. However, the effect size was smaller 
than for FMI SDS at the same period (1 AweightSDS increase in early growth was 
associated with a 0.29 SDS increase in later FFMI; 95% Cl -0.003, 0.58). The main 
findings did not change when birthweight SDS was removed from the models (data not 
shown).
5.3.5 Early growth and fat distribution
Higher AweightSDS 3-6 months was associated with a tendency for central fat distribution 
assessed by WC, and trunk FMI; the effect size was equivalent to a 0.52 SDS (95%CI 0.20, 
0.84) increase in WC and 0.51 SDS (95%CI 0.23, 0.80) increase in trunk FMI per 
1 AweightSDS increase in early weight (Table 5-3a). Since WC SDS was not available for 
subjects older than 17, analyses using WC adjusted for height were also performed; the 
association was similar to that using WC SDS. After adjusting for potential confounders 
(Table 5-3b), this association remained significant but the strength was attenuated.
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Moreover, there was also a weak positive association between A SDS 3-6wk and 6-12wk 
and trunk FMI SDS.
To separate the effects of early growth on the tendency to store fat centrally from effects on 
total fatness, further adjustment for total FM was performed. The positive association 
between AweightSDS 3-6 months and waist circumference was no longer statistically 
significant after adjusting for total FM (from 4C model) whereas the relationship with trunk 
FMI SDS reduced substantially but a positive trend still remained. This finding suggests 
that the association between AweightSDS 3-6 months and WC was not beyond its 
relationship with total fatness, whereas the association with trunk FMI might be to some 
degree.
5.3.6 Additional analyses
There was no significant association between AweightSDS in the second half of infancy 
with later body composition and fat distribution. Since the sample size in this period was 
smaller than for the other periods, analyses were repeated with imputed data (n=T78). 
AWeightSDS during this period did not show any significant association with body 
composition outcomes except for a weak positive association with later weight and height 
(data shown in Appendix E, Table 10-9). In addition, the results of the same analyses with 
imputed data for other periods of growth were comparable to those described in the 
previous sections.
The results table for the subgroup analysis in boys and girls for the 2 periods when the 
interaction between sex and AweightSDS was significant, and when there was a difference 
in AweightSDS between boys and girls is shown in Appendix E, Table 10-10. Results 
were comparable to those shown in Table 5-3 except that: 1) the period of AweightSDS 
that correlated with later fatness was confined to 3-6 months in girls and 2) boys showed a 
significant positive association between AweightSDS 3-6 months and FFMI SDS which
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persisted after adjusting for the potential confounders. There was no significant relationship 
between any other period of AweightSDS and FFMI SDS in boys (data not shown).
To compare my results with those from other published studies, the same analysis was 
repeated on using AweightSDS 0-6 months (Table 5-4). Weight SDS gain during the first 
half of infancy was positively associated with later FM, FFM, and central fat distribution. 
The effect size was slightly larger for FM than FFM; 1 AweightSDS increase in early 
growth was associated with a 0.34 SDS (95%CI 0.16, 0.51) increase in FMI and a 0.24 
SDS (95%CI 0.06, 0.42) increase in FFMI. A SDS 0-6 months explained 8.4% and 4.2% of 
the variability in FMI SDS and FFMI SDS, respectively.
Another issue is whether, using short periods of weight gain (e.g. A SDS 0-3 wk, 3-6wk, 6- 
12wk) compared to a 3 month period (3-6 months) makes associations with later body 
composition more difficult to detect. To investigate this, the same analysis was repeated 
using weight gain over the 3 month period from birth to 3 months (A SDS 0-3 months) 
(Table 5-4). A similar positive association with FMI SDS and various indices of central 
fatness was found; however, the strength of the association and the effect size were 
generally smaller than seen for A SDS 3-6 months. For example, 1A SDS increase from 0-3 
months was associated with a 0.28 SDS (95%CI 0.07, 0.49) increase in FMI whereas 1A 
SDS increase from 3-6 months was associated with a 0.48 SDS (95% Cl 0.20, 0.76) 
increase in later FMI. The percentages of variance in FMI SDS explained by A SDS 0-3 
months and 3-6 months were 3.8% and 7.1%, respectively. There was no significant 
association between A SDS 0-3 months and FFMI SDS.
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Table 5-4 Regression of current body size and composition on Aweight SDS from birth to 3 months and birth to 6 months&
Aweight SDS 0-3 mo (n=173) Aweight SDS 0-6 mo (n=161)
Later BC B SE P r2 B SE P r2
Wt SD S 0.43 0.12 <0.001 0.075 0.57 0.09 <0.001 0 .200
Ht SD S 0.34 0.10 0.001 0.063 0.44 0.08 <0.001 0.162
BMI SD S 0.34 0.13 0.01 0.038 0.38 0.12 0.001 0.064
FMI SD S 0.28 0.11 0.01 0.038 0 .34 0 .09 <0.001 0.084
FFMI SD S 0.17 0.11 0.13 0 .24 0 .09 0.01 0.042
Triceps SD S 0.33 0 .10 0.002 0.057 0.35 0 .08 <0.001 0.098
Subscapular SD S 0.25 0.12 0.03 0 .026 0.30 0 .10 0.003 0 .056
W C SDS* 0.34 0.12 0.01 0.048 0.46 0 .10 <0.001 0.135
W CS 0.03 0.01 0.01 0.035 0.03 0.01 0.001 0.075
W C00 0.004 0.01 0.53 0.01 0.01 0.34
TrunkFM ISDS 0.32 0.11 0.004 0.048 0.38 0.09 <0.001 0.104
TrunkFM ISDS* 0.06 0.05 0.21 0.10 0.04 0.011 0.041
& From multiple regression analysis, each row represents a different m odel with body size and BC in the left hand colum n as a dependent variable; Aweight SD S  
was an independent variable; birthweight SD S and gender were covariates.
* n=157, and 145 for Aweight SD S 0-3 m o, and Aweight SD S 0-6 m o, respectively since the database for w aist SD S was available only up to the age o f  17.
s Adjusted for current height (m ) WC was natural log transformed and presented in loge scale. For the m odel with WC, current age was also adjusted for.
oo
Adjusted for both current height (m ) and total FM (loge scale)
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5.4 Discussion
My analyses showed an association between early growth and later body size and body 
composition using the 4-component model. A summary of the findings is shown in 
Table 5-5. To recap, I have demonstrated that growth during early infancy (first 6 
months) was associated with FMI and central fat distribution whereas growth in the 
second half of infancy did not significantly relate to any of the body composition 
outcomes. These associations were independent of birthweight, current body size, sex, 
age, pubertal stage, physical activity, social class, ethnicity, and parental size. This 
finding might be of importance since early infancy is a period when infant growth can 
change considerably depending on infant feeding and weaning practice.
Interestingly, growth during 3-6 months of age also showed a weak positive relationship 
with FFMI in boys. This gender difference is in agreement with the findings from the 
previous chapter in that the association of birthweight and FFM was apparent only in 
boys. However, if the period of growth in the analysis was extended from birth to 6 
months, a positive association with FFMI was statistically significant in both boys and 
girls. Indeed, gender differences in this early growth analysis were not as obvious as in 
the birthweight analysis; the effect of early growth on later FMI and central fat 
distribution was substantial in both boys and girls.
In this discussion, I will focus on three specific issues: 1) comparison of my study with 
other studies investigating infant growth and later body composition outcomes, 2) 
different methods of analysis of early growth, and 3) criticisms of my study. Again, the 
potential mechanism of body composition programming and broader implication of my 
findings will be discussed in more detail later in Chapter 9.
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Table 5-5 Summary of the effect of early growth on later body size and composition*
Early growth period
Outcomes 0-3 weeks 3-6 weeks 6-12 weeks 3-6 months 6-12 months 0-3months 0-6months
Height T T T T - T t - TT T T
BMI - - t t T T - T T TT
FMI - - TT T T - T T T
FFMI - - - T ? - - T
Central fat distribution - T ? T? T T - TT T T
-  indicates no statistically significant association; f  indicates weak positive association, f  f  indicates strong positive association (i.e. B coefficient >  0.3 SDS  
increase in BC outcom es per 1A w eight SD S in infancy; ? = the results were only statistically significant in som e m odels with adjustment for different 
confounders.
#
Considered from WC, subscapular SF, and trunk FMI; how ever, m ost o f  the association with w aist circum ference or trunk FMI SD S were attenuated 
substantially after adjusting for total FM.
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5.4.1 Comparison with other studies
5.4.1.1 Early growth and later body size
A number of publications showed that rapid growth in early infancy was positively 
associated with later height, weight, and BMI in childhood and early adult life 
(82;84;85;87;182;196;210). My findings agree with these studies in that early infancy 
weight gain was positively related to later height and BMI; however, it gives more 
information about the possible ‘sensitive’ period of infant growth. Growth (defined by 
weight SDS change) in very early postnatal life i.e. the first 6 weeks, seems to have a 
long term association with later height. However, this relationship depends on parental 
height, suggesting that early AweightSDS may mediate the relationship between parental 
height and offspring height as well as birthweight, i.e. infants of taller parents grow 
more quickly during this period and have higher height SDS in later life. The positive 
correlation between parental height and AweightSDS 3-6 weeks seems to support this 
idea.
Most studies exploring the relationship between infant growth and later BMI (as a proxy 
for ‘adiposity’ or ‘obesity’) only present infant growth over a 6-month or 1-year period 
(see Chapter 2). This is probably because more detailed, reliable growth records during 
infancy are difficult to obtain. Stettler et al (211) recently published an article using 
detailed early growth data (weight at 8, 14, 28, 42, 56, 84, and 112 days) from several 
infant formula studies in relation to later BMI. They proposed that the period between 
birth and the first week as well as the first 112 days of life were potentially critical in 
predicting overweight status (defined by reported BMI > 25 kg/m2) in adults aged 20-32 
years. In my opinion, the early growth data in this study seem to be sound but, 
unfortunately, the outcome measure was quite crude since it was the ‘reported’ usual 
weight and height obtained by telephone interview which may be subject to 
underreporting in the case of overweight subjects. In my data, I did not have 
measurements at the age of 1 week, but growth from birth to 3 weeks did not show
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correlation with later BMI. However, my data agreed that growth in the first 3 months 
was positively associated with later BMI in childhood and adolescence. Again, it is 
difficult to directly compare the studies since available data on early growth and 
outcome measures were at different ages.
5.4.1.2 Early growth and later body composition and fa t distribution
There have been considerably fewer studies looking into the association between infant 
growth and later body composition that use measurements beyond BMI i.e. that consider 
FM and FFM separately (Table 5-6). Most have been published in the last few years. 
Wells et al (196) studied 172 Brazilian boys at the age of 9 years (with BIA) and found 
that AweightSDS from birth to 6 months was associated with later height, BMI and LM 
(not FM) whereas AweightSDS 6-12 months showed no relationship with later body size 
and composition. The association with LM found in their study was consistent with my 
study as I also found a positive association between AweightSDS 3-6 months and FFMI 
in boys. However, the main difference is that growth in early infancy in their study did 
not seem to be associated with later FM (adjusted for height). It should be noted that the 
two studies were different in that 1) the population studied by Wells et al were from a 
non-westem country, so the pattern of growth during infancy and childhood might be 
different from the western children in my study (supported by the fact that their 
birthweight and weight SDS during infancy were lower than the British reference), 2) 
Wells et al measured outcomes at a prepubertal age when the effect of early growth on 
FM might not be so apparent, whereas in my study the dataset includes both early and 
late pubertal subjects; and 3) the body composition technique used was different (BIA 
vs. 4C model). Indeed, an exclusive association between postnatal growth (birth to 2 
years) and FFM in adults was also found by Li et al (203) in a Guatemalan population. 
Unfortunately, their results cannot be directly compared with mine because the 
researchers used length gain as a proxy for postnatal growth. Their findings are perhaps 
not surprising since linear growth is usually highly correlated with adult height (which in 
turn is more strongly related to FFM than FM).
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Table 5-6 Summary of the studies investigating the association between early infant growth and later body composition in
children, adolescents and young adults
Reference Population Age n BC technique Gender Statistics Early growth variables Outcomes Covariates Results
Wells et al, 
2005(196)
Brazilian
boys
9-10y 172
BIA,
Anthropometry
Boys
ANOVA,
Regression
Quartile o f  AweightSDS 
0-6, 6-12mo, 1-4,4-9 yr
Height, BMI, 
LMI (height"), 
FMI, FM/LM"
SES,
maternal BMI
- AweightSDS 0-6 mo positively associated with later 
height, BMI and LMI
- AweightSDS 6-12 mo show no significant association 
-AweightSDS 1-4 yr positively associated with both FMI, 
LMI but AweightSDS 4-9 yr associated with only FMI
Ekelund et 
al, 2006 
(210)
Swedish
adolescents
17y 248 Bodpod
Both
sexes
included
GLM
(ANCOVA)
AweightSDS 0-6mo, 3- 
6y as continuous 
variable vs. divided into 
rapid, slow, no change 
(AweightSDS >0 67, <- 
0.67, and between)
Height, BMI, 
WC, %fat, FM, 
FFM
Sex,
gestation, 
height, SES, 
maternal FM, 
birthweight
- AweightSDS 0-6 mo and 3-6y were positively associated 
with later BMI, WC, %fat, FM, FFM
- only AweightSDS 0-6 mo was positively associated with 
height
- No significant interaction between birthweight SDS and 
AweightSDS with regard to any outcomes
- the effect size on both FM and FFM o f  AweightSDS 3-6y 
was bigger that that o f  0-6 mo
Euser et al, 
2005(182)
Dutch adult 
Preterm bom 
<32 wk, 
BW <1500 
gm
19y 403
Anthropometry 
(SF equation)
Both
sexes
included
Regression
AweightSDS 0-3 and 3- 
12 mo
W eight/ Height/ 
BMI/
WC/SumSF 
SDS, WHR, 
S:T,%Fat, FM, 
FFM
Height SDS, 
sex, race, 
SES, activity, 
birthweight 
SDS and 
earlier 
AweightSDS
- Both AweightSDS 0-3mo and 3-12 mo positively 
associated with HTSDS, WTSDS, BMISDS, WC SDS, 
FM, FFM, %fat
- No association between AweightSDS and WHR or S:T 
ratio
- No significant interaction between birthweight SDS and 
AweightSDS with regard to any outcomes 
-AweightSDS 0-3 mo contribute to larger r2 for BMI, WC, 
FM, FFM than AweightSDS 3-12 mo/ r 2 for FM was larger 
than FFM
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Table 5-6 (cont.) Summary o f the studies investigating the association between early infant growth and later body composition
in children, adolescents and young adults
Reference Population Age n BC technique Gender Statistics Early growth variables Outcomes Covariates Results
Li et al, 
2003(180)
Guatemalan
adults
21 -27y 267
Anthropometry 
(SF equation)
Both
sexes
included
Regression 
2-stage least- 
squares 
analyses
Birthweight, length, PI, 
Length at 2 yr
Height, weight, 
FFM, FM, 
%fat, WHR
SES, sex,
maternal
height,
physical
activity,
residency,
smoking,
birth length
-Birthweight, length, length at 2yr were positively 
associated with height, weight, FFM in both sexes 
- Birth length and change in length 0-2yr equally 
determined height, weight, and FFM
Sachdev et 
al, 2005 
(204)
Indian adults 26-32y 1526
Anthropometry 
(SF equation)
Both
sexes
included
Regression,
Partial
correlation,
conditional
SDS o f BMI
change
Birthweight, length, PI, 
BMI at 6mo, ly , 2y, 5y, 
8y, 1 ly , and 14y
Height, weight, 
BMI, WC, 
WHR, sum SF, 
lean residual, 
arm muscle 
area,
Age, sex, 
adult life 
styles, birth 
BMI
- BMI at all age correlated with lean residual > sum SF, 
differences were more significant in males
- BMI change (by conditional BMI SDS) 0-6 mo and 2-8 y 
showed a strong positive association with later lean 
residual
- BMI change 0-6 mo showed a weak positive association 
with later sum SF, strength o f  association increased 
steeply from 2-8 y and sustained.
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Sachdev et al. (204) studied another population from a developing country (New Delhi 
birth cohort) and reported a positive association between change in BMI SDS from birth 
to 6 mo and later lean residual (calculated from SF equation and adjusted for height in 
the regression model) in young adults. They also reported a weak positive association 
between growth in the same period and later sum of SF. This study, however, predicted 
fat and lean mass from anthropometry and used BMI SDS change as measure of growth 
rather than weight SDS change as in my study.
Euser et al (182) studied preterm-born Dutch young adults presenting FM and FFM 
calculated from a SF equation. Their findings support my results in that AweightSDS 0-3 
months and 3-12 months were both associated with FM and FFM (adjusted by height 
SDS) independent of birthweight. Moreover, the percentages of variance explained by 
AweightSDS in both periods were larger for adult FM than FFM. They also found a 
positive association between AweightSDS in both periods and later WC SDS which 
agrees with my data. The small inconsistency is that AweightSDS 0-3 months in their 
study contributed to a larger r2 for body composition outcomes than AweightSDS 3-12 
months. It could be argued that, although the population were from a western country, 
they were bom very preterm (GA<32 weeks) and these results might not be 
generalisable to term-born populations. Also the body composition measurements were 
derived from SF which predisposes to interobserver variation, and FFM was not directly 
measured.
A recent study from Sweden by Ekelund et al (210) showed that increase in weight SDS 
from birth to 6 months was positively associated with FM, FFM, and WC in late 
adolescence (17yr). The setting of this study is quite similar to my study in that it was 
conducted in a western population using a more precise body composition technique 
than SF (Air displacement plethysmography); their results support the findings in my 
study.
In short, there are some discrepancies between my results and the findings from 3 non- 
western countries in that they found a stronger or exclusive association of early infant
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growth and later FFM whereas I found a positive correlation with both components 
(stronger for FM). However, another 2 studies from western countries seem to support 
my findings. This inconsistency might be due to the fact that infants in a developing 
country (where prenatal nutrition might be restricted) are bom with a ‘suboptimal’ 
muscle mass compared to those from a developed country, and therefore have a higher 
potential to develop more FFM in early postnatal life. Another explanation could be 
differences in infant feeding practice in non-westem and western countries, where the 
latter tend to have an ‘excess’ nutrition compared to the former. See more detail 
discussion in Chapter 9.
5.4.2 Analysis of early growth data
5.4.2.1 Different statistical approaches
In this study, I used multiple regression analysis of body composition outcomes on 
AweightSDS during different periods of infancy, adjusted for birthweight since the aim 
was to look at the effects of ‘postnatal growth’ beyond the effect of ‘prenatal growth’ 
represented by birthweight. In my view this approach has the advantage of being 
statistically powerful and using the continuous nature of the early growth variables. 
However, it is more difficult to illustrate the findings in an easily understandable form 
such as a plot or graph. Data can be more easily presented if early growth data are 
analysed as categories (e.g. catch-up, no change, catch-down or dividing AweightSDS 
into quartiles or quintiles). In this dataset, the main findings of the association between 
AweightSDS 3-6 months quartiles and later FMI SDS or FFMI SDS were similar to the 
regression methods. For example, the adjusted mean (for birth SDS and gender) of FMI 
SDS was significantly higher in the 4th quartile of A SDS 3-6 months compared to the 1st 
and 2nd quartile of AweightSDS (p=0.011 for trend). See Figure 5-2.
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Figure 5-2 Adjusted mean for BMI SDS, FMI SDS, FFMI SDS, stratified according 
to A weight SDS 3-6 months quartiles
a) BMI SDS,
p = 0.007 for trend
-0.06*
1st quartile 2nd quartile 3rd quartile 4th quartile 
Weight SDS change 3-6 months
b) FMI SDS,
p = 0.011 for trend
C) FFMI SDS, 
p = 0.143 for trend
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Weight SDS change 3-6 months
From general linear model, adjusted for birthweight SDS and gender; BC variables were dependent 
variable, gender and A weight SDS 3-6 months quartile were fixed factors, birthweight SDS was a 
covariate. Arterisk show a significant difference from the 4th quartile at p <0.05. n=37, 38, 38, 37 in 1st, 
2nd, 3rd, 4 th quartile, respectively.
142
Another approach is the life course plot proposed by Cole TJ (212) in which the 
regression coefficients of size (e.g. weight SDS) at different periods are plotted against 
age. In my dataset, weight was measured at 6 ages over a relatively short period of time 
(the first year) and weight SDS were highly correlated (see Table 5-la); therefore, when 
weight SDS at combinations of the 6 different ages were put into the same regression 
model, the significance and regression coefficients changed dramatically (how they 
changed depended on which set of measurements were in the model). However, when 
AweightSDS were used instead of weight SDS (adjusting for each other and birthweight 
SDS at the same time), the result was consistent with my main analyses in that 
AweightSDS 3-6 mo was the most significant period for the association with later FMI 
or central fatness.
As mentioned previously, I also considered imputing the missing weight SDS data in 
order to increase the sample size and statistical power in the analysis. However, 
imputation relies on the assumption of linearity of weight SDS and data being missing in 
an unsystematic manner. The main findings of my analyses using imputed data were not 
substantially different from those using the original data (results are shown in Appendix 
E, Table 10-9). However, I decided to present non-imputed data since the main period 
of interest was the first 6 months when weight SDS can change dramatically; thus the 
assumption of linearity might not always be applicable.
5.4.2.2 Critical windows o f early growth
The attempt to find ‘critical windows’ for body composition programming also leads to 
difficulty in the selection of growth periods for the analysis. If the period of 
AweightSDS chosen is too short, there might be more ‘noise’ from measurement error at 
both ends, and the influence of growth over a short period might be too trivial to be 
significant. On the other hand, birth to 1 year might be too long a period to detect any 
meaningful ‘sensitive’ period of early growth. Therefore, in my analysis I presented
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AweightSDS for all available periods of growth to examine the different influence of 
each, as well as the sum of the smaller windows.
Another interesting issue is why growth in the second 6 months of life was not 
associated with any of the later outcomes. The generally slower relative growth rate 
during this period could make it less likely to be (statistically) significant or it may not 
be the ‘right’ window for body composition programming. In my opinion, both 
explanations could apply but the latter idea seems to make sense biologically as well, 
since it seems logical that the ‘critical’ period for programming later outcomes should be 
the period of greatest change (i.e. early infancy).
However, most of the studies published so far (including mine) use different time points 
in infancy and childhood depending on which data were available rather than selected 
for a biological reason. Therefore, it is even more difficult to draw a firm conclusion 
regarding any critical window(s) of early growth for different body composition 
outcomes.
5.4.3 Criticisms of the study
5,4.3.1 Characteristics o f the dataset
This dataset was a subset of the population analyzed in Chapter 4; therefore, their 
physical characteristics were similar—girls generally had higher SDS for body size and 
SF than the British 1990 reference.
In general, the infant growth pattern of my subjects was representative of the reference 
population, except for age 3 weeks when their weight SDS was significantly less than 
zero. This might be explained by: 1) the smoothing of reference growth data by the LMS 
method and 2) the fact that reference growth data were collected cross-sectionally;
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growth charts therefore cannot reflect the physiology of slower weight gain in this 
period (i.e. after the normal physiologic weight loss in the first 1-2 weeks); rather than 
indicating that the early growth pattern of my subjects was unusual.
5.4.3.2 Reliability o f early growth data
The majority of infant weight data in my dataset (139 out of 191, 73%) came from 
parent-held baby record books, and weight was generally not recorded at the precise 
times specified by the protocol for the prospective study. Although I have tried to 
overcome this problem by using SDS (which were calculated using the exact age at 
measurement) and selecting the measurement that was nearest to the age in the 
prospective cohort, the shorter periods of AweightSDS (3, 6, 12 weeks) inevitably 
suffered more noise. This could lead to some inaccuracies in the data analysis; however, 
when these short windows were added together, the main findings did not change.
5.4.3.3 Potential confounders
The effects of potential confounders on body composition outcomes were already 
discussed in the previous chapter. In fact, the main confounder that could significantly 
influence infant growth is the nutritional intake or at least infant feeding mode. 
Unfortunately, feeding mode data were only available in the prospective study (only 
27%); therefore, I could not adjust for the feeding mode in this analysis. Further 
analyses of the influence of early nutrition on body composition are shown in Chapter 
8.
5.4.3.4 Wide age range and inclusion o f children at different pubertal 
stages
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I have tried to rectify the criticism that my body composition outcomes were measured 
over a wide range of age and pubertal maturation (previously mentioned in Chapter 4) 
by using age and sex specific SDS for the body composition outcomes. Moreover, the 
results did not change after adjusting for pubertal maturation in the model. Therefore, I 
believe that the results from this analysis are at least not significantly clouded by the 
wide age range of outcomes measured. However, I have to accept that there is a 
possibility that some associations, which might only be seen at some stages of 
maturation i.e. prepubertal or late pubertal, might be missed in this analysis. The ideal 
solution would be to conduct a study with a big enough sample size to perform subgroup 
analysis according to stage of maturation, which might not be possible with more 
detailed body composition techniques such as those used in my study. See Chapter 9.
5.5  S u m m ary
- In western populations, growth in the first 6 months of life is associated with both FM 
and FFM in adolescence and adult life (with a stronger effect on FM).
- My study provides supporting evidence for the association between early growth and 
central fat distribution using a more precise body composition technique (regional FM 
by DXA).
- The clinical importance of these findings needs further investigation in terms of the 
relative importance of FM and FFM for health outcomes such as cardiovascular risk 
factors. Furthermore, although both FM and FFM were associated with early growth, the 
mechanism by which they are programmed could be dissimilar and warrants further 
investigation.
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Chapter 6
The Relationship between Body Composition 
and Cardiovascular Risk
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Chapter 6 The Relationship between Body 
Composition and Cardiovascular Risk
6.1 Introduction
In this chapter, I have analyzed the relationship between different body composition 
variables and several cardiovascular risk markers. The aims were 1) to test hypothesis I- 
2 that different components of body composition (which may themselves be 
programmed by early growth) have differential effects on cardiovascular risk factors; 
and 2) to compare associations of different ‘indices’ of central fat distribution from 
different body composition techniques with cardiovascular risk factors.
6.2 Methods
6.2.1 Subjects
Blood results were available in the prospective cohorts (cohort A, B, and C) only. Of the 
54 subjects who agreed to come to the study centre; 48 subjects had a blood test after an 
overnight fast. All completed the 4C model and had abdominal FM calculated from the 
DXA scan by manual region of interest analysis (details in Chapter 3).
6.2.2 Body composition data
FM and FFM were derived from the 4C model. The following regional DXA soft tissue 
measurements were used: trunk FM, trunk LM, and limb LM (both arms combined with 
both legs). These variables were adjusted for body size by height squared giving FMI, 
FFMI, trunk FMI, trunk LMI, and limb LMI. SDS was calculated (from 308 subjects 
who form the database in Chapter 4) for each variable using the LMS methods as
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described previously in Chapter 5 (details in Appendix C). Abdominal FM was 
assessed by the DXA manual region of interest (142)(see Chapter 3, Figure 3-3 
Examples of DXA scans)
WC, triceps SF, subscapular SF, trunk FM, and abdominal FM, which are generally used 
as proxies for central fat distribution, were compared. All were adjusted for height to 
take account of differences in body size.
6.2.3 Assessment of cardiovascular risk factors
Well-known risk factors for cardiovascular disease were measured. Details are described 
in Chapter 3. Briefly, triglycerides, total cholesterol, HDL cholesterol (HDL-C), 
glucose, insulin, proinsulin, and split-proinsulin were measured in fasting blood 
samples. LDL cholesterol (LDL-C) was calculated using Friedewald’s formula (172). 
HOMA (Homeostasis model assessment) was calculated by the HOMA Calculator @The 
University of Oxford 2004 (173; 174). Blood pressure was measured in triplicate while 
the subject was resting on a couch.
6.2.4 Statistical methods
Partial correlation (adjusting for age, sex and/or height) was used in the analyses. In 
addition, in order to test if the association between several indices for central fatness and 
cardiovascular risks were beyond their relationship with total fatness, total FM was also 
controlled for in some analyses.
All variables that were not normally distributed (Insulin, Proinsulin, 32-33 Split 
proinsulin, Insulin: glucose, HOMA, WC, Triceps, Subscapular, Trunk FM, Abdominal 
FM) were natural log transformed before analysis.
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6.3 Results
6.3.1 Characteristics o f subjects and cardiovascular risk factors
Characteristics of study subjects are shown in Table 6-1. Twelve (25%) subjects were 
overweight and one (2.1%) subject was obese according to the IOTF cut offs (119). 
Boys were comparable with the British 1990 reference whereas girls in this dataset had 
higher BMI, WC, triceps, and subscapular SF than the reference children. As expected, 
girls had more absolute trunk FM, abdominal FM, and SF than boys. However, this 
gender difference was no longer apparent when SDS were used, except for subscapular 
SF and WC.
In general, girls demonstrated higher triglycerides, insulin, 32-33 split proinsulin and 
HOMA IR than boys.
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Table 6-1 Characteristics of study subjects and cardiovascular risk factors
AH (n=48) Boys (n=18) Girls(n=30) P
A ge (y) 14.5 ± 2 .7 14.0 ± 2 .4 14.7 ± 2 .8 0.40
BMI SDS 0.40 ± 1.17 0.02 ±  1.30 0.63 ± 1.04 0.08
FMI SDS 0.20 ± 0 .8 9 0.11 ± 0 .9 0 0.25 ±  0.90 0.60
FFMI SDS -0.02 ±  1.09 -0.33 ±  1.09 0.16 ±  1.07 0.14
Trunk FMI SDS 0.18 ± 0 .9 4 0.08 ±  1.00 0.23 ± 0 .9 1 0.60
Limbs LMI SDS -0.01±  1.17 -0.38 ± 1 .1 5 0.22 ±  1.15 0.09
Trunk LMI SDS -0.05 ±  1.05 -0 .3 2 ±  1.15 0.11 ± 0 .9 7 0.18
Trunk FM (kg) 7.2 ± 4 .2 4.8 ± 3 .0 8.6 ± 4 .2 0.002
Abdominal fat by D X A (kg)$ 1.5 ±1.1 1.0 ± 0 .7 1 .9 ±  1.2 0.01
WC (cm) 71.3 ± 8 .6 69.9 ± 9 .3 72.2 ± 8.2 0.36
Triceps SF (mm) 15.1 ± 5 .5 11.6 ± 4 .8 17.3 ± 4 .8 <0.001
Subscapular SF (mm) 13.3 ± 7 .9 9.5 ± 5 .8 15.5 ± 8 .1 0.008
WC SD S# 0.89 ± 1 .1 1 0.31 ± 1 .0 9 1.27 ± 0 .9 7 0.008
Triceps SDS 0.60 ± 0.88 0.26 ± 1 .1 3 0.81 ± 0 .6 4 0.07
Subscapular SDS 0.42 ±  1.09 -0.11 ±  1.37 0.74 ± 0.73 0.02
Glucose (mmol/L) 5.1 ± 0 .3 5.2 ± 0 .3 5.0 ± 0 .3 0.05
Total cholesterol (mmol/L) 4.7 ± 0 .7 4.6 ± 0 .7 4.7 ± 0 .7 0.40
Triglycerides (mmol/L) 0.8 ± 0 .3 0.7 ± 0 .2 0.9 ± 0.4 0.02
HDL cholesterol (mmol/L) 1.5 ± 0 .3 1.5 ± 0 .3 1.4 ± 0 .2 0.23
§
LDL cholesterol (m m ol/L) 2.8 ± 0 .6 2.7 ± 0 .5 2.9 ± 0 .6 0.29
LDL: HDL ratio 2.0 ± 0 .6 1.9 ± 0 .6 2.1 ± 0 .6 0.18
Insulin (pmol/L) 55.2 ± 3 1 .1 41.7 ±  21.0 63.3 ± 3 3 .6 0.02
Proinsulin (pmol/L) 3.8 ± 2 .1 3.1 ±  1.2 4.1 ± 2 .5 0.12
32-33 Split proinsulin (pmol/L) 5.8 ± 3 .9 4.3 ± 3 .3 6.7 ± 3 .9 0.03
Insulin: glucose ratio 10.9 ± 6 .2 7.9 ± 3 .7 12.6 ± 6 .8 0.01
HOMA IR& 1.0 ± 0 .6 0.8 ± 0 .4 1.2 ± 0 .6 0.02
SBP (mmHg) ® 109.6 ± 6 .4 109.6 ± 6 .7 109.5 ± 6 .4 0.98
DBP (mmHg) ® 60.8 ± 6 .5 60.1 ± 6 .8 61.2 ± 6 .4 0.57
MAP (m m H g)@ 79.9 ± 5 .7 78.7 ± 6 .7 80.5 ± 5 .1 0.29
$ Measured by DXA manual region o f  interest (upper border o f  LI - lower border o f  L4)
$
n=38 since the database for waist SDS was available only up to the age o f  17
§
calculated by Friedewald formula (172): LDL = total cholesterol-HDL-0.456 x Triglycerides (mmol/L) 
& HOMA = Homeostasis Model Assessm ent, calculated by the HOMA Calculator ®The University o f  
Oxford 2004 from fasting glucose and insulin, IR = insulin resistance
@
Blood pressure was available in 51 subjects, SBP = Systolic Blood Pressure, DBP = Diastolic Blood  
Pressure, MAP = Mean Arterial Pressure
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6.3.2 Differences in the relationship between FM vs. FFM and 
cardiovascular risk factors
Partial correlations (adjusting for age and gender) between SDS for BMI, FMI, Trunk 
FMI, FFMI, Limb LMI, Trunk LMI and cardiovascular risk factors are shown in Table 
6-2. FMI was more strongly and positively related to total cholesterol, triglycerides, and 
LDL-C (correlation coefficients—r were 0.33, 0.41, and 0.37; p <0.05) than BMI. BMI 
showed a stronger correlation with LDL:HDL ratio than other BC indices. Higher FMI 
also correlated well with unfavourable insulin profiles and higher blood pressure (r = 
0.37-0.57); however, the correlations in general were not stronger than those for BMI (r 
= 0.45-0.57). FMI and Trunk FMI showed similar relationships with lipid and insulin 
profiles.
Interestingly, higher FFMI was associated with lower HDL-C (r = -0.54, p<0.001— 
scatter plots are shown in Figure 6-1) and the correlation was stronger than that for 
BMI; FFMI explained 29 % of variability in HDL-C whereas BMI only explained 19%. 
Although higher FFMI was also associated with various indices indicating a tendency 
towards insulin resistance and higher blood pressure, the correlations were lower than 
those for FMI or Trunk FMI. Regional LMI showed the same trends for association with 
cardiovascular risk factors as FFMI; generally, limb LM showed a stronger relationship 
with these markers than trunk LM, except for HDL-C, where trunk LM showed a greater 
correlation.
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Table 6-2 Partial correlation (r) between BC and cardiovascular risk factors
BM I FM I T runk FM I FFM I L im bs LM I T runk LM I
Glucose 0.23 0.10 0.15 0.15 0.21 0.07
Total cholesterol 0.09 0.33 * 0.26 -0.14 -0.10 -0.27
Triglycerides 0.29 0.41b 0.40b 0.09 0.07 0.10
HDL cholesterol -0.44 b -0.19 -0.25 -0.54 6 -0.46 b -0.58c
LDL cholesterol 0.25 0.37“ 0.33a 0.08 0.09 -0.06
LDL: HDL ratio 0.54 c 0.41b 0.41b 0.44b 0.41b 0.36*
Insulin 0.56 c O.S7c 0.61c 0.33 * 0.32 * 0.24
Proinsulin 0.51c 0.48 b 0.51c 0.38 b 0.38 b 0.27
32-33 Split proinsulin 0.45 b 0.37 b 0.43 b 0.3 5 h 0.32* 0.30*
Insulin: glucose 0.55 c 0.56c 0.59c 0.31* 0.29 0.23
HOMA IR O.S7c 0.57c 0.61c 0.33 * 0.32* 0.24
Systolic BP 0.54c 0.50c 0.54° 0.36a 0.34* 0.24
Diastolic BP 0.56c 0.56e 0.54c 0.31a 0.38 b 0.21
MAP 0.56c 0.49° 0.51c 0.39 b 0.43 b 0.29*
Controlled for age and gender, all BC variables were analyzed in SDS form; ap <  0.05, bp < 0 .0 1 ,cp<0.001
Figure 6-1 Scatter plots of body composition and later HDL cholesterol 
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Since FMI and FFMI were strongly correlated with each other, further analysis was 
performed by adjusting for FFMI in the partial correlation analysis of FMI and vice 
versa. The results are shown in Table 6-3. The relationships between FMI or trunk FMI 
and various cardiovascular risk factors were hardly affected while those of FFMI or 
regional LMI was substantially attenuated and became non-significant except for the 
association with HDL-C (which was a strong negative association, r range from-0.43 to - 
0.57) and LDL:HDL ratio (which was a weak positive association, r range from 0.30- 
0.35). This confirms that FM and FFM have differential effects on lipid and insulin 
profiles. The association between higher FFMI and an unfavourable insulin profile in 
Table 6-2 is mostly due to its association with FMI. However, the negative association 
between FFMI and HDL-C was independent of FMI.
Table 6-3 Comparison of partial correlation (r) between FMI vs. FFMI and 
cardiovascular risk factors adjusted for each other++
F M I 1 T runk F M I1 F F M I 2 L im bs L M I2 T runk L M I2
Glucose 0.05 0.10 0.13 0.18 0.06
Total cholesterol 0.41b 0.35“ -0.29 -0.26 -0.32“
Triglycerides 0.40b 0.40 h -0.07 -0.10 0.06
HDL cholesterol 0.01 -0.03 -0.51c -0.43 b -0.57c
LDL cholesterol 0.37a 0.33° -0.06 -0.06 -0.10
LDL: HDL ratio 0.30 a 0.28 0.35 a 0.30“ 0.35“
Insulin 0.51c 0.55 c 0.16 0.14 0.22
Proinsulin 0.40b 0.42 b 0.26 0.25 0.26
32-33 Split proinsulin 0.27 0.33“ 0.26 0.21 0.28
Insulin: glucose 0.51c 0.53c 0.14 0.10 0.21
HOMA IR 0.51c 0.55c 0.17 0.14 0.22
Systolic BP 0.43 b 0.47b 0.23 0.19 0.22
Diastolic BP 0.51c 0.47b 0.14 0.22 0.18
MAP 0.41b 0.42 b 0.27 0.30 “ 0.28
Controlled for age, gender, and either 'FFMI SDS or 2FMI SDS, all BC variables were analyzed in 
SDS form
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Further adjustment for WC reduced the association between FMI and these outcomes 
substantially; FMI and trunk FMI remained only weakly correlated with insulin and 
HOMA IR (r = 0.31, p < 0.05) (Table 6-4). On the other hand, FFMI and trunk LMI still 
showed a strong negative association with HDL-C, suggesting that the association was 
independent of WC.
Table 6-4 Comparison of partial correlation (r) between FMI vs. FFMI and 
cardiovascular risk factors adjusted for waist circumference
FM I T runk FM I FFM I T runk LM I
Glucose 0.12 0.19 0.12 0.03
Total cholesterol 0.28 0.19 -0.30 -0.37“
Triglycerides 0.15 0.12 -0.20 -0.08
HDL cholesterol 0.26 0.15 -0.42 b -0.50 b
LDL cholesterol 0.18 0.13 -0.10 -0.19
LDL: HDL ratio 0.02 0.02 0.26 0.22
Insulin 0.31“ 0.32* -0.09 -0.05
Proinsulin 0.02 0.02 -0.01 -0.01
32-33 Split proinsulin 0.03 0.10 0.06 0.10
Insulin: glucose 0.28 0.28 -0.11 -0.06
HOMA IR 0.31* 0.33“ -0.08 -0.05
Systolic BP 0.20 0.27 0.08 0.03
Diastolic BP 0.28 0.21 0.002 -0.01
MAP 0.19 0.21 0.13 0.10
- m-
Controlled for age, gender, waist circumference and height, all BC variables were analyzed in SDS  
form
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6.3.3 Relationship between different indices of central fat distribution 
and cardiovascular risk factors
To compare the various proxies of central fat distribution, partial correlations adjusted 
for age, gender, and height are shown in Table 6-5. Among the ‘central fat distribution’ 
indices used in my analysis, WC seemed to perform as well as trunk FM and abdominal 
FM (by DXA ROI) in relation to the association with cardiovascular risk factors. 
Interestingly, WC was negatively correlated with HDL-C, whereas trunk FM and 
abdominal FM were not significantly correlated; therefore, it also showed a stronger 
positive association with LDL:HDL ratio. Higher subscapular SF was more strongly 
related to an unfavourable insulin profile than higher triceps SF.
Table 6-5 Partial correlation (r) between proxies for central fat distribution and 
cardiovascular risk factors^
W C T riceps Subscapular T runk FM A bdom inal FM
Glucose 0.04 0.13 0.23 0.17 0.18
Total cholesterol 0.27 0.28 0.20 0.26 0.27
Triglycerides 0.38 b 0.33 a 0.39b 0.33“ 0.3 l a
HDL cholesterol -i0.33“ -0.01 -0.22 -0.19 -0.18
LDL cholesterol 0.37“ 0.24 0.24 0.31a 0.32 a
LDL: HDL ratio 0.47 b 0.19 0.31 a 0.34 a 0.34 a
Insulin 0.56c 0.53 c 0.59e 0.59° 0.58c
Proinsulin 0.58° 0.29 0.46b 0.45 b 0.42 b
32-33 Split proinsulin 0.43 b 0.26 0.36b 0.39b 0.35“
Insulin: glucose O.S5c 0.51c 0.56c 0.57c O.S5c
HOMA IR 0.56c 0.53c 0.60° 0.60c 0.58c
Systolic BP 0.47b 0.50c 0.53c 0.51Q 0.51°
Diastolic BP 0.50c 0.49c 0.59c 0.53c O.S3c
MAP 0.46b 0.42 b 0.54c 0.48 b 0.50c
+++
Controlled for age, gender, and height
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After adjusting for total fatness (by 4C FM, and in the case of trunk and abdominal FM 
by non-trunk or non-abdominal FM accordingly) (Table 6-6), the proxies that remained 
significantly correlated with lipid and insulin profile were WC (negatively associated 
with HDL-C and positively associated with LDL:HDL ratio and proinsulin), triceps SF 
(negatively associated with LDLiHDL ratio and proinsulin), and trunk FM (positively 
associated with SBP).
Table 6-6 Partial correlation (r) between proxies for central fat distribution and
+++
cardiovascular risk factors adjusted for total fatness
W C 3 T riceps3 Subscapular3 T runk FM 4 A bdom inal F M 5
Glucose -0.13 0.03 0.24 0.17 0.19
Total cholesterol 0.03 0.01 -0.13 -0.03 -0.02
Triglycerides 0.19 0.06 0.19 0.12 -0.02
HDL cholesterol -0.4 l b 0.29 -0.20 -0.26 -0.15
LDL cholesterol 0.19 -0.15 -0.10 0.07 0.06
LDL: HDL ratio 0.39“ -0.32“ 0.05 0.20 0.13
Insulin 0.15 -0.02 0.21 0.27 0.11
Proinsulin 0.42 b -0.34“ 0.13 0.21 -0.01
32-33 Split proinsulin 0.27 -0.17 0.11 0.26 0.05
Insulin: glucose 0.18 -0.02 0.16 0.24 0.07
HOMA2 IR 0.14 -0.01 0.22 0.28 0.13
Systolic BP 0.14 0.17 0.25 0.34“ 0.21
Diastolic BP 0.06 -0.07 0.25 0.13 0.03
MAP 0.13 -0.04 0.29 0.23 0.19
None of the relationships between body composition and cardiovascular risk factors 
shown in this chapter were considerably changed after adjusting for physical activity
Controlled for age, gender, height, and total fatness (by adjusting for 34C FM and 4non-trunk FM or
5non-abdominal FM, accordingly)
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assessed by parents or self- rating from 1 (much less active than peers) to 5 (much more 
active than peers).
6.4 Discussion
6.4.1 Body composition and cardiovascular risk factors
Despite a relatively small sample size, my dataset was reasonably representative of 
contemporary UK children with a similar proportion of overweight children to that 
reported by Lobstein et al (4). Gender difference in the indices of insulin resistance in 
my data corresponds with recent studies of type 2 diabetes in children that show a 
predominance of affected girls than boys, and also the finding that healthy girls might be 
intrinsically more insulin resistant than boys (213).
Although my data supports the increasing evidence from paediatric populations that 
BMI is significantly related to cardiovascular risk factors (see Chapter 2), it also 
showed that separate measurements of FMI and FFMI might provide further information 
for health outcomes. Compared to BMI, FMI had a stronger association with total 
cholesterol, triglycerides, and LDL-C whereas FFMI had a stronger association with 
HDL-C. The latter correlation was independent of FMI and waist circumference. On the 
other hand, FMI and FFMI showed the same correlation with LDL:HDL ratio which 
might be a better predictor of cardiovascular risk than absolute LDL-C or HDL-C. 
However, in this dataset, the relationship between FMI and LDL:HDL ratio arises from 
its positive correlation with LDL-C whereas the same association of FFMI was mediated 
by its negative correlation with HDL-C.
The findings presented here are quite interesting, in that most published literature 
regarding body composition and cardiovascular risk factors only reports the relationship 
between fat or central fat and metabolic outcomes rather than the effect of FFM. 
However, there are a few studies comparing the effects of the FM and FFM components 
of BMI on cardiovascular risk factors. Schubert et al studied middle-age men and
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women from the Fels Longitudinal Study (214) and also reported this negative 
association between FFMI and HDL-C (independent of FMI) in 126 men. Pietrobelli et 
al (215) also reported that there is an inverse correlation between HDL-C and the 
nonadipose component of the body (i.e. adipose tissue-free mass and skeletal mass by 
whole body MRI, and body cell mass by 40K counting) but not between HDL-C and any 
adipose tissue component, in an adult population (using height -normalised indices). 
Indeed, other studies (that did not measure body composition directly) also found that 
HDL-C was lower in power athletes (e.g. weight lifters) compared to normal or 
endurance-trained persons (216;217). This leads to the idea that skeletal muscle might be 
important in HDL-C regulation as supported by evidence from animal studies showing 
that HDL-C concentrations may be altered by increased HDL-C catabolism through 
skeletal muscle lipoprotein lipase (218). Pietrobelli et al (215) also proposed in their 
study that aerobic physical activity is associated with increase in HDL-C whereas 
skeletal muscle hypertrophy per se might not be beneficial for health.
Even fewer studies have actually reported the relationship of FFM and cardiovascular 
risk factors in children or in the context of body composition programming. There is a 
recent report from 234 prepubertal children from the Early Bird study showing that FFM 
(assessed by BIA) had a negative association with triglycerides and total 
cholesterol/HDL-C ratio after controlling for FM in boys (219). The authors suggested 
that this finding supports the argument proposed by Singhal et al (80) that higher 
birthweight predicts lower metabolic risk because it programs more lean mass. I did not 
find a negative association between FFM and triglycerides (which would be regarded as 
a ‘desirable’ effect), but found that higher FFMI was strongly associated with lower 
HDL-C and hence higher LDL:HDL ratio, which would be regarded as an ‘undesirable’ 
effect. A similar effect has been found in a large cohort (n=2000) of Brazilian young 
adult males (age 19-20) and in a smaller group (n=250) of 8-12 year old preterm-born 
children (Fewtrell MS, unpublished data). Although, it is still not clear what the 
underlying mechanism for such an effect might be, further investigation is clearly 
warranted, especially given the apparent positive relationship between birthweight and 
later FFM in males. Moreover, Toikka et al showed that constantly low HDL-C alone
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(for 2 years) without other cardiovascular risk factors was associated with endothelial 
dysfunction and increased in vivo LDL-oxidation in healthy young men (220) 
suggesting that HDL-C may act as an antioxidant and inhibit LDL oxidation (which 
causes arterial dysfunction). Therefore, lower HDL-C in children might be of clinical 
importance.
This is a very good example of the importance of considering the FM and FFM 
components of BMI separately, and preferably by normalising for height since the effect 
of these two components cannot be distinguished when using only percent body fat as a 
representative of body composition. In fact the findings presented here can explain the 
weak negative correlation between BMI and HDL-C found in some large-scale studies 
(221), and suggest that it was perhaps explained by the FFM component rather than FM.
My study confirmed in a non-obese adolescent population the consistent findings from 
other studies showing a strong positive association between total FM or visceral fat and 
triglycerides and LDL in obese populations (222-224) and non-obese adults 
(129;214;215;225). Moreover, the association between FM and insulin resistance indices 
is consistent with a number of publications (138;226;227). There are several possible 
mechanisms that link adipose tissue with the metabolic syndrome. Recent investigations 
have shown that although adipose tissue was once considered metabolically inert, it is in 
fact metabolically active. For example, adipose tissue produces leptin (which is a critical 
hormone in energy balance), a family of cellular mediators (adipocytokines) e.g. TNF-a, 
IL-6 (228) (which play a role in inflammatory process), resistin and adiponectin (which 
is related to insulin resistance). There is evidence that the increase in production of these 
adipocyte factors leads to the metabolic and cardiovascular complication of obesity 
(9;136;228;229).
My results also correspond with other studies in that higher BMI during the adolescent 
period was associated with higher blood pressure (96; 131; 132;230), but it also suggests 
that the FM component of BMI is responsible for this association. Murphy et al studied a 
bigger number of prepubertal children (133 boys, and 101 girls) and also showed a
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positive correlation between systolic blood pressure and FM (219). One potential 
explanation could be an increase in metabolically active factors produced from 
adipocytes e.g. angiotensinogen, the substrate for renin in the renin-angiotensin system 
which plays a central role in blood pressure regulation (231).
In short, my analyses agree with the general assumption that FM contributes to most of 
the adverse cardiovascular risk factors; however, I also demonstrate that FFM also 
shows a significant ‘undesirable’ effect on HDL-C. Therefore, the ‘ideal’ body 
composition to minimize cardiovascular risk factors could be both low FM and 
proportionate FFM. I propose that one might need to bear this in mind when selecting 
the interventions for a ‘healthier’ lifestyle in children since anaerobic exercise that will 
put on disproportionate muscle mass might not always be beneficial for health.
6.4.2 Central fat distribution indices
The importance of visceral adipose tissue and central fat distribution for cardiovascular 
risk factors was reviewed in Chapter 2. All the central fatness indices are associated 
with cardiovascular risk factors but with differing magnitudes. For central fat 
distribution indices presented here, I showed that subscapular SF (which is a more stable 
trunk depot) is a better predictor of insulin profile than triceps SF. WC seems to be the 
best predictor of metabolic profiles in this analysis (or at least not worse than trunk or 
abdominal FM). This finding is supported by other studies in children, showing that WC 
correlated well with visceral adipose tissue and performed better than BMI in predicting 
abdominal fat (by CT) and metabolic profiles (53;232;233). A study in middle-aged 
women comparing anthropometric measurements of central fat distribution and DXA 
abdominal fat (by region of interest L1-L4) also found that the latter did not show a 
stronger association with metabolic variables (234). Despite being assessed using a more 
sophisticated technique, either trunk FM or abdominal FM assessed by DXA are not 
ideal for studying central fat distribution (see explanation in Chapter 2 and Chapter 3). 
Moreover, this technique has limitation for the measurement of soft tissue composition
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(particularly at the extremes of body mass) as well as lack of ability to distinguish 
subcutaneous from intra-abdominal fat. In my opinion, WC is a good screening tool for 
central fat distribution and risk; however, for a medium scale study (in a non-obese 
population) where MRI is not suitable, further research in a larger sample of children 
and adolescent is still needed to see whether DXA regional FM is valuable in estimating 
central fat distribution. In the context of body composition programming, my results in 
C hapter 4 and C hapter 5 show consistent results either when using WC or trunk FM as 
a proxy for central fat distribution.
However, it is worth noting that there was a discrepancy between the magnitude of the 
association of WC vs. trunk FM and HDL-C. WC showed a strong negative association 
with HDL-C whereas trunk FM showed a non-significant relationship with HDL-C (both 
before and after adjusting for total or non-trunk FM). I suggest that this discrepancy 
might be explained by the strong negative association between trunk LM and HDL-C i.e. 
the negative association between WC and HDL-C could be.due to its lean component 
rather than the fat component. This example suggests that in order to fully understand 
the relationship between BC and health outcomes, specific measurement of BC is 
needed even though WC seems to be a good predictor of the well-known risks at the 
population level.
To address the issue of whether total fatness or central fat has more influence on health 
outcomes, I have also further analysed these associations by adjusting for WC in the 
relationship between total FM and cardiovascular risk factors (Table 6-4) and adjusting 
for total fatness in the analysis of proxies of central fatness and cardiovascular risk 
factors (Table 6-6). The positive association between FMI and lipid profile or blood 
pressure was significantly attenuated after adjusting for WC; however, among children 
with the same WC, higher FMI still predicted higher insulin and HOMA IR. In a similar 
manner, for children with the same amount of FM, a larger WC was still associated with 
lower HDL-C and higher proinsulin. Moreover, despite general agreement that visceral 
fat is more metabolically active than subcutaneous fat, there is also some evidence that 
elevated leptin in childhood obesity might be more closely link to subcutaneous than
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visceral FM (235). For these reasons, I believe that good measurements of total fatness 
as well as central fat distribution are just as important.
6.4.3 Criticisms o f the study
The sample size in this dataset is rather small, therefore I cannot perform the analyses 
separately in boys and girls (who have been shown to have differences in insulin 
resistance markers and body composition). Moreover, I do not have the gold standard for 
central fat distribution (MRI or CT) data to compare with other simpler measurements of 
central fat distribution. The findings should therefore be interpreted with caution and a 
bigger sample size is needed to confirm the findings.
It is important to consider, for practical purposes, whether more detailed BC 
measurements have an advantage over ‘simple’ measurements in terms of predicting 
cardiovascular risk. My finding that different components may be differentially related 
to cardiovascular risk suggests that this may be the case. However, since it is more 
difficult, time-consuming and expensive to obtain more detailed measurements, the 
decision may depend on the situation. From the findings discussed here, I think that for 
screening purposes in a normal population, BMI and WC are valid tools for identifying 
children who might be at a higher risk for developing cardiovascular disease in later life. 
On the other hand, more detailed measurements of BC may be useful for 1) research 
purposes e.g. investigating the long-term health outcomes of BC programming or 
investigating health outcomes in populations (e.g. athletes) whose FM and FFM 
proportions might be different from normal; and 2) for clinical purposes. Examples 
might include: an obesity treatment programme in which the effects of different 
treatments on health outcomes could depend on whether they mainly affect FM, FFM, or 
central fat; or patient groups in whom nutritional interventions designed to promote 
weight gain may change body composition dramatically resulting in a disproportionate 
gain in FM compared to FFM which could have differential effects on their long-term 
health.
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6.5 Summary
- FM showed a consistent association with most of the cardiovascular risk factors except 
HDL-C while FFM showed a consistent negative association with HDL-C that was 
independent of FM and central fat distribution.
- WC as well as trunk and abdominal FM assessed by DXA are good predictors for 
cardiovascular risk factors.
- Separate measurements of FM, FFM, and central fat distribution can offer more insight 
into the impact of body composition programming on health outcomes.
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Chapter 7
The Influence of Infant Body Composition 
on Later Outcomes
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Chapter 7 The Influence of Infant Body Composition 
on Later Outcomes
7.1 Introduction
In the previous chapters, I have shown that birthweight and early growth have a 
significant influence on body composition in childhood and adolescence. In this chapter, 
I test hypothesis II, that components of infant BC are differentially related to later BC, 
and possibly mediate the relationship between prenatal and postnatal ‘growth’ and body 
composition in later childhood or early adult life.
7.2 Methods
7.2.1 Subjects
Only subjects from cohorts A, B, and C (description in Chapter 3) had infant BC data 
available for analysis in this chapter. 54 subjects agreed to come to the study centre and 
completed the four-component model and cardiovascular risk factor assessment. 5 
children had a home visit, with anthropometry and deuterium dilution to assess body 
composition (see Chapter 3).
7.2.2 Infant body composition measurements
The subjects from cohort A had detailed anthropometric measurements at age 2-3 days,
3, 6, 12 weeks, 6 and 12 months as a part of the randomised controlled trial of different 
energy infant formulas. Doubly-labelled water measurements were performed at 6 weeks 
and 12 weeks in cohort C and at 12 weeks only in the other cohorts. Infant FM and FFM 
were adjusted by length squared (giving FMI, FFMI) to adjust for differences in body 
size. FMI and FFMI SDS were derived using data from the total group of 48 infants 
from the original cohorts who had BC measured at 6 weeks and 150 infants at 12 weeks.
167
7.2.3 Body composition outcomes
For the 5 home visit subjects who were measured using deuterium dilution, the two- 
component model of body composition was calculated from TBW assuming a FFM 
hydration fraction of 0.751 for boys and 0.746 for girls (obtained from the ongoing body 
composition reference study, unpublished data). For these 5 subjects, FMI SDS and 
FFMI SDS were calculated manually by the LMS method (for age and sex); the 
equations is shown in Appendix C. Body composition data from 54 subjects who 
completed the 4C model were presented as described in Chapter 5 and 6.
7.2.4 Statistical methods
Anthropometric data which were not normally distributed were loge transformed to 
reduce skewness in distribution. SF measurements in infancy were adjusted for gender 
and for the exact age at measurement.
Multiple regression analysis was used to assess the associations between infant body 
composition (measured both by SF and doubly-labelled water) and later body size and 
composition adjusted for potential confounders.
7.3 R e su lts
7.3.1 Characteristics o f study subjects
7.3.1.1 Infant growth and body composition parameters
Weight SDS at 5 ages during infancy (3, 6, 12 weeks, 6 and 12 months) are shown in 
Figure 7-1. Weight SDS dropped at the age of 3 weeks before stabilising at around zero
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and then dropping again at age 12 months. At these two ages, weight SDS in this dataset 
was significantly different from the 1990 reference. When boys and girls were analyzed 
separately, girls showed no significant difference in weight SDS compared to the 
reference whereas boys had lower weight SDS at most ages except for 12 weeks.
There were no significant differences in triceps and subscapular SF between boys and 
girls at these 5 ages during infancy. SF increased with age except for at age 12 months 
when weight SDS also dropped. (Figure 7-2)
Infant body composition data are shown in Table 7-1. There was a trend towards higher 
FFM in boys at 12 weeks but the difference was no longer statistically significant after 
taking length into account using FFMI.
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Figure 7-1 Mean and 95% confidence interval of weight SDS at different ages #
a) All subjects
0.2-
0.0-
-0.2-
-0.4
- 0.8
3 weeks 6 weeks 12 weeks 6 months 12 monthsBirth
b) Separate plots for boys and girls
0.6
0.3
0.0 -
- 0 .3 -
-0 .6 -
- 0 .9 -
0.6-
0 .3 -
0.0 -
- 0 .3 -
-0.6 -
- 0 .9 -
3 weeks 6 weeks 12 weeks 6 months 12 monthsBirth
170
Girls 
B
oys
Figure 7-2 Mean and 95% confidence interval of SF at different ages # 
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# Different samples size at different ages:
3 w eek measurements only available in cohort A (11 boys, 20 girls)
6  w eek measurements only available in cohort A  and C (15 boys, 27 girls)
12 w eek measurements available for all cohorts (22 boys, 36 girls)
6  month measurements only available in cohort A and C (14 boys, 25 girls) 
12 month measurements only available in cohort A and C (11 boys, 21 girls)
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Table 7-1 Characteristics of infant body composition
All Boys Girls P
FM 6 wk (kg)" 1.0 ± 0 .3 1.0 ± 0 .3 1.0 ± 0 .3 0.93
FFM 6 wk (kg) 3.7 ± 0 .2 3.8 ± 0 .3 3.7 ± 0 .2 0.48
FMI 6 wk (kg/m2) 3.3 ± 0 .9 3.4 ± 0 .9 3.3 ±  1.0 0.90
FFMI 6 wk (kg/m2) 12.3 ±  1.2 12.9 ± 0 .9 11.9 ± 1.3 0.23
FMI 6 wk SDS* 0.63 ±  1.03 0.66 ±  0.94 0.61 ±  1.15 0.94
FFMI 6 wk SDS* -0 .16 ±  1.20 0 .10  ±  1.06 -0.32 ±  1.33 0.61
FM 12 wk (kg)"" 1.3 ± 0 .5 1.4 ± 0 .6 1.3 ± 0 .4 0.34
FFM 12 wk (kg) 4.4 ±  0.5 4.6 ± 0 .6 4.3 ±  0.4 0.05
FMI 12 wk (kg/m2) 3.6 ±  1.4 3.8 ±  1.5 3.5 ±  1.3 0.59
FFMI 12 wk (kg/m2) 12.2  ±  1.2 12.4 ±  1.5 12.1 ±  1.0 0.41
FMI 12 wkSDS* -0 .26 ±  1.16 -0.01 ±  1.22 -0.41 ±  1.12 0.30
FFMI 12 wk SDS* 0 .0 2  ±  1.06 -0.18 ± 1.18 0.14 ± 0 .9 8 0.35
Results only available in cohort C (4 boys, 7 girls)
¥
Results available for 15 boys and 26 girls 
SD S was calculated in relation to 48 infants at 6 weeks and 150 infants at 12 weeks.
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73,1,2 Current body composition outcomes
There were two age bands for BC outcomes measured. Subjects in cohorts A and B, 
which were set-up in 1991-1993, were 12.0 -14.4 years old (n=48). The other cohort 
(cohort C) were 18.2-20.4 years old (n=T 1). Body composition data are shown as SDS 
where possible. The body composition data presented here are from 54 children who 
completed the 4C model and 5 children who had the 2C model. All were Caucasian and 
bom in the Cambridge area. For the older cohort, all were Tanner stage 5.
In the younger group (Cohorts A and B—Table 7-2a), girls were taller, had higher BMI, 
waist circumference, triceps and subscapular SF compared to the British 1990 reference. 
Girls had higher FMI than boys but the difference was no longer statistically significant 
when SDS were used. However, for some indices (BMI, waist circumference, and 
subscapular SDS), the differences were beyond normal gender differences.
In the older group, despite a small sample size, gender differences in terms of final adult 
height, FMI, and FFMI were clearly seen (Table 7-2b).
The potential confounders did not differ in boys and girls. The results of all subsequent 
analyses were similar whether the 5 home visit subjects were included or not.
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Table 7-2 Characteristics of study subjects at the time of later BC measurements
a) Cohorts A and B
All (n=48) Boys (n=19) Girls(n=29) P
A ge (y) 13.2 ± 0 .7 13.1 ± 0 .5 13.3 ± 0 .7 0.24
H eight (cm ) 157.8 ± 7 .2 156.7 ± 9.1 158.5 ± 5 .6 0.39
Height SDS 0.25 ±0 .88 0.16 ±0.91 0.31 ±0 .87 0.57
BMI (kg/m 2) 19.9 ± 3 .5 18.2 ± 2 .6 20.9 ± 3 .6 0.006
BMI SDS 0.25 ± 1.19 -0.16 ± 1.19 0.53 ± 1.13 0.05
FMI (kg/m 2) 5.2 ± 2 .5 3.8 ± 1.7 6.1 ± 2.5 0.001
FFMI (kg/m 2) 14.7 ± 1.7 14.4 ±  1.8 14.9 ± 1.6 0.35
FMI SDS 0.07 ± 0.86 0.03 ± 0.87 0.09 ± 0.88 0.82
FFMI SDS -0.02 ± 1.03 -0.40 ± 1.08 0.22 ± 0.94 0.05
Trunk FMI SD S# 0.05 ± 0.99 -0.06 ± 1.00 0.12 ±0 .99 0.58
WC (cm ) 68.6 ± 7.3 70.0 ± 6.7 69.8 ± 7 .5 0.20
WC SD S 0.80 ± 1.09 0.29 ±0 .98 1.13 ± 1.04 0.008
Triceps SD S 0.48 ± 0.95 0.18 ± 1.08 0.68 ± 0 .80 0.07
Subscapular SD S 0.22 ± 1.07 -0.24 ± 1.26 0.52 ±0 .82 0.02
Pubertal status (n, %) 
Prepubertal 
Early pubertal 
Late pubertal
(3, 6.3%) 
(27, 56.2%) 
(18, 37.5%)
(2, 10.5%) 
(10, 52.7%) 
(7, 36.8%)
(1,3.4% ) 
(17, 58.6%) 
(11,37.9% )
0.61
Physical activity (n, %) 
M uch less or less 
Same as peers 
More
M uch more
(3, 6.3%) 
(23, 47.9%) 
(20,41.7% ) 
(2,4.1% )
(1,5.3% ) 
(7, 36.8%) 
(10, 52.6%) 
(1,5.3% )
(2, 6.9%) 
(16, 55.2%) 
(10, 34.5%) 
(1,3.4% )
0.60
Social class (n, %) 
Class 1 
C lass 2 
C lass 3
C lass 4 or more
(5, 10.4%) 
(17, 35.4%) 
(11,22.9% ) 
(15,31.3% )
(3, 15.8%) 
(5, 23.6%) 
(4,21.1% ) 
(7, 36.8%)
(2, 6.9%) 
(12,41.4% ) 
(7, 24.1%) 
(8, 27.6%)
0.58
n=43 (17 boys, 26 girls) for trunk FMI SDS since D XA  data were not available for the 5 home visit 
subjects
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b) Cohort C
AH ( n = l l ) Boys (n=4) G irls(n=7) P
A ge (y) 19.6 ± 0 .6 19.4 ± 0 .9 19.7 ± 0 .4 0.60
Height (cm ) 173.8 ± 9 .0 181.6 ±  6.1 169.3 ± 7 .3 0.02
Height SDS 0.82 ±  1.07 0.61 ± 0 .8 7 0.94 ±  1.21 0.65
BMI (kg/m 2) 23.1 ± 2 .9 22.9 ± 3 .0 23.2 ± 3 .1 0.88
BM I SDS 0.34 ±  1.08 0.26 ±  1.34 0.39 ±  1.03 0.86
FMI (kg/m 2) 6.7 ± 2 .8 4.4 ±  1.9 8.0 ± 2 .4 0.03
FFMI (kg/m 2) 16.4 ± 2 .2 18.4 ±  1.3 15.2 ±  1.6 0.008
FMI SDS 0.31 ± 0 .8 1 0.17 ± 0 .7 2 0.39 ± 0 .9 0 0.70
FFMI SDS -0.30 ±  1.01 -0.28 ± 0 .8 0 -0.31 ± 1 .1 7 0.97
Trunk FMI SD S 0.22 ±  0.78 0.30 ± 0 .6 6 0.17 ± 0 .8 9 0.81
WC ( c m / 79.1 ± 6.8 81.3 ± 5 .9 77.8 ± 7 .4 0.44
Triceps SDS 0.54 ±  0.85 0.28 ± 1.04 0.69 ± 0 .7 8 0.48
Subscapular SD S 0.63 ±  0.96 0.26 ± 1.15 0.84 ± 0 .8 5 0.36
Physical activity (n, %) 
Much less or less 
Same as peers 
More
Much more
(1 ,9 .1% ) 
(6 , 54.5%) 
(4, 36.4%) 
(0 , 0 %)
(0 ,% ) 
(1 ,25% ) 
(3, 75%) 
(0 , 0 %)
(1, 14.3%) 
(5 ,71.4% ) 
(1, 14.3%) 
(0 , 0%)
0.13
Social class (n, %) 
Class 1 
Class 2 
Class 3
Class 4 or more
(2 , 18.2%) 
(6 , 54.5%) 
(1 ,9 .1% ) 
(2 , 18.2%)
(1,25% ) 
(2, 50%) 
(1 ,25% ) 
(0 , 0 %)
(1, 14.3%) 
(4, 57.1%) 
(0 , 0 %) 
(2 , 28.6%)
0.38
#
N o WC SDS calculated for cohort C since the database for waist SDS was available only up to the age 
o f  17
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7.3.2 Infant BC and later body size and composition
Unfortunately, the sample size for subjects who had BC measurements at both 6 weeks 
at later follow-up was too small to give meaningful results (n=l 1). Only the results from 
subjects who had BC measurements at both 12 weeks and later follow-up are shown in 
Table 7-3. FFM at 12 weeks was positively associated with later height (Figure 7-3). 
The association persisted after adjusting for birthweight SDS (data not shown). 
However, this association depended heavily on one boy with high FFM at 12 weeks 
(6.08 kg, FFMI SDS = 2.51). There was no significant association between infant BC at 
12 weeks and later BC. These results were not substantially changed after adjusting for 
birthweight SDS, infant diet groups (breast-fed, reduced energy formula, standard term 
formula), puberty, physical activity, social class, or parental size (one at a time due to 
the small sample size-data not shown).
Figure 7-3 Scatter plot of FFM at 12 weeks and later height SDS
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Table 7-3 Association of infant BC at 12 weeks and later body size and composition
Infant FM Infant FFM Infant FMI SDS Infant FFMI SDS
Later BC B SE P r2 B SE P r2 B SE P r2 B SE P r2
Wt SDS 0.10 0.45 0.82 2.22 1.60 0.17 0.007 0.15 0.96 0.05 0.17 0.75
Ht SDS -0.13 0.40 0.76 3.30 1.36 0.02 0.14 -0.06 0.13 0.69 0.07 0.15 0.67
BMI SDS 0.31 0.48 0.52 0.62 1.76 0.73 0.07 0.16 0.66 0.02 0.18 0.92
FMI SDS 0.18 0.37 0.62 -0.37 1.34 0.78 0.03 0.12 0.84 -0.04 0.14 0.75
FFMI SDS 0.15 0.43 0.72 0.86 1.55 0.58 0.04 0.14 0.80 0.01 0.16 0.97
Triceps SDS 0.35 0.38 0.36 0.55 1.39 0.70 0.10 0.13 0.46 0.02 0.14 0.88
Subscapular SDS 0.55 0.42 0.20 -0.11 1.57 0.94 0.19 0.14 0.20 -0.04 0.16 0.80
WC SDS* -0.03 0.50 0.96 1.15 1.79 0.53 -0.07 0.17 0.67 0.03 0.19 0.89
WCS 0.01 0.04 0.74 0.02 0.15 0.88 0.002 0.01 0.87 0.002 0.02 0.90
WCX -0.01 0.02 0.62 0.06 0.08 0.44 -0.003 0.01 0.71 0.004 0.01 0.64
TrunkFMI SDS# 0.20 0.43 0.64 -0.41 1.57 0.79 0.04 0.14 0.79 -0.06 0.16 0.71
TrunkFMI SDSX -0.05 0.17 0.76 -0.49 0.62 0.44 -0.01 0.06 0.83 -0.07 0.06 0.29
++ Adjusted for exact age at 12 w eeks and gender, (n = 41 , 15 boys and 26 girls). Results are from the m ultiple regression analysis, each row represents a
different model with later body size and com position in the left hand colum n as the dependent variable; infant BC (FM , FFM, FMI SD S, or FFMI SD S) was an 
independent variable; exact age at 12 w eeks and gender were covariates; B = the coefficient o f  infant BC i.e. the change in later BC per 100% increase in FM and 
FFM, or per 1 SDS increase in FMI and FFMI, SE = standard error, highlighted p value indicate significant at p < 0 .05 , r2^  coefficient o f  determination (calculated  
from partial r o f  infant BC). Infant FM, FFM at 12 w eeks were natural log transformed before analysis, WC was natural log transformed and presented in loge 
scale.
#
n= 31 for WC SD S since the database for waist SD S was available only up to the age o f  17, n=37 for trunk FMI SD S since D X A  data were not available for the 
5 hom e visit subjects
5 Adjusted for current height (m)
oo
Adjusted for both current height (m ) and total FM (loge scale)
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7.3.3 SF and later body size and composition
Due to the small sample size for the isotope results and the possibility that the detailed 
BC measurements might have been done at a time (12 weeks) that was perhaps ‘beyond’ 
the critical period for programming effects, I analyzed the SF at 5 different ages in 
relation to later body composition. The models with infant triceps SF (which is most 
sensitive to changes in weight or nutritional status) as an independent variable showed 
more significant results than those with subscapular SF. Results using the sum of infant 
triceps and subscapular SF were in the same direction but less strong compared to those 
with triceps SF. Therefore, results are only shown for infant triceps SF adjusted for age 
at measurement and gender (Table 7-4). The models with adjustment for infant size by 
length at different ages provided similar results as the models with adjustment for age at 
infant measurements (data not shown). Triceps SF at 3 weeks was positively associated 
with adolescent BMI, FFMI, SF, and WC (Figure 7-4). Triceps SF at 6 weeks was 
positively related to BMI, FMI, later SF, WC, and trunk FMI (Figure 7-5 and Figure 
7-6). The association persisted after adjusting for birth SDS, infant diet group, puberty, 
physical activity, social class, or parental size in the model (one at a time due to the 
small sample size -data not shown). The results were in the same direction if A triceps 0- 
3 weeks (between age 2-3 days and 3 weeks) was used instead of triceps SF at 3 weeks 
and A triceps 0-6 weeks (between age 2-3 days and 6 weeks) was used instead of triceps 
at 6 weeks (data not shown).
As seen in the scatter plot, there was one boy who was small in infancy (triceps SF 4.8 
and 4.4 mm at 3 weeks and 6 weeks old) and in adolescence (current BMI SDS -2.33, 
FMI SDS -1.57, FFMI SDS -1.34) who appeared to influence the association 
substantially. Therefore, the same analysis was performed after he was excluded.
Triceps SF at 3 weeks was still positively related to later FFMI SDS (n=30, p=0.02, 
r2=0.20) and BMI SDS (p=0.03, r2=0.18). Triceps SF at 6 weeks was still positively 
related to later WC SDS (n=30, p=0.04, r2 =0.16) but the relationship with BMI, FMI, 
and Trunk FMI SDS was no longer statistically significant.
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Table 7-4 Association of triceps SF at different periods in infancy and later body size and composition++
Triceps 3wk (n=31) Triceps 6wk (n=42) Triceps 12 wk (n=58) Triceps 6 mo (n=39) Triceps 12 mo (n=32)
Later BC B SE P r2 B SE P r2 B SE P r2 B SE P r2 B SE P r2
Wt SDS 1.29 1.05 0.23 1.40 0.83 0.10 0.83 0.85 0.33 0.95 0.88 0.29 -0.05 0.76 0.95
Ht SDS -0.86 0.95 0.37 -0.08 0.76 0.92 0.30 0.76 0.69 -.002 0.80 0.99 -0.14 0.67 0.84
BMI SDS 2.56 1.06 0.02 0.18 2.21 0.87 0.02 0.14 0.89 0.91 0.33 1.12 0.95 0.25 0.02 0.82 0.98
FMI SDS 1.24 0.86 0.16 1.36 0.68 005 0.10 0.42 0.70 0.55 0.90 0.72 0.22 -0.26 0.63 0.68
FFMI SDS 2.36 0.94 0.02 0.19 1.18 0.82 0.16 0.63 0.82 0.45 1.10 0.85 0.20 0.27 0.74 0.72
Triceps SDS 2.02 0.84 0.02 0.18 1.82 0.69 0.01 0.16 0.84 0.72 0.24 1.12 0.74 0.14 0.24 0.65 0.71
Subscapular SDS 1.97 0.94 0.05 0.14 2.10 0.76 0.008 0.17 0.86 0.81 0.30 0.89 0.81 0.28 0.43 0.70 0.55
WC SDS* 1.81 0.98 0.08 2.47 0.88 0.009 0.22 0.86 0.88 0.33 0.23 1.02 0.83 0.002 0.78 0.99
WC$ 0.25 0.08 0.006 0.26 0.16 0.07 0.03 0.12 0.04 0.08 0.58 0.04 0.08 0.63 -0.02 0.07 0.79
WC°° 0.09 0.05 0.09 0.02 0.04 0.64 -0.02 0.04 0.69 -0.01 0.04 0.79 -0.01 0.04 0.71
TrunkFMI SDS 1.84 0.96 0.07 1.62 0.78 0.04 0.11 0.44 0.81 0.59 1.10 0.82 0.19 -0.19 0.72 0.80
TrunkFMI SDS00 0.02 0.43 0.97 -0.07 0.30 0.81 -0.22 0.31 0.47 0.60 0.31 0.06 -0.11 0.28 0.71
H—h
Adjusted for exact age at 3, 6 , 12 weeks, 6 , 12 months and gender. Results are from the multiple regression analysis, each row represents a different model 
with later body size and composition in the left hand column as the dependent variable; triceps SF at different ages was an independent variable; exact age at 
each tim e point and gender were covariates; B = the coefficient o f  triceps SF (loge scale) i.e. the change in later BC per 100% increase in triceps SF, SE =  
standard error, highlighted p value indicate significant at p <0.05, r2=  coefficient o f  determination (calculated form partial r o f  triceps SF at each age). Infant 
triceps SF were natural log transformed before analysis; WC was natural log transformed and presented in loge scale 
$
n = 3 1, 31, 48, 29, 29 for the m odel with WC SDS and triceps SF at 3, 6 , 12 weeks, 6 , and 12 months, respectively since the database for waist SDS was 
available only up to the age o f  17; n= 28, 39, 53, 36, 29 for the m odel with trunk FMI SDS and triceps SF at 3, 6 , 12 weeks, 6 , 12 months, respectively.
$ Adjusted for current height (m)
00
Adjusted for both current height (m ) and total FM (loge scale)
Figure 7-4 Scatter plots of Triceps SF at 3 weeks and later body composition
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Figure 7-5 Scatter plots of Triceps SF at 6 weeks and later body composition
a) FMI SDS
b) FFMI SDS
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Figure 7-6 Scatter plots of Triceps SF at 6 weeks and later central fatness
a) W aist circumference SDS
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7.3.4 Infant body composition and later cardiovascular risk factors
From the above results, infant triceps SF at a very early age showed correlations with 
later BC, which was in turn shown in Chapter 6 to be highly associated with lipid and 
insulin profiles. Further analysis was therefore performed to examine associations 
between infant BC and the later cardiovascular risk markers. No statistically significant 
association between birthweight SDS and later lipid profile, insulin profile or blood 
pressure found in this dataset, either with or without current body size adjustment (data 
not shown). There was no significant association between BC at 12 weeks and later 
cardiovascular risk factors.
None of the SF (triceps, subscapular, sum of triceps and subscapular) at 3, 12 weeks, 6, 
12 months were significantly associated with later cardiovascular risk markers.
However, at 6 weeks (n=33) after adjusting for gender and length at 6 weeks, triceps and
'y
subscapular SF were positively correlated with 32-33 split proinsulin (p=0.04, r = 0.12 
and p = 0.04, r2= 0.14 (Figure 7-7a) whereas subscapular SF was also positively 
correlated with proinsulin (p= 0.05, i^= 0.11). See Figure 7-7b. Due to the small sample 
size and the fact that one outlier appeared to exert a large effect on the results, I 
reanalyzed the data without this subject (a girl who had very high 32-33 split proinsulin 
(21 pmol/L)). Triceps SF at 6 weeks was still positively related to 32-33 split proinsulin 
(p = 0.04, r2 =0.12). However, if the same girl (who also had high proinsulin (10.1 
pmol/L)) was excluded, the positive relationship between subscapular SF at 6 weeks and 
later proinsulin was no longer significant.
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Figure 7-7 Scatter plot of SF at 6 weeks and later insulin profiles 
a) Triceps SF at 6 weeks and later 32-33 split proinsulin
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7.4 Discussion
There have been hardly any studies relating infant body composition to long-term 
outcomes, largely due to the limitations of infant BC techniques. Sample sizes in 
existing studies are inevitably small and the results are inconsistent. Butte et al (117) 
found that differences in body composition (by multicomponent model; deuterium 
dilution, total body potassium, and DXA) in early infancy (up to 6 months) which 
were associated with infant feeding mode (40 breast-fed vs. 36 formula-fed infants) 
did not persist into the second year o f life. In contrast, Wells et al. (118) reported that 
infant fatness (by doubly labelled water study in 30 infants) showed a strong 
relationship with childhood fatness at the age 2.5-3.5 years.
In my study, I attempted to follow-up a group of infants who had BC measured at 12 
weeks into adolescence and early adulthood. The subjects are unique in having 
detailed measurements in infancy with long-term follow-up. Unfortunately, despite 
the initial sample size of 199, the total number o f subjects who completed both the 
doubly-labelled water measurement at 12 weeks and the later follow-up was only 41 
(out of 59 subjects who had later BC outcomes measured). See Chapter 3, 3.5.5 
Recruitment and follow-up rates for cohorts A, B, and C and 3.6 Key study 
design features. Therefore, I recognize that my findings have to be interpreted with 
extreme caution. In this discussion, I will focus on: 1) the relationship between infant 
BC and later BC, 2) the possible association between infant BC and later 
cardiovascular risk factors, and 3) the limitations of this study. The potential 
mechanism and implication o f the findings will be discussed later in Chapter 9.
7.4.1 Infant BC and later BC
I did not find any association between infant BC measured by stable isotopes at 12 
weeks o f age and later BC. There are a number of possible explanations for this lack 
o f relationship. 1) The sample size may be too small (n=41) to detect an association; 
2) 12 weeks o f age (when the detailed BC measurements were made) could 
potentially be ‘beyond’ the critical period for the programming of later BC through
185
infant BC. The fact that SF at 3 and 6 weeks (which had a comparable sample size, 
n=31 and 42) were related to later BC whereas SF at 12 weeks (n=58) did not show 
any association, lends some support to this concept; 3) the long term influence of 
early growth on later BC might not be mediated through changes in infant BC (see 
more discussion in C hapter 9).
The following discussion is based on infant SF in relation to later outcomes. 
Although I recognize that the use o f SF may not be ideal (it would have been 
preferable, for example, had detailed BC been measured using stable isotopes at 
these earlier time-points), but this is one of the first attempts to study the relationship 
between any measure o f infant BC and later outcome. Moreover, the use of SF 
allows the investigation o f infant BC at different ages in infancy, not just 12 weeks 
which might not be the ‘right’ window as mentioned previously. Interestingly, triceps 
SF at 3 weeks was positively correlated with later FFM more strongly than FM. This 
seems counter-intuitive since triceps SF is most likely to be a proxy for FM rather 
than FFM. One explanation might be that triceps SF at 3 weeks might simply 
represent body size i.e. body weight at that time. However, additional analysis 
showed that after adjusting for weight SDS at 3 week, this positive association was 
weaken but still statistically significant (p=0.046, data not shown); in other words, 
higher triceps at 3 weeks was related to higher FFM in later life even in infants with 
same weight SDS. Another explanation could be that the mechanism of later FFM 
programming is not as simple as the tracking o f FFM from birth and infancy through 
to adolescence and that early gain in FM predicts later FFM. On the other hand, 
triceps SF at 6 weeks showed a positive association with later indices of fatness, 
which supports the idea that higher fatness in infancy might result in higher FM and 
a more central fat distribution in later life.
In order to test whether infant BC ‘explains’ the association between early growth 
and later BC, I performed additional analyses o f the early growth data in this small 
group o f subjects (n=59). AWeight SDS from birth to 3 weeks was positively 
associated with FFMI SDS (n=31, p=0.005, r2=0.26), but not with other BC 
outcomes, whereas Aweight SDS from birth to 6 weeks was positively related to WC 
SDS (n=31, p=0.03, r2=0.17) in adolescence. Furthermore, these positive 
associations between Aweight SDS and later BC was largely attenuated and became
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non-significant if  triceps SF at 3 weeks or triceps SF at 6 weeks were added to the 
models. Therefore, I propose that the relationship between growth in early postnatal 
life (first 6 weeks) and later BC might be mediated by infant ‘fatness’ - as measured 
by SF. Again, this postulation is based on the findings from only 30 to 40 
individuals. In order to confirm or refute this hypothesis, a follow-up study (with a 
bigger sample size) o f infants with BC measurements at an earlier age than 12 weeks 
e.g. 3 or 6 weeks) is required.
In comparison with my findings from Chapter 5, there seems to be some 
discrepancy regarding the ‘critical’ window for programming of later BC, since in 
Chapter 5 I found no association between A weight SDS before 6 weeks and later 
BC. There are a number o f potential explanations for this discrepancy. 1) The early 
weight measurements in the prospective cohorts are likely to be more precise than 
the measurements obtained from the baby books. This is likely to be most relevant 
during the first few weeks o f life when weight SDS can change dramatically. As a 
result, the analyses presented in Chapter 5 might be expected to have more ‘noise’ 
during this early period making it more difficult to detect any relationship between 
very early infant growth and later FFM or FM. 2) Infants from cohort A (only the 
original RCT had a 3 week measurement) may have had different BC than normal 
babies due to the trial formula (see Chapter 8). 3) The relationship between very 
early growth and later BC might be apparent only beyond a certain age, as seen in the 
baboon studies (13; 14). However, this last explanation is unlikely, since when I 
reanalyzed early ‘baby book’ growth data for subjects in the same age-range as 
subjects from the prospective cohorts (n=55-60), I still found no association between 
very early infant growth and later BC.
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7.4.2 Infant BC and later cardiovascular risk factors
A number o f studies have shown that children with low birthweight have reduced 
glucose tolerance and that those with low birthweight and high BMI in later 
childhood are at greatest risk of developing type II diabetes mellitus (34;94;236;237), 
suggesting that rapid postnatal growth might be associated with later insulin 
resistance. I did not find any association between birthweight and later insulin 
profiles; however, my finding that higher SF at age 6 weeks (or change in SF or 
weight from birth to 6 weeks) was related to higher 32-33 split proinsulin in 
adolescence seems to support this idea. Nevertheless, these findings were only based 
on 33 subjects and some o f the associations depended substantially on just 1 or 2 
individuals. Therefore, my confidence in these findings is limited.
7.4.3 Criticisms of the study
As discussed above, my sample size is really too small to draw firm conclusions. 
Despite showing ‘statistically’ significant associations, some of these depended 
greatly on only 1 or 2 individuals. Moreover, due to the small sample size, I could 
not adjust simultaneously for potential confounders.
Using the method o f Dupont and Plummer (238) I calculated that, with my sample 
size o f 5 8 ,1 would be able to detect a minimum regression coefficient of 1.87 SDS 
with 80% power at 5% significance. This has implications for the interpretation of 
my results, in that I may have missed a ‘real’ but biologically significant association 
due to low power. For example, in the case of the association between SF at 12 
weeks and later FMI SDS, I only had 49% power to detect the regression coefficient 
observed in my analysis as statistically significant. It is thus possible that there is a 
real association - albeit smaller in size than that for SF at 6 weeks.
Despite these limitations, I consider that my analyses have raised some interesting 
questions which could now be tested in a further, larger, study of infants with body 
composition measurements. My findings also have implications for the design of
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such a study in that they suggest that infant BC measurements should be performed 
earlier than 12 weeks.
7.5 Summary
- From this study, there is no evidence that infant BC at 12 weeks is associated with 
later BC in adolescence but a larger study is required to confirm the findings.
- There is limited evidence from the SF measurements earlier than 12 weeks that 
infant ‘fatness’ as measured by SF at 3 weeks seems to be positively related to later 
FFM whereas higher SF at 6 weeks seems to positively correlate with later FM and 
waist circumference; this suggests that the period prior to 12 weeks might also be 
important for BC programming but this hypothesis requires testing in a larger study.
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Chapter 8 The Influence of Infant Nutrition on Body 
Composition
8.1 Introduction
Nutritional intake during infancy has been shown to have a significant influence on 
growth pattern during infancy (see C hapter 2). However, only a limited number of 
studies have explored its effects on infant BC and none of these studies has included 
longer term follow-up.
8.2 Methods
8.2.1 Subjects
Infant growth and body composition data from the 2 randomised controlled trial 
(RCT) groups (cohort A) were compared with data from breast-fed babies from 
cohorts B and C. Body composition outcomes o f the subjects who participated in the 
follow-up study during adolescence (described in C hapter 7) were analysed 
according to infant diet groups.
8.2.2 Infant diet groups
For the purpose o f this analysis, the subjects were divided according to their infant 
diet into 3 groups. In cohort A (randomised controlled trial of different energy 
formulas), the reduced energy (60 kcal/100 ml, RE) formula (n=53 during infancy) 
and standard term (67 kcal/100 ml, TF) formula groups (n=54 during infancy) were 
fed the assigned study formula as the sole energy source from birth through the 
initial 12-week study period. Solid food was introduced at a time determined by the 
parents with advice from their health care professionals (the Department of Health 
recommendation for term infants at the time was not to introduce solids before 3
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months o f age). Detailed composition of these 2 formulas and details of the RCT is 
shown in A ppendix A. The breast feeding group (n=46 during infancy) were 
exclusively breast-fed until at least 12 weeks of age by the study design (from 
cohorts B and C which aimed to study energy metabolism in breast-fed and formula- 
fed infants at 12 weeks o f age).
8.2.3 Statistical m ethods
Independent sample t-tests were used to test the difference between the 2 RCT diet 
groups. One-way ANOVA was used to test the difference between the 3 diet groups. 
Dunnetf s post hoc test was used to test pairwise differences between 2 RCT diet 
groups and breast-fed group.
8.3 Results
Characteristics o f the study subjects during infancy and at adolescent follow-up are 
described in C hapter 7. In this chapter, I will focus on the short-term effects of early 
nutrition on growth and BC in infancy and its long-term effects on BC during the 
adolescent period.
8.3.1 The effects o f early nutrition on infant growth and BC
Between 2 infant formulas with different energy content
Comparisons between the 2 RCT groups are shown in Table 8-1. There was no 
significant difference between the groups in weight or length. Infants fed reduced 
energy formula (RE) had significantly lower subscapular SF at 6 weeks and 12 
weeks than those who received standard term (TF) formula. At 3 months of age, the 
RE group showed higher milk volume intake than the TF group; consequently, they 
had a higher protein intake but still a lower fat intake than the TF group. Infant BC 
results are shown in Table 8-2. The RE group had significantly lower FM (mean
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difference -0.25 kg; 95%CI -0.49, -0.01), FMI (mean difference -0.62 kg; 95%CI - 
1.24, 0.01) and higher FFMI (mean difference 0.65 kg/m2; 95%CI 0.08, 1.23) at 12 
weeks o f age compared to the TF group.
Between breast-fed and formula-fed groups
Results for the comparison o f the 2 RCT groups and breast fed babies are also shown 
in Table 8-2. The number o f subjects who were first-born babies was higher in the 
breast-fed group. Breast-fed babies showed slower weight gain than formula-fed 
babies from 6-12 weeks (mean difference 0.25 SDS, 95% Cl 0.03, 0.49 for the RE 
group and mean difference 0.21 SDS, 95% Cl -0.01, 0.44 for the TF group). They 
also had lower triceps and subscapular SF than the formula-fed groups (particularly 
the TF group) at 6 weeks and 12 weeks old. Although there were no statistically 
significant differences in FM or FFM at 12 weeks between the breast-fed and 
formula-fed groups, breast-fed infants showed a trend towards lower FM and higher 
FFM compared to infants fed TF.
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Table 8-1 Summary of the results from the RCT of different energy infant 
formulas ++
RE formula® 
(n = 53)
TF formula® 
(n = 54)
P
W eight SD S
Birth 0.13 ± 0 .7 0 0.10 ± 0 .6 3 0.8
3 w eeks -0 .10  ± 0 .7 9 -0 .06  ±  0.72 0.8
6  w eeks 0.04 ±  0.77 0.19 ± 0 .6 7 0.3
3 m onths 0.10  ± 0 .8 3 0.21 ± 0 .7 3 0.8
6  months 0.10  ± 0 .8 9 0.09 ±  0.79 1.0
9 m onths 0.14  ± 0 .9 6 0.07 ±  0.82 0.7
12 m onths 0.06  ± 0.90 0 .0 2  ±  0.88 0.7
Length SD S
Enrolm ent -0.23 ±  0.94 -0.22 ± 0.85 0.9
3 w eeks 0.05 ± 0.90 0.04 ±  0.80 1.0
6  w eeks 0.21 ± 0 .9 4 0.33 ±  0.94 0.5
3 m onths 0.35 ± 1.03 0.36 ± 0 .7 6 0.9
6  m onths 0.30  ±  1.09 0.42 ± 1.05 0.6
9 m onths 0.38 ± 1.11 0.39 ± 1.16 1.0
12 m onths 0.21  ±  1.00 0.47 ± 1.04 0.3
Subscapular SF (m m )
Enrolm ent 5.7  ± 0 .9 5.9 ± 1.2 0.3
3 w eeks 6.8  ±  1.2 7.3 ±  1.3 0.07
6  w eeks 7.1 ±  1.2 7.9 ± 1.4 0.005
3 m onths 7.8 ±  1.5 8.5 ±  1.3 0.014
6  m onths 7.6 ±  1.5 7.9 ± 1.6 0.4
9 m onths 7.7 ±  1.9 8 .0  ± 1.8 0.4
12 m onths 7.2 ± 2 .1 7.0 ±  1.7 0.6
Total energy expenditure (kcal/kg/day)# 80.6 ± 2 2 .3 78.4  ±  22.6 0.7
M ilk  intake (m l/kg/day)# 172 ± 2 4 .6 158 ± 2 2 .8 0.03
C alculated nutrient intake at age 3 months
Fat (gm /kg) 4.9  ±  0.7) 5.8 ± 0 .8 0.001
Protein (gm /kg/day) 2.3 ± 0 .3 2.1 ± 0 .3 0.04
E nergy (kcal/kg/day) 102 ±  15 106 ±  15 0.4
Data are show n as m eans ±  SD; Independent sam ple t-test was used to test the difference betw een  
the 2  form ula groups.
® R E= R educed Energy formula, TF= Standard energy infant formula, detailed com position show n in  
A ppendix  A#
M easured by doubly-labelled  water at the age o f  3 months; n=32 and 43 in RE and TF
194
Table 8-2 Com parison o f infant growth and BC according to diet group&
Breast-fed
(n=46)
RE formula 
(n = 53)
TF formula 
(n = 54) P
B irthw eight (kg) 3 .54  ± 0 .4 1 3.54 ±  0.34 3.51 ± 0 .3 2 0.87
G estational age 4 0 .0  ±  1.3 40.1 ±  1.4 40 .0  ±  1.2 0.87
B irthw eight S D S 0 .14  ± 0 .7 3 0.14 ± 0 .7 1 0.11 ± 0 .6 3 0.96
B oys (n, %) 16, 34.8% 24 ,45 .3% 26,48 .1% 0.38
First-bom  (n, % )§ 23, 50.0% 12, 25.0% 19, 38.0% 0.04
A w eigh t SD S 0 -6  w eek s# 0 .04  ±  0.72 -0.08 ±  0.57 0.06 ±  0.43 0.34
A w eigh t SD S 6 -12  w eek s# -0 .19  ± 0 .3 8 0.07 ±0.44 0.02 ±0.35 0.04
A w eight SD S  0 -12  w eeks 0.03  ±  0 .76 -0.02 ±  0.78 0.08 ± 0 .5 6 0.82
W eight SD S  6  w eek s 0.31 ± 0 .6 7 0.04 ±  0.77 0.19 ± 0 .6 7 0.31
Length S D S  6  w eek s 0 .29  ± 0 .9 1 0.24 ±  0.94 0.38 ± 0 .8 4 0.73
Triceps 6  w eek s (m m ) 6 .6  ± 0 .8 7.4 ±1.5 7.6 ±1.6 0.03
Subscapular 6  w eek s (m m ) 6 .6  ± 0.8 7.1 ±1.2 7.9 ±1.4 <0.001
W eight SD S  12 w eek s 0 .17  ± 0 .7 9 0.10 ± 0 .8 3 0.21 ± 0 .7 3 0.78
Length SD S  12 w eek s 0.53 ±  0 .90 0.33 ±  0.90 0.45 ±  0.70 0.53
Triceps 12 w eek s (m m ) 7 .6  ±  1.2 8.3 ±  1.7 8.7 ±1.8 0.004
Subscapular 12 w eek s (m m ) 7.2 ±  1.1 7.8 ± 1.5 8.5 ±1.3 <0.001
FM  12 w eek s (kg)## 1.4 ± 0 .4 9 1.35 ±0.43 1.60 ± 0.47 0 .12
FFM  12 w eeks (kg)## 4 .4 4  ±  0.49 4.49  ± 0 .5 1 4.32  ± 0 .5 1 0.40
FMI 12 w eek s (kg /m 2)## 3.91 ±  1.27 3.70 ±1.14 4.31 ± 1.21 0.15
FFM I 12 w eek s (kg/m 2)## 12 .2 0  ±  1.20 12.35 ± 1.06 11.69 ±1.12 0.07
& O ne-w ay A N O V A  w as used  to test the mean difference o f  continuous variables betw een the 3 diet 
groups, h igh lighted  p values w ere significant at <0.05; Chi square test was used to test the difference 
in  categorical variables betw een groups.
H igh lighted  and italic figures were significantly different (p<0.05) from breast-fed group by D unnett’s 
post hoc test; b old  figures show ed the significant difference (p<0.05) betw een the 2 RCT groups by 
independent sam ple t-test.
§
Parity data w as m issing in 9 subjects
#
n=21, 47 , 48  for 6  w eeks measurement and n = 4 6 ,4 6 ,4 8  for 12 w eeks measurement in breast-fed,
RE form ula, TF form ula, respectively
##
n=41, 26 , 32 for breast-fed, RE formula, TF formula, respectively
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8.3.2 The effects of early nutrition on later BC
The comparison o f BC outcomes during adolescence between the 2 RCT diets 
groups and the breast-fed group is shown in Table 8-3 and Figure 8-1. There was no 
significant difference between RE and TF groups in later body size or composition. 
The breast-fed group was significantly older than the two RCT formula groups due to 
the fact that cohort C was followed-up at 18.2-20.4 years old. Not surprisingly, the 
breast-fed group also had a significantly higher number of subjects in a higher social 
class than the 2 formula groups. There was no statistically significant difference in 
BC between the 3 diet groups despite a trend towards a lower BMI, FMI and waist 
circumference in the adolescents who had been breast-fed rather than formula-fed.
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Table 8-3 Comparison of adolescent body size and composition according to 
infant diet group&
B reast-fed
(n= 17)
R E form ula  
(n  =  15)
T F  form ula  
(n = 16) P
Current age 16.1 ± 3 .3 13.3 ± 0 .8 13.0 ± 0 .8 <0.001
B oys (n, %) 8 ,4 7 .1 % 5, 33.3% 6 , 37.5% 0.72
Early puberty (n, %) 6 , 35.3% 10, 66.7% 11 , 6 8 .8% 0 .1 0
M ore/m uch m ore active (n,% ) 10, 58.8% 5, 33.3% 7, 43.8% 0 .2 0
Social class <  2 (n, %) 14, 82.4% 4, 26.7% 7, 43.8% 0.005
M aternal B M I 25.5  ± 5 .0 25.5 ± 5 .9 26.3 ± 5 .1 0.88
Paternal B M I 25 .8  ± 3 .9 26.0  ± 3 .8 26.2 ± 3 .6 0.96
H eight SD S 0 .5 6  ± 0 .9 9 0.05 ±  1.00 0.42 ±  0.85 0.30
BM I SD S -0 .12  ±  1.09 0.50 ± 0 .8 2 0.26 ±  1.28 0.27
FMI SD S -0 .14  ± 0 .6 3 0.31 ± 0 .6 7 0.07 ±  0.95 0.28
FFMI SD S -0 .30  ±  1.23 -0.14 ± 0 .8 6 0.09 ±  0.76 0.52
Triceps SD S 0 .48  ±  0.70 0.64 ±  0.59 0.23 ± 1.24 0.43
Subscapular SD S 0 .19  ± 0 .8 3 0.48 ±  0.90 0.08 ±  1.28 0.53
WC SDS# 0 .27  ±  1.12 0.92 ± 0.76 0 .80 ±  1.23 0.30
TrunkFMI SDS## -0 .17  ± 0 .6 7 0.23 ± 0.80 0 .07 ± 1.09 0.50
& O ne-w ay A N O V A  w as used  to test the mean difference o f  continuous variables betw een the 3 diet 
groups; Chi square test was used to test the difference betw een categorical variables betw een groups.
#
n= 10 , 15, 16 for breast-fed, RE formula, TF formula since the database for w aist SD S was available 
on ly  up to the age o f  17
##
n=16, 13, 15 for breast-fed, RE formula, TF formula since D X A  data w ere not available for 5 
hom e visit subjects
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Figure 8-1 Com parison o f adolescent body composition between the 3 diet
#groups
q  0 .2
SS 6?
»■>
BMI FMI FFMI Waistc
□ Breast-fed
□ Reduced E 
u T erm  F
#
n=17, 15, 16 for breast-fed, RE formula, TF formula, respectively. Each bar chart represents means 
SD S and y-error bar represent SE o f  mean.
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8.4 Discussion
In the following discussion, I will focus on 1) comparison of infant growth and BC 
between the 2 formula groups and also between the breast-fed and formula-fed 
infants, and 2) the long-term influence of early nutrition on later BC. The implication 
o f these findings will be discussed later in Chapter 9.
8.4.1 The effects o f early nutrition on infant growth and BC 
Different energy infant formulas
Healthy term infants randomly assigned to receive the RE formula in this trial 
showed no significant differences in growth in terms of weight, length, or change in 
weight SDS compared to infants fed the TF formula. Despite the fact that the energy 
content was reduced to mimic that in breast milk (as measured non-invasively by 
stable isotopes rather than in samples of expressed breast milk—details are shown in 
Appendix A), infants who received the RE formula did not demonstrate the slower 
weight gain typically seen in breast compared to formula fed infants (239-243). One 
explanation could be that infants fed RE formula up-regulated their milk volume 
intake resulting in similar energy intakes to the TF group by the age of 3 months.
This regulation o f intake following dietary manipulation has been reported in other 
studies by Fomon et al (29;30) and Brooke et al (28). It seems not to operate during 
the first 6-8 weeks o f life but to become more obvious after this age. This might also 
explain why the difference in adiposity indices was greatest at age 6 weeks to 3 
months but not significantly different after that.
My analyses confirm that although body weight was not different between the 2 diet 
groups, infant BC can be manipulated by different nutrient intakes in early life. The 
RE group showed a significantly lower FM and higher FFM at age 12 weeks than the 
TF group. The results corresponded with the calculated lower fat and higher protein 
intake in the RE group. Although body composition data earlier than 12 weeks were 
not available, SF measurements at 6 weeks o f age suggested similar findings, with 
lower values in the RE group. This finding is in agreement with a study by Schulze et
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al (105), who studied preterm infants and demonstrated that the relative composition 
o f the new tissue deposited reflected the proportional intakes o f protein and energy.
In addition, a previous study (103) o f protein-energy ratio in term infants showed that 
infants fed with a lower protein-energy ratio (1.7 gm/100 kcal) gain more weight but 
not length, suggesting more fat accumulation when compared to a higher protein- 
energy ratio (1.8 to 2.7 gm/100 kcal). Thus, the fact that RE formula group had a 
higher protein-energy ratio than TF group (2.25 vs. 2.02 gm/100 kcal) might 
contribute to the higher FFM and lower FM, even though absolute energy intake was 
similar between the 2 groups at that time (age 3 months).
Breast-fed and formula-fed groups
There are a large number o f studies examining the growth patterns of breast-fed and 
formula-fed babies. They generally agree that the average weight gain o f the former 
is lower than that o f the latter, especially after complementary foods are introduced. 
Because o f this difference, breast-fed infants are generally leaner (by SF) than 
formula-fed infants by 12 months o f age (242;244). In my analyses, breast-fed babies 
from cohort B and C showed slightly less weight gain than both formula groups from 
6-12 weeks o f age, a finding supported by Nelson et al, who reported lower weight 
gain in 419 breast-fed compared to 720 formula-fed infants from 42-112 days o f age 
(245) but slightly earlier than other studies which usually found the difference after 4 
months o f age (239;240;243). Indeed, this difference can also be seen between the 
infants who were breast-fed and those who received RE formula, which was 
designed specifically to be more similar to breast milk; this could probably be 
explained by the up-regulation o f milk volume intake or the higher protein: energy 
ratio o f the diet in the RE group. Moreover, I also demonstrated that breast-fed 
babies had lower adiposity (measured by SF) than the formula-fed groups 
(particularly TF group) at 6 weeks and 12 weeks. This SF result was consistent with 
a trend from the isotope study that showed a lower FM and higher FFM in the breast­
fed group compared to the TF group. This finding, again, is supported by other 
studies comparing breast-fed and formula-fed infants, which generally report lower 
SF in breast-fed infants; however, in those studies, the difference typically became 
apparent after the first 4 months of life (242).
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To recap, I have demonstrated that infant BC can be influenced by manipulating 
nutrient intakes during early infancy. Although differences in growth and body 
composition seem to be transient, data from animal studies show that this could have 
long-term programming effects which might ‘emerge’ later in childhood or 
adolescence.
8.4.2 The effects o f  early nutrition on later BC
As reported in the previous chapter, I did not find an association between infant BC 
at 12 weeks o f age and later BC, even though there was some evidence (from SF 
results) that infant ‘fatness’ at 3 and 6 weeks might have a long-term effect on BC in 
adolescence. Therefore, it is perhaps not surprising that, although I can demonstrate 
clear effects o f infant diet on infant BC at 12 weeks, there is no evidence that this in 
turn has any longer term effect on BC. Moreover, the difference in SF at 6 weeks 
(which is the period during which SF showed a significant association with later BC 
in the previous chapter) between the 2 diet groups did not seem to have a long-term 
effect on later BC. In fact, this finding is in agreement with other studies of different 
infant formulas in that the effect o f different diets on infant growth and BC is 
apparent during infancy (and may be dramatic)( 107-110) but does not generally 
persist at follow-up (111;112). Unfortunately, the sample size in my follow-up study 
was very small (around 16 in each RCT group). Consequently I only had the power 
to detect a difference o f 1 SD between groups. This limits my ability to draw 
conclusions about whether BC differences due to dietary manipulation in infancy 
result in differences during adolescence. Another possibility to be considered is that 
the effect may not become apparent until later on in life i.e. not until after puberty as 
in the baboons (13; 14).
Despite fairly consistent data from a number of studies, including recent systematic 
reviews, suggesting a long-term protective effect o f breast-feeding against later 
overweight and obesity (defined by BMI above a percentile cut-off) (246-248) or the 
reduction o f average level o f ‘adiposity’ (i.e. mean values of BMI)(249), the long­
term effects o f breast feeding on later body composition have rarely been reported. 
Butte et al reported that (117) the differences in infant body composition (by multi­
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component model) at 3 and 6 months between breast-fed and formula-fed infants did 
not persist into the second year o f life. However, the DARLING study, which used 
SF as a measurement o f fatness, found that when infants were breast-fed throughout 
the first year o f  life, the difference in adiposity between breast and formula-fed 
infants persisted until at least 18-24 months of age. In my study, despite the fact that 
there was no statistically significant difference between BC in adolescents previously 
breast-fed compared to those formula-fed, there was a trend towards lower BMI, 
FMI, and waist circumference in the breast-fed group, which supports the BMI data 
above. This effect also corresponds with my findings o f slower weight gain and 
lower SF in breast-fed infants at 6 and 12 weeks, and this slower growth and reduced 
fatness early in infancy might partly explain any long-term influence of breast­
feeding on later BC. Again, due to the very small sample size at this follow-up, a 
bigger study is needed to verify this assumption.
8.5 Sum m ary
- Early infant growth and infant BC can be manipulated by different nutrient intakes 
in early life. The reduced energy formula group, who had lower fat and higher 
protein intakes, showed lower FM and higher FFM compared to the standard term 
formula group at the age o f 12 weeks.
- Breast-fed infants showed a slower weight gain and lesser adiposity by SF 
measurement at 6 and 12 weeks compared to formula-fed infants.
- Unfortunately, the sample size in this follow-up study was very small. The long­
term effects o f early nutrition on later BC are not conclusive. There was no evidence 
for a long-term effect o f the different infant formulas on body composition, although 
subjects who had been breast-fed showed some evidence o f reduced fatness. These 
findings are limited by the small sample size.
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Chapter 9 Overall Discussion and Conclusions
9.1 Sum m ary o f the findings
In Chapter 3 , 1 set out 2 main hypotheses. The first was to test whether early growth 
can program specific components o f body composition later in life, and thereby 
potentially influence the development o f obesity and cardiovascular risk factors. I 
found that birthweight (regarded as a proxy for prenatal growth) is positively related 
to later height in both sexes, and positively associated with FFM in boys. In contrast, 
postnatal growth during the first 6 months of life positively influences later FM and 
central fat distribution, with a weaker effect on FFM. Hypothesis I was therefore 
confirmed using the 4C model.
In Chapter 6 ,1 demonstrated that whilst FM showed a consistent association with 
most measured cardiovascular risk factors except HDL-C, FFM showed a strong 
negative association with HDL-C that was independent of FM and central fat 
distribution. This supports the concept that BC programming by prenatal or postnatal 
growth may have a differential impact on health outcomes— at least as assessed 
using proxy measures in an adolescent population.
I could neither confirm nor refute my second hypothesis that components o f infant 
BC are differentially related to later BC. In Chapter 7 ,1 found no significant effect 
o f infant BC at the age o f 12 weeks on later BC, but the sample size was rather small. 
With 41 subjects who had BC measurements at both 12 weeks (by isotope) and later 
follow-up, I would only be able to detect a significant association if the correlation 
between infant BC and later BC was higher than 0.42 (183) - i.e. the results would 
be significant only if  infant BC explained around 18% of the variance in later BC 
(which is around 2.5 times more than the proportion of the variance explained by 
birthweight or postnatal growth). Therefore, a bigger study is needed to definitively 
answer this question. On the other hand, based on my findings, it could be argued 
that 12 weeks of age might be beyond the critical window for programming of BC,
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since my SF data support the concept that the critical window could be earlier than 
this.
Lastly, in Chapter 8 ,1 confirmed that postnatal nutrition can affect both infant 
growth and infant BC. I could not demonstrate any effect of infant nutrition on later 
BC; however, a bigger study with long-term follow-up is needed to address this 
issue.
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Figure 9-1 Diagram of the potential inter-relationships between early growth, infant BC and later BC
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9.2 Potential mechanisms for BC programming
9.2.1 The mechanism  by which prenatal growth may program later 
FFM
There are several plausible explanations for the observed association between 
birthweight and FFM in childhood and adolescence. For instance, it has been shown that 
in humans the number o f muscle fibres is set before birth (43;250) and hyperplasia does 
not occur to any significant extent during postnatal life. If this is the case, it would seem 
unlikely that post-natal growth beyond the ‘window’ during which new muscle fibres 
are developing would be associated with FFM later in life. However, there is evidence 
from rats (251) that protein restriction immediately after birth resulted in reduced muscle 
mass during adult life, indicating that there is an early postnatal period during which 
muscle development (e.g. differentiation and hypertrophy) is also highly sensitive to 
nutritional insults. This could perhaps explain the relationship observed in some studies 
between early post-natal growth and later FFM (see later).
Fetal growth constraint due to undemutrition could result in lower IGF-1 and thus 
compromise muscle growth and skeletal length in utero (252). There is indeed some 
evidence that small for gestational age infants show a larger deficit in lean mass (by 
DXA) than in FM (253). These ‘smaller’ babies might then be expected to have lower 
FFM in later life. It could also be argued that fetal muscle and skeletal growth is 
determined (at least in part) by an individual’s genetic potential (40;254;255) and that 
this is responsible for the relationship with later FFM. This idea cannot, however, 
explain the association between the intrapair difference in birthweight of monozygotic 
twins and later FFM described by Loo et al (78;79). Therefore, I suggest that the 
mechanism by which FFM is programmed probably involves insults or stimuli (e.g. 
nutrition) in fetal life, and to a lesser extent, early postnatal life.
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Catalano et al (40) showed that male neonates had higher FFM than females, which 
corresponds with the well-recognized gender differences in body composition during 
adolescence and adult life. I propose that this might be one of the reasons why I found 
that the relationship between birthweight and FFM was more obvious in boys.
Using birthweight as a proxy for prenatal growth has some limitations for the study of 
body composition programming. There is some evidence, for example, that body 
composition at birth may be different even when birthweight is the same and/or falls 
within the ‘normal’ range. Catalano et al (256) reported that the offspring of mothers 
with gestational diabetes have increased body fat (by total body electrical conductivity) 
compared with infants of women with normal glucose tolerance. Yajnik et al (257) 
showed that Indian babies have a more adipose body composition despite being ‘small 
and thin’ relative to UK infants. The later effects of having more ‘fat’ or more ‘lean’ , 
albeit with the same birthweight, clearly warrant further investigation and may provide 
more information about the mechanism by which FFM is programmed.
9.2.2 The m echanism  by which infant growth may program later FM  
and central fat distribution (and, to a lesser extent, FFM)
Prenatal influences on infant growth
Data from the ALSPAC study (Avon Longitudinal Study of Pregnancy and Childhood) 
confirm that around a quarter of contemporary newborn infants show significant catch­
up growth (defined as weight crossing more than one centile band upwards) whereas a 
further quarter show postnatal ‘catch-down’ growth (85). Infants who show catch-up 
growth tend to be longer with a larger head circumference at birth relative to their 
birthweight (suggesting reduced adiposity). Moreover, maternal factors that might be 
expected to constrain fetal growth (e.g. nulliparity, poor pregnancy weight gain, and 
smoking) are closely related to catch-up growth (239). The researchers suggested that 
the postnatal growth pattern might be driven by the regulation of satiety, based on the
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finding that the cord blood level of leptin was positively related to birthweight and 
subsequent weight gain (258); consequently, they proposed that inherent patterns of 
increased or decreased appetite and satiety may help to return the infant who 
experienced growth retardation in late gestation towards its genetic growth trajectory. 
On the other hand, there is also convincing evidence that infant feeding practices (breast 
or formula milk, formulas with different composition, age at weaning) have a strong 
effect on infancy weight gain (24;243;259;260). Moreover, the pattern of growth among 
small for gestational age infants can also be manipulated by nutritional intake (112), at 
least initially (28). As a result, I conclude that the pattern of infant growth is determined 
by both antenatal factors and by the postnatal environment. Important unanswered 
questions remain: 1) do the factors that determine birthweight (e.g. those related to 
constraint of fetal growth) influence both the pattern of infant growth and later BC? 2) 
do the programming effects of infant growth on later BC depend on or interact with 
birthweight, i.e. does infant growth have a long-term influence on later BC only in low 
birthweight babies?
With respect to the second question, I showed in Chapter 5 that early growth in the first 
half of infancy has a positive association with later FM and central fat distribution 
regardless o f birthweight. In fact, in my dataset only 11 out of 191 subjects had 
birthweight less than 10th centile for gestation. Moreover, I used separate adjustment for 
FM and FFM; therefore, the higher FMI associated with infant growth found here is 
unlikely to be confounded by lower FFMI related to lower birthweight (which might be 
the case if  percentage fat was used as discussed in Chapter 4). Therefore, I propose that 
rapid infant growth can programme later fatness regardless of whether it is driven 
primarily by preceding slow fetal growth or by postnatal ‘ovemutrition’.
In Chapter 5 ,1 also highlighted the discrepancy in findings from non-westem and 
western populations. In the former, early postnatal growth seemed to have a greater 
long-term influence on FFM; this was less obvious in the latter. There is evidence that 
muscle growth during early postnatal life relies largely on protein accretion leading to 
muscle fibre hypertrophy (261) and is susceptible to protein restriction as discussed
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above. One potential explanation for the apparent population differences could be that, 
in non-westem populations where the intrauterine development of muscle fibres might 
be less optimal, there is a greater potential for growth and nutrition in the early postnatal 
period to influence later FFM. The findings of Yajnik et al (257) that Indian infants are 
more ‘adipose’ despite being smaller at birth than UK infants lends some support to this 
idea. According to this argument, fetuses in the western world would have (on average) 
better (or more ‘complete’) development of muscle mass in utero, hence early postnatal 
growth might have less influence on their later FFM. In my data, I found a weak 
association o f postnatal growth between 3-6 months and later FFM in boys, which seems 
to support this concept since males generally develop larger skeletons and higher muscle 
mass than females. This might make these associations more obvious.
What mediates the association between *early growth ’  and later BC?
An important question is whether the association between early ‘growth’ (generally 
early weight gain) and later BC is mediated through structural changes in infant BC 
which then track through adolescent and adult life, or through some other mechanism 
that does not involve infant BC. If the latter is true, weight gain might be regarded as 
essentially an ‘epiphenomenon’. From the results discussed in Chapter 7, the evidence 
implicating infant BC in the programming process was not strong, although my 
conclusions were limited by the relatively small sample size. Infant BC at 12 weeks of 
age was not associated with later BC, although a proxy for infant fatness (SF) at 3 and 6 
weeks seemed to have some long-term influence on later BC, which might indicate that 
the critical period for any programming effects of infant body composition are earlier 
than 12 weeks. The other possibility, not tested in my study, is that early infant growth 
programs later BC by changing some functional component(s) that in turn regulate the 
subsequent development of fatness. Likely candidates include the set-point of hormones 
regulating growth or appetite such as insulin, IGF-1, or leptin (26;262;263). Such effects 
could persist and explain the observed long-term influence on later BC and risk of 
obesity.
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Is early nutrition involved in the mechanism?
From Chapter 8 and other published work on nutritional manipulation during infancy 
(see Chapter 2), there is good evidence that infant growth and BC can be changed by 
nutritional intake. There is little evidence for long-term effects of different infant 
formulas on later body composition, even though they may produce fairly marked 
differences in infant growth. On the other hand, breast-feeding seems to be associated 
with long-term effects on later BC (decreased fatness, seen as a trend in my study, and 
reported in a significant number o f studies on breastfeeding and later obesity defined by 
BMI). This observation might support the idea that the mechanism by which infant 
growth programs later fatness or obesity risk is more complicated than a simple effect of 
macronutrient intake on infant tissue accretion. It has been suggested that the apparent 
benefits of breastfeeding for later obesity risk are due to the slower early growth seen in 
breast-fed infants. However, if this is the mechanism, it is surprising that the same 
effects are not seen in infants fed lower energy formulas, and showing reduced fatness in 
early life. In my opinion, these observations fit with the concept that functional 
mechanisms link early growth and later BC — for example, learned self-regulation of 
energy intake or metabolic programming, as proposed by Dewey KG (264).
Studies in animal models support the idea that nutrition in early postnatal life is 
influential for long-term appetite regulation through the effects of two important 
hormones— insulin and leptin (26;27;265;266). On the other hand, BC in early life has 
not been explored in animal models. Available data in humans suggest that plasma 
insulin, which stimulates greater adipose tissue deposition during childhood (267), can 
be influenced by the mode of feeding. Formula-fed infants have been shown to have 
higher plasma insulin levels at 6 days of age compared to breastfed infants (268), 
although it is not known how long this difference persists. Insulin secretion in formula- 
fed infants might be stimulated by higher protein intake. An association between high 
protein intake in early life and overweight in childhood has been reported by some 
researchers (269;270). Leptin is a key regulator of appetite and body fatness. It has been 
suggested that breastfeeding might affect leptin metabolism during infancy and later in
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life, either via direct exposure to leptin in human milk or indirectly via the rate of early 
weight gain (264). There is some supporting evidence that the early diet of preterm 
infants (human milk vs. formula) is associated with plasma leptin concentration at 13-16 
years of age (100)— a lower leptin to FM ratio was seen in subjects who were fed with 
human milk, suggesting they might be less leptin resistant.
To recap, I think that the mechanism by which early growth ‘programs’ later BC 
involves both prenatal and postnatal nutrition. Prenatal nutrition influences the 
development o f FFM in utero and also affects postnatal catch-up growth to a certain 
extent. Infant nutrition might program later FM through effects on hormonal regulation 
or infant fatness. These potential mechanisms warrant further investigation, since this 
information could be useful in terms of designing effective early intervention to reduce 
obesity prevalence in childhood and adolescence.
9.3 Implications for public health
Early intervention
For the purpose of comparison, the relative contributions of birthweight, infancy weight 
gain, and other factors that might affect later BC are shown in Table 9-1. Birthweight 
can explain 7.8% of the variability in FFMI whereas Aweight SDS 0-6 months can 
explain a further 3%. Change in weight SDS from birth to 6 months accounts for 7.3% 
and 9.1% of the variance in FMI and trunk FMI, respectively. The percentages of 
variance explained by these early growth parameters seem to be similar to the effect of 
parental BMI, but greater than those of physical activity. Of course, there are other 
unidentified or unmeasured contributing factors that might have a bigger impact on later 
BC (e.g. other inheritable factors, current life style, dietary intake or physical activity 
that cannot be accounted for by the rating assessment used). However, my data show 
that later BC is determined to a certain extent by early growth, which can be 
manipulated through nutrition either prenatally or postnatally, and that the effect size is 
comparable to that of other factors considered important in terms of interventions to
212
prevent obesity. Hence the findings may have implications for public health; for 
instance, I propose that interventions aimed at altering early growth might be as 
effective as those aimed at changing current physical activity levels. In my study the 
proportions of overweight and obese children (by IOTF cut-off (119)) were around 
21.8% and 5.5%, respectively which is similar to the average UK population (4); 
therefore, my findings should be reasonably generalisable. However, whether the 
direction and magnitude of the observed associations are similar in normal-weight and 
obese children is another issue to consider and would require a larger sample size than 
that was available in my study.
In a recent systematic review, Kramer and Kakuma (271) reported that nutritional 
interventions during pregnancy aiming to improve birthweight are only moderately 
successful. They reported that nutritional advice to increase energy and protein intake 
was successful in achieving those goals, but no consistent benefit was observed on 
pregnancy outcomes. In 13 trials involving 4665 women (most were from under­
nourished populations), balanced energy/protein supplementation was associated with 
modest increases in maternal weight gain and in mean birthweight, and a substantial 
reduction in risk o f SGA birth. Since SGA infants are more likely to show rapid infant 
growth, it could be argued that reducing low birthweight might reduce the risk of later 
fatness/obesity, by removing the stimulus for catch-up during the post-natal period. 
However, high-protein or balanced protein supplementation alone was not beneficial and 
was associated with an increased risk of SGA birth. There is a recent study showing that 
the type of carbohydrate in the maternal diet influences infant birthweight; gravidas with 
a low dietary glycemic index had reduced infant birthweight and a twofold increased 
risk o f a SGA birth (272) but the effect of increasing the dietary glycemic index on 
reducing risk of SGA birth still needs more research.
Since my findings suggest that only postnatal growth actually has a long-term influence 
on later FM, and given the limited success of pregnancy interventions, I consider that, 
for the purpose of reducing obesity in childhood and adolescence, focusing on infant
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growth in the first 6 months of life (which depends greatly on nutrition) may be more 
successful. This supports the promotion of breast-feeding since from the evidence so far 
it seems to protect against obesity (defined by BMI) in childhood and in my small study 
there is also a trend towards lesser adolescent FM in the breast-fed group. Another 
alternative is to reduce the energy or protein content in infant formula. However, as 
discussed previously, although infant growth and body composition can be manipulated 
by differences in energy or protein content of infant formula, so far there is no evidence 
that the effect lasts beyond infancy period. Clearly, more research is needed in this area.
214
Table 9-1 Coefficient of determination (r2) for birthweight SDS, A weight SDS 0-6 months, and other confounders for
#
explaining BC outcomes in childhood and adolescent
Height SDS BMI SDS FMI SDS FFMI SDS TrunkFMISDS
Independent variables B SE r2 B SE r2 B SE r2 B SE r2 B SE r2
Birthweight SDS 0.39 0.09 0.116 0.32 0.11 0.059 0.10 0.09 0.33 0.10 0.078 0.16 0.09
A Weight SDS 0-6 months 0.42 0.09 0.151 0.36 0.10 0.084 0.30 0.08 0.073 0.19 0.09 0.030 0.31 0.08 0.091
Gender 0.07 0.14 0.30 0.17 0.021 0.08 0.14 0.03 0.15 0.09 0.14
Puberty 0.15 0.09 0.023 -0.11 0.10 -0.11 0.08 0.08 0.09 -0.09 0.09
Physical activity 0.14 0.09 -0.14 0.11 -0.28 0.09 0.064 0.17 0.10 0.020 -0.21 0.09 0.035
Social class -0.05 0.07 -0.01 0.09 -0.01 0.07 0.03 0.08 -0.01 0.07
Ethnicity 0.15 0.24 -0.20 0.29 0.04 0.24 -0.42 0.26 0.04 0.24
Maternal BMI 0.001 0.02 0.08 0.02 0.121 0.06 0.01 0.104 0.06 0.02 0.074 0.06 0.02 0.104
Paternal BMI 0.02 0.02 0.08 0.03 0.080 0.05 0.02 0.048 0.04 0.02 0.032 0.06 0.02 0.057
# From multiple regression analysis, all independent variables were entered sim ultaneously in the sam e m odel for each o f  the BC outcom es which was a
dependent variable; B = the coefficient o f  each independent variable, SE = standard error, r2 =  coefficient o f  determination (calculated from partial r)
n=150 due to m issing data for parental BMI
Puberty was coded as: 1 = prepubertal, 2 = early pubertal, 3 = late pubertal
Physical activity was coded as: 2=  much less or less active than peers, 3=  sam e as peers, 4= more active than peers, 5= much more active than peers 
Social class ranged from 1 which is the highest to > 4 w hich is the lower social class 
Ethinicity was coded as: 1 =  w hite, 0 =  non-white
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Impact on later health
In my study, I demonstrated that early growth has a significant influence on BC in 
childhood and adolescence and that BC in turn had a significant association with 
cardiovascular risk factors. Thus, I think it is likely that childhood and adolescent BC 
may provide a ‘link’ between rapid early growth and cardiovascular risk factors in 
adolescence, although I could not directly test this concept in my study since 
cardiovascular risk factors were not measured in the larger cohort. In Chapter 6 ,1 
showed that FM and FFM in healthy adolescents are differentially related to lipid, 
insulin, and blood pressure profiles. There is some evidence that these cardiovascular 
risk factors track from adolescence into adult life (273-275). However, the long-term 
clinical impact o f variation in plasma lipids or insulin during adolescence is not 
clear, particularly as most values were considered to be within the normal range. It is 
possible that the ‘unfavourable’ cardiovascular risk factors found in young people 
with higher FM might amplify over time. These questions are difficult to answer 
since the indices measured early on are predictors of the disease, rather than early 
markers o f the pathological process. Assessment of the earliest stages of 
atherosclerosis might help to clarify the situation. There are recent studies showing 
that obese children had increased arterial stiffness (276;277) and carotid intima- 
media thickness (277) which are markers o f early atherosclerosis. These effects 
appear to be mediated, at least in part, by insulin resistance. Therefore, it seems that 
these changes could begin in childhood and potentially accumulate overtime. 
However, whether these associations apply over the whole range of lipid and insulin 
concentration or only beyond a certain cut-off needs further investigation.
We know that BMI tracks from childhood and adolescence through to adult life with 
a more stable pattern o f tracking as individuals grow older (83;278;279), but little is 
know about the ‘tracking’ o f the FM and FFM components of BMI. Demerath et al 
(134) reported from 494 children age 8-18 years that whereas FFMI (by 
hydrodensitometry) had a linear relationship with BMI percentile, FMI tended to 
increase sharply only at a higher BMI percentiles; therefore, BMI percentile change 
may not reflect changes in adiposity, especially in male adolescents and children 
with lower BMI. To date, there is still no direct evidence showing the extent to which
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the FM or FFM components o f BMI in childhood and adolescence ‘track’ into adult 
life.
A further question is whether the fatness that is associated with some markers of 
cardiovascular risk  in childhood and adolescence will remained associated with 
morbidity and mortality from chronic diseases such as coronary heart disease or 
stroke in later life. Although it is well-recognized that adult BMI is strongly 
associated with cardiovascular disease morbidity and mortality, there are a limited 
number studies examining the association between childhood and adolescent BMI 
and later cardiovascular disease, and the results were inconsistent. Some studies have 
reported that higher BMI in childhood and adolescence is associated with higher 
coronary heart disease mortality among men (123;280) or in both sexes (125). 
However, more recent studies in 4 UK historical cohorts (124;281) did not support 
an association between childhood BMI and later risk of coronary heart disease and 
stroke. In my opinion, since these cohorts were bom between the 1920s and 1950s 
when the prevalence o f overweight and obesity was lower than in contemporary 
children and the environment was less obesogenic (i.e. less energy-dense food and a 
more active life style), it is difficult to extrapolate the findings to modem children. 
The findings from Wells et al (52) also support this concept. They found that 
contemporary children have more FM for the same BMI than Fomon’s reference 
children (36) from the previous 2 decades. In addition, despite a report on the 
differential effects o f FM and FFM on lipid profiles in middle-age men and women 
(214), the study o f the influence o f FM and FFM component of BMI in childhood on 
later health outcomes is hardly reported. Therefore, in order to answer this question 
more clearly, more longitudinal follow-up study is required.
9.4 T.imitations o f the study
Despite giving more accurate results, the 4C model requires relatively complex 
measurements and specialized equipment. In Chapter 4 ,1 showed that using the 4C 
model or DXA to assess body composition in a paediatric population gave a slightly 
different answer to the research question of whether there was any association
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between birthweight and later FM (FM derived from DXA or SF equations showed a 
weak positive association with birthweight whereas 4C model FM did not). Since it 
is more difficult, expensive and time-consuming to use the multicomponent models 
o f body composition in a large study, one needs to consider the benefits of a small 
study with very accurate measurements and a larger study with simpler 
measurements.
It is important to consider whether BMI is satisfactory as an outcome for research in 
this area. In my opinion, this depends on the research question. As discussed in 
Chapter 6, for screening purposes at a population level, BMI and WC might be 
adequate. However, one should keep in mind that BMI is a composite of FMI and 
FFMI and does not only reflect ‘adiposity’. I think that separate measurements of FM 
and FFM are essential for investigating the long-term health outcomes of BC 
programming or investigating health outcomes in populations (e.g. athletes) whose 
FM and FFM proportions might be different from normal. In a large scale study, a 
2C model such as isotope dilution would probably be sufficient. However, it is 
important to appreciate the limitation o f each BC technique used before interpreting 
the results. The validation o f ‘field’ methods against a ‘more accurate’ method and 
the use o f assumptions suitable for the population of interest are essential.
M y ability to draw meaningful conclusions from the analyses in Chapter 7 and 
Chapter 8 was limited by sample size. In such a small study, I could only detect a 
strong relationship between infant BC or nutrition and later outcomes, and might 
have missed a smaller effect that could still be important for health. Therefore, I 
believe that a bigger study with an acceptable method of BC assessment could 
provide further information on the mechanisms discussed above. However, in order 
to conduct a long-term follow-up study with detailed measurements, the initial 
sample size needs to be large enough to allow for a significant loss to follow-up. The 
alternative would be to use a very simple outcome measure (for example, current 
weight and height from telephone interview or questionnaire), which would 
undoubtedly result in a significantly higher follow-up rate, but with less reliable and 
informative data. Therefore, I think it is important to consider, for each study, the 
balance between sample size, follow-up rate and quality of outcome measures.
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9.5 Future research
Based on my findings I would propose three areas for further research in the area of 
body composition programming:
1. A study o f body composition at birth in relation to later body composition and 
health outcomes, to investigate the mechanism by which fetal growth influences later 
outcomes.
2. Cohorts with prospective assessment o f both (i) candidate hormones/ appetite 
regulators such as insulin or leptin, and (ii) infant body composition assessment 
would be o f benefit to clarify the mechanism by which ‘infant growth’ and ‘infant 
nutrition’ influence later health outcomes.
3. Further investigation o f the relationship between different components of BMI 
(i.e. FM vs. FFM) and health outcomes in paediatric populations with follow-up into 
adulthood.
9.6 C onclusions
The research documented in this thesis has a number o f important implications for 
future research in this area and, potentially, for public health. These are briefly 
outlined below:
- FFM in later life is influenced by birthweight -  a proxy for prenatal growth - as 
well as other factors such as genetic potential and life style. A study with 
measurements o f body composition at birth in relation to later outcomes might help 
to clarify the mechanism underlying this observation.
- Whether infant growth influences later FM through structural changes in infant BC 
which then track through later life, or through functional changes (i.e. the set-point of 
hormones regulating growth or appetite) is not clear. In my study, the evidence 
implicating infant BC in the programming process was not strong, although my
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conclusions were limited by the relatively small sample size. There is limited 
evidence that infant ‘fatness’ as measured by SF earlier than 12 weeks might have a 
long-term influence on later BC; this suggests that the period prior to 12 weeks might 
be important for BC programming. However, this hypothesis requires testing in a 
larger study.
- It is likely that both prenatal and postnatal nutrition are involved in ‘programming’ 
later BC. Prenatal nutrition influences the development of FFM in utero and also 
affects postnatal catch-up growth to a certain extent. Infant nutrition (particularly 
breast feeding) might program later FM through effects on hormonal regulation or 
infant fatness. These potential mechanisms warrant further investigation, since this 
information could be useful in terms o f designing effective early intervention to 
reduce obesity prevalence in childhood and adolescence.
- It is likely that childhood and adolescent BC may provide a ‘link’ between rapid 
early growth and cardiovascular risk factors in adolescence, with differential effects 
o f different components on outcome. FM showed a consistent association with most 
o f the cardiovascular risk factors except HDL-C, while FFM showed a consistent 
negative association with HDL-C that was independent of FM and central fat 
distribution.
- For screening purposes in a normal population, BMI and WC are valid tools for 
identifying children who might be at a higher risk for developing cardiovascular 
disease in later life. On the other hand, more detailed measurements of BC may be 
useful for investigating the long-term health outcomes of BC programming or 
investigating health outcomes in populations whose FM and FFM proportions might 
be different from normal, such as obese or other patient group.
- The method o f statistical analysis (especially body size adjustment) and BC 
techniques (based on different assumptions which vary between populations) chosen 
to assess these relationships is crucial for the interpretation of the findings.
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from my supervisors, and statistical input from Professor Tim Cole and Dr Deborah 
Ridout.
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Appendix A
Summary o f  the randomised controlled trial (cohort A) 
R andom ised  tria l o f low  energy versus standard term formula in 
healthy term  infants: m ethods and results during infancy
Based on the observation that formula-fed infants might effectively be overfed when 
consuming current infant formulas, a randomised controlled trial (RCT) was set up in 
1991 by Professor Alan Lucas at the Dunn Nutrition Unit in Cambridge to test the 
following hypotheses:
1) The use o f a formula with an energy content similar to that in breast milk 
(metabolisable energy density around 60 kcals/lOOml, as determined by doubly 
labelled water study (144)) would result in the pattern of growth, body composition 
and energy metabolism seen in breast-fed babies. If the difference in energy 
metabolism observed between breast-fed and formula-fed infants is solely or largely 
due to the difference in energy intake, it should be seen in two groups of formula fed 
infants consuming diets differing only in energy content.
2) Differences in energy intake, energy metabolism and growth in early life would 
have a “programming” effect on body fatness and metabolism later in childhood. 
(Specifically, infants fed the lower energy formula would have reduced body fatness. 
If  the lower energy intake and slower early growth and fatness of breast-fed infants is 
responsible for the lower risk o f later obesity, the same effect should be seen between 
the two groups o f formula fed infants consuming diets differing only in energy 
content.)
M ethods
Healthy term infants (appropriate for gestational age, 37-42 weeks) were recruited 
from the Rosie Maternity Hospital, Cambridge between 1990 and 1992, with 12- 
month follow up completed in 1993. All had weight at birth within the 10th and 90th
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percentiles o f the Cambridge Standards and were free from congenital malformations 
or conditions known to affect growth or development. Infants were eligible for the 
study if  their parents agreed to provide them with the study formula ad libitum as the 
sole source o f calories from birth to at least 3 months and together with 
supplementary food thereafter for the duration of the study and agreed not to provide 
any vitamin or mineral supplements to the infants for the duration of the study.
The infants were randomised onto the reduced energy formula (RE) or standard term 
formula (TF) at enrolment (before planned hospital discharge) and were evaluated at 
3 weeks, 6 weeks, and 3, 6, 9, and 12 months. Written informed consent was 
obtained, and the study protocol was approved by the ethics committee of the MRC 
Dunn Nutrition Unit, Cambridge. Randomization schedules were prepared at the 
Dunn Nutrition Unit for the enrolment o f 108 subjects (54 males, 54 females), using 
a permuted block randomization. The sample size represented a compromise between 
the need for adequate power for detecting differences in outcome measures, and the 
detailed (and expensive) nature o f the stable isotope measurements.
The composition o f formulas in comparison with mature human milk is shown in 
Table 10-1. The reduced energy formula differed from the standard formula in its 
lower fat (and hence energy) content. Both were supplied by Ross Products 
(Columbus, Ohio). Composition o f these formulas complied with the levels of 
nutrients recommended by the European Economic Community and the Committee 
on Nutrition o f the American Academy of Pediatrics and the Infant Formula Act of 
1980. The assigned study formula was fed as the sole energy source from birth 
through the initial 12-week study period. Solid food was introduced at a time 
determined by the parents with advice from their health care professionals (the 
Department o f Health recommendation for term infants at the time was not to 
introduce solids before 3 months of age).
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Table 10-1 Composition of study formulas compared with expressed mature 
human milk
C o m p o n e n t p er  100 m L
S tu d y  form u la E xp ressed  m ature hum an m ilk
RE TF D H S S 1 M acy et al2 A A P 3
Protein  (g) 1.34 1.35 1.34 1.45 1.0
Fat (g ) 2.86 3.64 4.2 3.8 3.9
Carbohydrate (g ) 7.11 7 .19 7.0 7.2 7.2
C alcium  (m g) 51 51 35 33 28
P hosphorus (m g) 39 39 15 15 14
S od iu m  (m g) 19 19 15 15 18
Iron (m g) 1.2 1.2 0.08 0.15 0.4
Z inc (m g) 0.51 0.51 0.30 0.53 1.2
E nergy (kca l) 59 .53 66.92 70 68 68
P rotein:E nergy ratio  
(g/lO O kcal)
2  25 2.02 1.91 2.13 1.47
1 D H S S  R eports on H ealth and Social Subjects.(282-284)
2 M acy, K e lly  and S loan  (284 ;285 ) and M ettler (284;286)
3 A m erican  A cad em y o f  Pediatrics(287)
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At each follow-up visit, weight, length, OFC (Occipito-frontal head circumference), 
MU AC (Mid-upper arm circumference) and SF measurements (triceps and 
subscapular) were performed by the investigators and details of intercurrent illnesses 
(type, duration, and treatment/management) were recorded on the case report form. 
Weight was measured using a paediatric scale accurate to ±5 gm, length using a 
horizontal infant stadiometer (with the infant’s head held by one observer, and both 
legs extended and held by a second observer) and OFC and MU AC using a non- 
stretchable encircling tape. All SFs were measured using Harpenden callipers.
Subjects were removed from the study if they had poor compliance, vomiting for 
more than 3 consecutive days, diarrhea necessitating a change in diet for more than 3 
consecutive days during the first 3 months, any illness necessitating dietary change 
for more than 3 days or any condition which would prevent normal growth and 
development during the study period.
Doubly-labelled water measurements
The doubly-labelled water method (144-147) was used to determine body 
composition, energy expenditure, energy intake, metabolisable energy intake and 
milk intake at the 3 month visit. Two samples of urine were obtained from each 
infant before the isotope study to measure natural concentrations o f2H and 180  in a 
body fluid. An accurately weighed dose of sterile isotope solution providing roughly 
0.28 g H21sO and 0.1 g 2H20  per kg body weight was given orally(146). Subsequent 
samples o f  the urine were collected at four and five hours and then daily for seven 
days (a period that ensured two to three biological half lives of the isotopes) using 
cotton wool balls left inside the infant’s nappy and, after urination, extracting the 
urine sample by inserting the cotton wool in a syringe (288). The parents were asked 
to check the nappy frequently for urination (at least once per hour) and the time of 
voiding was taken as the midpoint between the last two times of checking.
The principle o f the doubly labelled water method is that two stable isotopes of water 
(H21sO and 2H20 )  are administered simultaneously and their initial enrichment in a 
body fluid and subsequent rates o f disappearance from this fluid are monitored by 
isotope ratio mass spectrometry. The initial enrichment of either isotope reflects
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body water pool size (from the principle o f dilution) and permits an estimation of 
body composition. Subsequently, the rate o f disappearance of 2H20 reflects water 
output (and hence water intake) while that of H2 1 8 0  reflects water output plus 
production o f carbon dioxide because l80  is free to interchange between water and 
carbon dioxide through the action o f carbonic anhydrase. The difference between the 
two rates o f disappearance is, therefore, a measure of the rate of production of carbon 
dioxide. With additional knowledge of the subject’s respiratory quotient (derived 
from previous studies on a similar population = 0.85), energy expenditure can be 
calculated. Details o f the method and principles of the calculations used are reported 
elsewhere(147).
Statistics
The calculated sample size (50 infants per randomised group) permitted detection of 
0.6 SD difference in anthropometric measurements at 5% significance level with 
80% power. Data for randomised groups were compared using independent sample t- 
test. Categorical variables were compared using Pearson Chi-Square test. Repeated 
measures analysis o f variance was performed to determine the effect of formula on 
anthropometric parameter change at each time point. Weight, length and OFC SDS 
were calculated using British reference data(185). FM and FFM were normalized for 
infant length by dividing by height2 to give FM index (FMI) and FFM index (FFMI) 
(189).
R esults
Randomised trial
The trial profile is shown in Figure 10-1. A total of 107 infants were randomised, 53 
to reduced energy formula (RE) and 54 to standard term formula (TF). There were no 
significant differences in the proportion of infants withdrawn from each formula 
group or in the number o f subjects withdrawn by their parents or investigators; 40, 
75.5% o f the RE group and 46, 85.2% of the TF group completed the study at age 12 
months. However, only 32 and 43 out of 46 and 48 infants (in RE and TF groups
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respectively) participated in the doubly labelled water measurements, and only 28 
and 33 infants from RE and TF groups had complete results to permit calculation of 
changes in body composition over the 7-day study period.
Figure 10-1 Trial profile
Randomization
W ithdrawn from the study before 3 w eeks
Standard term formula group 
________ n = 54_____________
R educed  energy form ula group  
n =  53
H ealthy term infants 
(B irthw eight betw een 10th and 90th centiles) 
n =  107
n =  6
U nsettled  infant@ n =  3 
T oo frequent feed in g ®  n =  1 
V om itin g®  n =  1
D iagn osed  as H irschprungs d isease# n =1 
1
n = 4
Unsettled infant® n = 3
Parent unsatisfied with milk® n = 1
Seen at 3 w eek s, n =  47 Seen at 3 w eeks, n = 50
n =  0
W ithdrawn from the study between 3-6 w eeks
n = 2
Parent unsatisfied with m ilk® n = 1
S een  at 6 w eek s , n -  4 7
Too frequent feeding®  n = 1
Seen at 6 w eeks, n = 48
W ithdrawn from the study between 6 w eeks-3 months 
n =  1 n = 0
U n settled  infant®  n =  1X
Seen  at 3 m onths, n -  46 Seen at 3 months, n = 48
W ithdrawn by parents
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Withdrawn from the study between 3-6 months
n = 3
U nsettled infant® n =  2 
Poor com pliance# n = 1
n = 0
I
Seen at 6 months, n = 42 Seen at 6 m onths, n = 47
Withdrawn from  the study betw een 6-9 months
n =  1
Parental concern about not 
thriving® n =  1
1
Seen at 9 m onths, n = 41 Seen at 9 months, n = 45
Withdrawn from the study betw een 9-12 months
n=2
U nsettled infant@ n = 1
n =  0
I
Seen at 12 months, n =  40 Seen at 12 months, n=46
n W ithdrawn by investigator 
® W ithdrawn by  parents
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The baseline characteristics of the randomised diet groups are shown in Table 10-2. 
The groups were well matched for birthweight, gestation, gender, rank of birth, 
parental anthropometry. However, mothers in the TF group had a higher educational 
achievement (A-level or higher professional qualification 29.6% vs. 8%, p=0.08). No 
infant was weaned earlier than age 3 months and there were no differences in the 
percentages weaned at age 3 and 6 months: 37%v.s.35.4%, p=1.0 at 3 months; 
95%v.s.l00%, p=0.2 at 6 months in RE and TF group respectively.
Table 10-2 Baseline characteristics of infants according to randomised diet 
group &
RE formula 
(n -  53)
TF formula 
(n = 54)
P
G estation (w k) 40.1 ±  1.4) 39 .9  ±  1.2 0.6
B irthw eight (g) 3 .54  ± 0 .3 4 ) 3.51 ± 0 .3 2 ) 0.6
B oys (n, %) 24, 45.3% 26, 48.1% 0.8
Maternal age (yr) 26.9  ± 4 .7 27 .0  ± 4 .2 0.9
Paternal w eight (kg) (n = 23, 26) 77.7 ± 12 .9) 79.4  ± 9 .7 0.6
Paternal height (cm ) (n = 24, 26) 179.8 ± 6 .0 ) 177.7 ± 5 .4 0.2
Maternal w eight (kg) (n =  26, 28) 64.6  ±  12.7) 65.1 ±  15.1 0.9
Maternal height (cm ) (n = 25, 30) 161.8 ± 6 .6 ) 163.9 ± 6 .7 0.2
M others with A  level/h igher professional 
qualification (%)
8 % 29.6  % 0.08
Rank o f  Birth (%) 
1st 
2nd 
3rd 
4 th
25 % 
4 8 %  
23 % 
4 %
38 %
4 0 %
18%
4 %
0.6
& Data are show n as m eans ±  SD; Independent sam ple t-test was used to test the difference betw een  
the continuous variables; Chi-square w as used to test the difference betw een the categorical variable.
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Outcome measures
Growth
There were no significant differences between the 2 formula groups in attained 
weight, length, or OFC, expressed either as absolute values or as SDS (Table 10-3). 
However, the RE group had significantly lower subscapular SF by 0.8 mm (95%CI:- 
1.31,-0.23; p=0.005) at 6 weeks, by 0.7 mm (95%CI: -1.30, -0.15; p=0.014) at 3 
months.
There were no significant differences in age at follow up between the two groups for 
all six time points although age at 3 week follow up in the RE group was slightly 
less than for the TF group by 0.6 days (95%CI: -1.22, 0.02; p=0.06).
Table 10-3 Anthropometric data according to randomised group &
RE formula 
(n = 53)
TF formula 
(n = 54)
P
W eight SDS
Birth 0.13 ± 0 .7 0 0 .10  ± 0 .6 3 0.8
Enrolment -0 .22  ±  0.78 -0 .27  ±  0.66 0.7
3 w eeks -0 .10  ± 0 .7 9 -0 .06  ±  0.72 0.8
6 w eeks 0.04 ±  0.77 0.19  ± 0 .6 7 0.3
3 months 0.10  ± 0 .8 3 0.21 ± 0 .7 3 0.8
6 months 0 .10  ± 0 .8 9 0 .09  ±  0.79 1.0
9 months 0.14 ± 0 .9 6 0.07  ±  0.82 0.7
12 months 0.06  ± 0.90 -0 .02 ±  0.88 0.7
Length SD S
Enrolment -0.23 ±  0.94 -0 .22 ±  0.85 0.9
3 w eeks 0.05 ±  0.90 0.04  ±  0 .80 1.0
6 w eeks 0.21 ± 0 .9 4 0.33 ±  0.94 0.5
3 months 0.35 ±  1.03 0 .36  ± 0 .7 6 0.9
6 months 0 .30  ±  1.09 0.42 ±  1.05 0.6
9 months 0.38 ±  1.11 0.39  ± 1.16 1.0
12 months 0.21 ±  1.00 0.47 ±  1.04 0.3
& Data are show n as m eans ±  SD; Independent sam ple t-test was used to test the difference betw een 2 
formula group
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RE formula 
(n =  53)
TF formula 
(n =  54)
P
OFC SD S
Enrolment 0.20 ± 0 .8 5 0.15 ± 0 .7 9 0.8
3 w eeks 0.47 ± 0.82 0.44  ±  0.82 0.9
6 w eeks 0.48 ±  0.76 0.46  ±  0.77 0.9
3 months 0.29 ± 1.07 0.30  ±  0.84 1.0
6 months 0.21 ± 0 .9 0 0.15 ±  1.01 0.8
9 months -0.01 ±  0.95 0.02 ±  1.05 0.9
12 months -0.15 ± 0 .9 4 0.05 ±  1.12 0.4
Triceps SF (m m )
Enrolment 5.6 ±  1.4 5.5 ±  1.3 0.9
3 w eeks 6.6 ±  1.4 7.0 ±  1.5 0.14
6 w eeks 7.4 ± 1.5 7 .6  ±  1.6 0.5
3 months 8.3 ± 1.7 8.7 ±  1.8 0.3
6 months 9.7 ± 1.8 9.9 ± 2 .1 0.7
9 months 9.5 ± 2 .0 9 .9  ± 2 .3 0.4
12 m onths 9.4 ± 2 .5 9.3 ± 2 .4 1.0
Subscapular SF (m m)
Enrolment 5.7 ± 0 .9 5.9 ± 1.2 0.3
3 w eeks 6.8 ±  1.2 7.3 ±  1.3 0.07
6 w eeks 7.1 ± 1.2 7.9  ±  1.4 0.005
3 months 7.8 ±  1.5 8.5 ±  1.3 0.014
6 months 7.6 ±  1.5 7 .9 ±  1.6 0.4
9 months 7.7  ±  1.9 8.0 ±  1.8 0.4
12 months 7.2 ± 2 .1 7.0 ±  1.7 0.6
M id-upper arm circum ference (cm )
Enrolment 10.2 ± 0 .6 10.1 ± 0 .7 0.5
3 w eeks 10.6 ± 0 .7 10.8 ± 0 .7 0.3
6 w eeks 11.2 ± 0 .8 11.5 ± 0 .8 0.15
3 months 12.3 ± 0 .7 12.4 ± 0 .9 0.5
6 months 14.0 ± 0 .9 14.1 ± 0 .9 0.9
9 months 14.6 ± 0 .9 14.8 ± 1.2 0.5
12 months 14.9 ±  1.1 15.0 ±  1.4 0.8
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Body composition at 12 weeks
Infants in the RE group had a significantly lower FM than the TF group and had a 
trend towards lower calculated FM accretion: by 2.2 g/day (95%CI: -4.8, 0.3; 
p=0.08). Furthermore, the RE group also had higher FFM than the TF group 
although the differences did not reach statistical significant and there were no 
differences in FFM or protein accretion (Table 10-4).
When FM and FFM were normalized for length, FFMI was significantly higher in 
the RE group: by 0.65 kg/m2 (95%CI: 0.08, 1.23; p=0.03) while FMI was lower in 
the RE group: by -0.62 kg/m2 (95%CI: -1.24, 0.01; p=0.05).
Metabolisable energy intake
From the doubly-labelled water study, there was no difference in total energy 
expenditure and metabolisable energy intake between the two groups (Table 10-4). 
However, the RE group showed a trend towards lower energy deposited as fat by 
20.8 kcal/day (95%CI: -44.2, 2.7; p=0.08) and hence lower total energy deposited in 
new tissue by 20.9 kcal/day (95%CI: -48.8, 7.1; p=0.14).
Milk and nutrient intake
Infants in the RE group consumed significantly greater volumes o f milk than the TF 
group: by 15 mL/kg/day (95%CI: 3.2, 27.0; p=0.01) at 3 weeks, by 14 mL/kg/day 
(95%CI: 1.6, 25.9; p=0.03) at 3 months (Table 10-5). Consequently, the reduced 
energy formula group had slightly higher protein intake than the standard infant 
formula group: by 0.18 gm/kg/day (95%CI: 0.02, 0.34; p=0.03) at 3 weeks, by 0.17 
gm/kg/day (95%CI: 0.01, 0.33; p=0.04) at 3 months. However, they still had a 
significantly lower fat intake than the TF group due to lower fat content in the 
formula: by 1.1 gm/kg/day (95%CI: -1.50, -0.72; p<0.001) at 3 weeks, by 0.84 
gm/kg/day (95% Cl: -1.24, -0.44; p=0.001) at 3 months. Thus, the total energy intake 
was slightly lower in the RE group at 3 weeks but there was no difference between 
the two groups at 3 months.
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Table 10-4 Body composition, energy deposition, energy expended, 
metabolisable energy intake measured by doubly labelled water method over a 7 
day period at age 3 months &
RE formula TF formula P
FM (kg) 1.35 ± 0 .4 3 1.60 ± 0 .4 7 0.04
FFM  (kg) 4.49  ± 0 .5 1 4 .32  ± 0 .5 1 0.2
FMI (kg/m 2) 3.70  ± 1.14 4.31 ±  1.21 0.05
FFMI (kg/m 2) 12.35 ± 1.06 11.69 ±  1.12 0.03
B ody com position  accretion  
during 7 days study period*
FFM (g/day) 25 .9  ±  13.2 26.1 ±  13.7 1.0
FM (g/day) 7.1 ± 4 .7 9.4 ± 5 .1 0.08
Protein (g/day) 4.1 ± 2 .1 4.1 ± 2 .2 1.0
Energy deposited in new  tissue*
A s fat (kcal/day) 66 .0  ± 4 3 .3 86.8 ±  47.3 0.08
A s protein (kcal/day) 22.8 ±  11.6 22 .9  ±  12.1 1.0
Total (kcal/day) 88.8 ± 5 1 .6 109.7 ± 5 6 .6 0.14
Total energy expenditure
K cal/day 478 ±  147 4 6 7 ± 134 0.7
Kcal/kg/day 80.6  ± 22.3 78 .4  ± 2 2 .6 0.7
M etabolisable energy intake00
kcal/day 5 6 1 ± 156 547 ± 1 1 8 0.7
kcal/kg/day 92.8 ± 2 3 .1 90.5 ±  17.3 0.7
& Data are shown as m eans ±  SD; Independent sam ple t-test w as used to test the difference betw een  
the 2 formula groups. n=28 and 33 for body com position, n=32 and 43 for energy expenditure in RE  
and TF
s FFM accretion (144) (gm /day) = difference in FFM  betw een start and end o f  period divided by 7; 
FM accretion = difference in FM betw een start and end o f  period divided by 7; Protein accretion =  
FFM  accretion x proportion o f  protein in FFM (published value=15.7%  at age 3 months average for 
boys and girls)(36).
#
C onversion factors (9 .25 for fat and 5 .6 for protein) were used to derive energy stored as fat and 
protein during the study period (carbohydrate storage was assum ed to be neglig ib le). (144)
00 M etabolisable energy intake = total energy expended ± total energy deposited. (144)
235
Table 10-5 Milk intakes at age 3 weeks and 3 months and calculated nutrient 
intake per kilogram body w eight#
Reduced energy  
formula
Standard infant 
formula
p-value
M ilk intake at age 3 w eeks *
m L/day 853 (147) 8 0 4 (1 3 6 ) 0.10
m L/kg/day 2 1 3 (2 7 ) 198 (30) 0.01
M ilk intake at age 3 m onths**
mL/day 1 0 3 8 (2 0 1 ) 951 (148) 0 .06
m L/kg/day 172 (24.6) 158 (22.8) 0.03
Calculated nutrient intake at age 3 w eeks
Fat (gm /kg/day) 6.1 (0 .8) 7.2 (1 .1) <0.001
Protein (gm /kg/day) 2.8 (0.4) 2.7 (0 .4) 0.03
Energy (kcal/kg/day) 1 2 7 (1 6 ) 132 (20) 0.15
Calculated nutrient intake at age 3 months
Fat (gm /kg) 4 .9  (0 .7) 5.8 (0 .8) 0.001
Protein (gm /kg/day) 2.3 (0 .3) 2.1 (0 .3) 0.04
Energy (kcal/kg/day) 1 0 2 (1 5 ) 1 0 6 (1 5 ) 0.4
Calculate from Table 10-1 Composition of Trial formulas
n =  44 and 47 for m ilk intake at 3 w eeks in RE and TF, n = 28 and 33 for m ilk intake at 12 w eeks in 
RE and TF
* B y  bottle w eighing before and after feeding
* *
B y doubly labeled water study (147;289)
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Appendix B
Examples o f  the questionnaires used in the study
Figure 10-2 Pubertal status questionnaires
a) For girls
S'.is<ly Subject No:
• Please put a  tick in th e  
box that looks m ost like 
you now....
Th» Bmitft tre flat
Tho Breosta form small mounds. The brsatts form largar mounds than In 2.
■ P le a s e  pu t a  tick in the 
box th a t  looks m ost like 
you now ....
Y
Vary HWa hair Cuiia a !« oi h»r
/hfppia 
t. Areola
The nipple and the surroundng part 
PM Anoio) make up a mound I hat 
st-cks up above the treaa t
Only the nipple sticks out boyond the breast The hair has not 
ap.'aad over the thighs
5. 4 . 5 .
( T  1 ( T 1
The hair hns spread 
over the ihitjhs
b) For boys
S tu d y  Sub jec t No: •  P lease look at the Penis and 
Scrotum  only In these pictures.
•  Please put a  tick In the box that looks 
most like you now.
and the Penis 
is a  little larger.
The Pants Is longer 
and wider fte Scrotum 
Is darker and bigger 
than before
same size as when you
2. 3.
The Scrotum has
The Penis and 
Scrotum are the 
size and shape 
of an adult
•  P lease look at the Pubic Hair £nly in 
th ese  pictures.
•  P lease put a  tick in the box that looks 
most like you now.
Very UUle hair Quite a lot of hair
/
IT
The hair has not 
spread over the 
thighs
The hair has spread 
over the thighs
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Figure 10-3 Data collection forms
idf l  I 1/
Confidential data
Date of interview j j | / 1 j | /  j 2 | p J
Subject's surname  ^
Subject's first name
Date of birth j j j / j | j /  R T gj
Mother's surname
Address
Post code I
Home telephone number (+code) T 
Work telephone number (+code) [
NHS number J 
GP's name I I I
Address
Initialsm
Tel (+code)|
C onfidential information: p ag e  1
3 3
9952 Social data 1
D ate of birth
m / m / '
T oday 's d a te  [
T T T I i
□ 'H M 2 0
O ccupation  of sub ject 
O Full-time school (yrs 9-12)
O Full-time co llege (yr11/12)
O Full-time s tu d en t (post A-level, y ea r 12) 
O Part-tim e s tu d en t with part-tim e work 
O Part-tim e work (<35hr/wk)
O Full-tim e work (>35 hrs/wk)
Is h om e ow n o r re n te d ?  If h o m e is re n te d - is il from:
O O w ned O P rivate landlord
O R en ted  O Council
O H ousing  assoc ia tion  
O Not ren ted  
O N /A
N um ber of room s in hom e (incl dining, living + b ed ro o m s, e x d  kitchen + bathroom ) j j j 
N um ber of adults living a t h om e (include su b jec t if > 16 y ea rs) | I
N um ber of children living a t hom e (include su b jec t if 16 or younger)
Is m other m arried? O Y es 
O N o
O Living with partn e r
□
M other's d a te  of birth / / 1 9
I N o e d  q u als  ,-2 < 3  CSE'c or'GCSE's jbelpw.C‘g ra d e  .
3 >3 CSE’s o r any O .levels'or GGSE grade'A-C .....
*4 A  levels; ONC/OND/BEC/TEC, S C E  Highers,- NVQ level 3 /
, 5 Degree/H N D /H N G  professiorial training (incl:SRN/RGN/RM /RHV). NVQ levels- 
4/5, B E C /T E C H igher . ' "  ■ ■
M other's educational a tta inm en ts  (h ighest com pleted ) j | 
M other's h ig h est qualification
Social d a ta  - pg 2.1
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3 3
9952
Social d a ta  2
Mother’s occupation
How many months employed in the last year? [
Father's date of birth / / 1 9
Father’s educational attainments (highest completed) j | 
Father's highest qualification
Father’s occupation
How many months employed in the last year? [
Who is the primary earner for the family? O Father
O Mother 
O Grandparent 
O Both parents 
O missing
Social class (use primary earner’s occupation) [
Social code as below □
I ,
Code as. 1 = 1, 2 = 2, 3N = 3, 3M = 4, 4 = 5, 5 = 6 omprimary earners occupation 
Single parent mother unsupported and not working -  >7 r-v- v
* Parentfs^unemployed and living on jhenefits = 8 
i Mother a'single parent anda.student = 9 ■ < -
Social data - pg 2.2
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Medical History: 1 id [ / j
Fractures
Have you ever had a fracture? Q  yes=1 ■00=2 if no- 9 ° t0 medical section
Indicate s ite /s id e  of frac ture 
First Fracture__________________________________________________________________
Second Fracture
Third Fracture
C a u se  of frac tu re
First Fracture Second Fracture Third Fracture
0|=fall gl&yground apparatus; |04=RTAin car f  i : > |D7|Mhjury at home 
02=fa!l from bike **>’■ f ’ 05=RTA|3edesfrian X)fe=other f 
03=R TA bike ' 06=sports injury — I j
Medical data: 3.1
0 8
Medical History: 2
For questions below answer: yes = 1, no = 2
Are you clinically well?
Have you ever suffered with asthma? j j 
Have you ever suffered with eczem a? Q  
Have you ever suffered with hayfever?
Is there any family history of asthma, eczem a or hayfever? Q
Code A - asthma, E - eczem a, H - hayfever + relative code below (code 0 for 
no d isease)
1- Mother , /  '  2 - Father* ? | ' , 1 ,  ^ 1
3- Brother u  ■■ ( 4- Sister > „i
5 |$ sltem al Grandmother ■ % ’6 -  iyiaternal(Grand(p%ier ■' ]
7- Paternal Grandmother 8 - Paternal-Grandfather
Asthma
Eczema
Hayfever
Medical da ta  3.2
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M edical History: 3
Have you been on long term medication/or currently taking medication?
(yes=1, no=2 if no. turn to next section)
Current Medication (name, dose, duration and frequency)
Frequency
1= once/day 2= twice/day 3= three/day 4= four/day 5= > four/day 6= alternate days 7 -  less  than alternate days 
8s  m issing, N/A
Past Medication (name, dose, duration and frequency)
Frequency
1* once/day 2= twice/day 3= three/day 4= four/day 5= > four/day 6= alternate days 7= less than alternate days 
8= m issing, N/A
Medical da ta  pg 3.3
[ 3
Medical History: 5
Family history of other disease:
With respect to subject (not parent), code 0 for no disease:
1 - mother 2 -
3 - brother 4 -
5 - maternal grandmother 6 -
7 - paternal grandmother 8 -
father 
sister
maternal grandfather 
paternal grandfather
High C h o le s te ro l 
H e art d i s e a s e
O s te p o ro s is  
H y p e rten sio n  
D ia b e te s  - non-insu lin  d e p e n d a n t  
D ia b e te s  - insulin  d e p e n d a n t
O v e rw e ig h t, re qu iring  m ed ica l tre a tm e n t 
O th e r  fam ily  h is to ry
H a v e  y ou  e v e r  re q u ired  su rg e ry  fo r a n y  o f th e  follow ing: (1 = y e s .  2 =  no ) 
lung  h e a r t  j Gl trac t k idney
P le a s e  g iv e  d e ta ils  o f a n y  su rg e ry
H a v e you  e v e r  re q u ired  m ed ica l t re a tm e n t  fo r a n y  o f th e  follow ing :(1 = y e s ,  2=  n o ) 
lung h e a r t G l tra c t liver k idney
P le a s e  g ive d e ta ils  o f  a n y  m ed ica l tre a tm e n t
Medical da ta  3.4
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3339 M edical History: 4 /
Vitamin an d  m ineral su p p lem en ts
In the past year have you taken any supplements?
Multivitamins o  yes  
o  no
name of multivitamin
date started date stopped
no capsules/day
Calcium supplements o  yes 
o  no
still taking multivitamins 
o y e s  
o  no
name of calcium supplement
date started date stopped
m ' [ D '
no capsules/day
still taking calcium supplements 
o y e s  
o  no
Calcium intake (mg)/day derived from C alquest analysis
M edical d a ta  3 .5
s r a
E xercise: 1 R G S /
C h ild ren 's  E xerc ise  Q u estionnaire
How many PE lessons do you have per week? J
How long is each PE lesson? (mins)
How many hours per week do you spend watching 
TV and videos, plus playing on the computer and 
video gam es (school nights only)
How many hours per week do you spend 
watching TV and videos, plus playing on the 
computer and video gam es (weekend)
How many hours per week do you spend on each of these  
activities outside PE classes:
Riding bike 
Swimming 
Running 
Football 
Aerobics/dancing 
Gymnastics 
Walking
t - i  I
Tennis I
l-l I
l - l  I
Netball I
l - l  I
I - ;  i
Hockey I
l - l
I - :  I Basketball | l - l  I
!■: I
Rugby| |
l - l  I
I -  i
Skating j j
l - l  I
l - ;  I Other sport l - l  I
Other, please specify [
Exercise data - 3.1
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E xerc ise  da ta : 2 R G S /
Parent's opinion of the child 's physical 
activity levels
Total hours child spents in vigorous activity per week j j j 
Level of child's activity compared to peers Q 1 =  m u ch  l e s s  th a n  p e e r s  2 =  le s s  
3 =  s a m e  
4=  m o re  
5 =  m u c h  m o re
Pubertal Development (if 9 year or older)
d ata  to transfer from confidential d a ta  sh ee t
Breast/genital development stage (1-5)
Pubic hair development (1-5) j~~j 
For girls onlv:
Have periods started yes  
no
not applicable o  
Age of first period (years:months) I j
Date of first day of last menstrual period I 
Number of days in whole menstrual cycle
For exam ple; 5  days m enstruation then 25  days to next 
m enstruation  =  30 d ay  cycle.
Oral contraceptive or implant? Y e s  = 1 
N o = 2
Exercise - pg 3.2
£ 3
Anthropometry 1 /
Birth Weight (g )Q Birthweight (lb:oz)
SeX □  2
= m a ie
2 = fe m a le
S u b je c t 's  A nthropom etry
MUAC (cm)
Waist circum (cm)
Thigh circum (cm)
Sitting Height (cm)
Gestation (wks) lO
Mother's reported wt (kg)
Mother's reported ht (cm)
Father's reported wt (kg)
Father's reported ht (cm)
| Mother's height (ft:in) Q  I"
_ Father's weight (st:lb) | | | [ 
_ Father's height (ft:in) Q
Head circum (cm)
Hips (cm) 
Calf circum (cm)
Skinfold Thickness Measurements
Biceps (mm) 
Triceps (mm) 
Subscap (mm) 
Suprailiac (mm)
A nthro  - p g  4.1
£ 3
Anthropometry 2
BODPOD
id / j
I / | / |  |  |
Time | | ~~[. | | | Temp (c) | | . |.
Pressure (mmHg)
Final Test System
Test Data
Raw Volume
Test One
SD Mean Volume
Test Two Test Three
Best Mean
% Fat]■□ mo
Raw Density (weight/volume)
n-rm o om
Weight 1 Weight 2
lO
Weight 3
Comments
Height . Lung Volume | | | .
A nthro  - p g  4 .2
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i e a
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Anthropometry 3
DEUTERIUM DILUTION
Full bottle of diluted deuterium (g) Post dosing bottle weight (g)
Post dose fluid intake (mis) Time post dose saliva sample taken
BIOELECTRICAL IMPEDANCE
Log no . d is ta n c e  (cm )
Whole arm 
Lower arm 
Upper arm 
Trunk 
Upper leg
Whole leg 
Lower leg 
Whole body 
Whole body
A nthro  - p g  4 .3
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Step  te s t
Is s u b je c t  h a p p y  to  d o  s te p - te s t  (Y /N )? j j
If 'n o ' s ta te  r e a s o n
D o e s  s u b je c t  cu rren tly  h a v e  a s th m a  (Y /N )? j |
If Y e s  to  a s th m a , d o e s  su b je c t  h a v e  in h a le r (Y /N )? | j 
If subject has asthma, but no inhaler - do not continue with step-test
H eigh t o f s u b je c t  (cm )
E s tim a te d  s te p  h e ig h t (0 .1 8 8  x h t) j j j j j S te p  h e ig h t u s e d  (cm ) j j | j j
Step height made up of:
1 xR eeb ok step  15cm (79.8cm of height)
  x Reebok inserts 5cm (26.6cm of height)
  x 1,2cm platforms 1.2cm (6.4cm of height)
  x 0.6cm platforms 0.6cm (3.2cm of height)
e g . H e igh t o f 1 5 5 cm  w ou ld  n e e d  a  s te p  o f  2 9 .1 4 c m  m a d e  u p  of:
I x s te p  (1 5 c m ) + 2 x R e e b o k  in se rts  (1 0 c m ) + 3 x 1 ,2 cm  (3 .6 ) + 1 x0 .6cm  
= 2 9 .2 c m
Set metronome rate:
O  M ales  9 6  b e a ts /m in  O  F e m a le  8 8  b e a ts /m in
R es tin g  HR (b e a ts /1 5  s e c o n d s )
3  m in u te  s te p  t e s t  c o m p le te d  (Y/N) □
HR im m e d ia te ly  p o s t  s te p - te s t  ( b e a ts /1 5 s e c o n d s )  
H R  1 m in u te  p o s t  s te p - te s t  (b e a ts /1 5  s e c o n d s )
P9 5.1
1/E E21670
Lifestyle data:1
Please fill this questionnaire in as honestly as possible 
Please complete all the questions
This information will be treated as CONFIDENTIAL and will not be passed  
on to anyone outside the study.
Today's date | | | / | | | / [2
Smokinq
---------------“  H a v e  you  e v e r  s m o k e d  a  c ig a re tte ?  O Y E S
ONO
If y e s , d o  y ou  s m o k e  c ig a re tte s  re g u la rly ?  O Y ES
ONO
If y ou  s m o k e , h o w  m a n y  p e r  d a y ?
H ow  long  h a v e  you b e e n  sm o k in g  for? (y rs .m th s)
W h e n  did  you  la s t  s m o k e  a  c ig a re t te ?  | j j j  j j j j  | 2 | q  | 
Alcohol
H a v e  yo u  e v e r  d ru n k  a lc o h o l?  O  Y E S  
ONO
If y e s , d o  y ou  drink a lc o h o l reg u la rly ?  O  Y ES 
ONO
H ow  long  h a v e  you  b e e n  drink ing  a lc o h o l for? (y rs .m th s) j j
1 drink means:
1 h alf pint o f  b e e r
1 sm all g la s s  o f  w ine
1 p u b  m e a s u r e  o f  sp irits  o r  1 sh o t o f  spirit
0 .5  b o ttle  A lc o p o p s  fo r e x a m p le  'B arcard i B re e z e r
If you  drink  regu la rly , how  m an y  a lc o h o l d rin k s  d o  you h a v e  e a c h  w e e k ?
H ow  m a n y  d a y s  s in c e  y ou  la s t h a d  an y  a lc o h o l?
P a g e  6.1 - sm k /a lc
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■  EEE
21670 id I I | |  I
Lifestyle da ta :2  
Ethnic origin
P le a s e  fill th e  c irc le  th a t  y ou  th ink  b e s t  
d e s c r ib e s  y o u r e th n ic  origin:
O  White
O  Black - Caribbean 
O  Black - African 
O  Black - other 
O  Indian 
O  Pakistani 
O  Bangladeshi 
O  Chinese 
O  Asian - other 
O  Other 
O  Refused
Thank-you for completing this questionnaire -
please put it in the envelope and give back to the researcher.
P a g e  6 .2  - sm k /a lc
Appendix C
Curve fits for internal SDS calculation by LMS methods for body 
composition variables
The lmsChartMaker program fits smooth centile curves to reference data using the LMS 
method (290). Reference centile curves show the distribution of a measurement as it 
changes according to some covariate, e.g. age. The LMS method summarises the 
changing distribution by 3 curves representing the median (M), coefficient of variation 
(S) and skewness (L). More details can be found in the User’s guide to lmsChartMaker© 
1997-2005 Medical Research Council, UK.
SD score (Z) of a child’s measurement (y) is calculated from the L, M and S curves, 
using values appropriate for the child’s age and sex. Two formulae are relevant 
depending on the value of L;
Z = (VM)l -1 if 0
LxS
Z = log fy/M) if L=0
S
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LMS Curve fits used for body composition SDS calculation
Figure 10-4 Boys FM I centile chart (n = 145)
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Body composition data were derived from 4-com ponent model and regional composition data were 
derived from DXA. Subjects used to create the centile charts were part o f  an ongoing body composition  
reference study at the MRC Childhood Nutrition Research Centre, Institute o f  Child Health, London, UK.
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Figure 10-5 Girls FMI centile chart (n=163)
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Figure 10-6 Boys FFMI centile chart (n=145)
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Figure 10-7 Girls FFMI centile chart (n=163)
20
18
164
14
12
10 L 
0
2+
-1+
-34-
Age
A ▲
10
Age
15 20 25
250
Figure 10-8 Boys Trunk FMI centile chart (n=145)
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Figure 10-9 Girls Trunk FMI centile chart (n=163)
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Figure 10-10 Boys Limbs LMI centile chart (n=145)
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Figure 10-11 Girls Limbs LMI centile chart (n=163)
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Figure 10-12 Boys Trunk LMI centile chart (n=145)
to
(U
(V 9 +Z
7 +
0 5 10 15
Age
3 .0 -r
2.5- 
2.0+
1.5- 
1.0+  
0.5- 
0.0 
-0.5- 
-1.0— 
-1.5—  
- 2 . 0—  
-2.5—  
-3.0—
▲ *
▲ 
A A
t  A
a * * aa
a . A <£*■
*A A 1 0 *  15 a  A 20
A a  " a  *a  *  4 a  1
*  A
▲
A
^A
A
A*
25
Age
255
M
ea
su
re
Figure 10-13 Girls Trunk LMI centile chart (n=163)
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Appendix D
Example o f the information sheets and consent forms
'C,* Institute of Child Health -  UCL
and Great Ormond Street Hospital for Children NHS Trust
Version 4 5.5.05
YOUNG PERSO N ’S IN FORM ATION SHEET
E arly Diet and  L ate r Body Composition and  Blood Vessel Function
We would like to ask you to take part in this research project. Please read the information sheet 
carefully and ask us about anything you do not understand. This study is voluntary which means 
th a t it is vour choice w hether o r  no t to take p a r t  in this study and vou should only do so if you 
w ant to.
1. The aim  of the study.
The aim o f  this project is to find out whether the type o f milk you received as a baby, and your 
pattern o f  growth, especially in the first year o f  life, has any effect on: 1) body composition (how 
much fat, muscle and bone you have) and 2) how blood vessels work later in life.
2. W hy is the study being done?
Many people now think that the type o f  ntilk you are fed as a baby, the size you are at birth and how 
you grow in the first year o f your life has an effect on whether or not you get heart and blood vessel 
disease later on. These factors may also affect your bones and how fat you are later on. We have 
asked you to take part in this study because we have good records o f  your early diet and growth. 
This is because when you were a baby you took part in a baby feeding study and you were weighed 
and measured during your first year o f  life.
3. How is the study being done?
If you decide to take part in this voluntary  study wc would ask you to spend a day at our special 
clinic in London where the study has been arranged. Your parents can come with you. If  this is not 
possible for any reason, we could arrange to come and visit you at home and do a shorter version of 
the study. We would not be able to do the tests marked * in the list below. Before your clinic visit 
we will send you a container so that you can provide a sample o f  the first urine passed on the day o f 
the appointment. If  you are willing to have a blood test, we would like you not to have anything to 
eat or drink (except water) on the morning o f your appointment, or if its going to be a long journey, 
4 hours before coming to London. Lots o f  food and drink will be available all day at the centre.
At the clinic we will ask you do the following:
a) Alter the study has been explained to you, and we have answered all your questions, we 
would like you to sign a form. Signing this form tells us that you are willing to take part and 
that we can use the information collected w-hen you took part previously in the baby feeding 
study to answer our research questions.
To measure how much fat, muscle and bone you have we will ask you to:
b) Lie on a bed with a machine above you that measures your bones using very low dose o f X- 
rays (a DXA machine). This will also take a picture o f your skeleton, which you can keep. 
You should not have a DXA scan if there is any chance you might be pregnant*.
c) Sit mside a chamber (with a window) called a Bodpod for a few minutes. This chamber
measures your body volume. You will need t 
shorts) (please bring one with you) and a swir
d) To drink a small amount o f  water that conta 
water is entirely safe; it is not radioactive an 
sample o f  your saliva before and after the drir
e) M easure your height and weight, waist, an 
fingers and your skinfotds (by pressing the 
You will not be asked to undress completely 
An electrical signal will be measured to deh 
body. This m easurem ent is com pletely painles 
times before (even in  small babies).
f) M easure the strength o f  the bones in your wr 
The m easurements take a few m inutes, are cot
For the blood vessels part o f  the study w e will ask
g) Rest on a bed for 10 m inutes and then mcas 
occasions. W e w ill then look at the m ain blot 
(using an ultrasound scanner which is the sam 
how fast your pulse travels dow n the arm (wh 
tight cu ff will be inflated around your lower 
feel som e tingling in the fingers before the cti 
will be measured. This measurement has bee: 
as young as S years o f  age and is painless and 
m ain artery in your neck using the sam e scanr
h) If  you agree, som e blood for testing will be I 
numbed the area. The level o f  a  num ber of 
vessel disease in adults and the amount o f  be 
asked to give us your perm ission to tell your 
this study and i f  any o f  the results are abnom  
you do  n o t w an t to. We will also measure 
could be useful for you, because if  the level i 
lifestyle to a healthier one.
i) Step on and o ff  a low bench for 3-5 m inutes tc
j)  You will b e  asked to fill in a form to tell us ;
function (such as smoking and drinking alcoh 
are m aturing into adults). A private room w 
provided. Y ou will no t be asked to undress i 
and not know n to the people doing the measur
k) We will ask you som e questions about your n<
1) We will ask you to w ear a  small instrument 
movem ent and so will also tell us how physic 
this, and the equipm ent can be posted back to
All o f  the things w e have asked you to do are easy, f  
are at the clinic (w ith lots o f  breaks!). You can  take 
vo lun tary  an d  vou  d o n ’t  have  to  do any th ing  th a t
4. A re th e re  an y  risks a n d  d iscom forts?
W e do not think that any o f  the tests w e plan to do ' 
scan m ay be a little uncomfortable but is not painful
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5 years o f  age) A lthough a cream  will be used to num b the skin for blood tak ing  there still m ay be 
som e d iscom fort and bruising. T he R esearch  E thics C om m ittee at the Institute o f  Child H ealth has 
given its approval for the study.
5. W h o  w ill have  access to  th e  ca se /re se a rc h  re c o rd s?
O nly  the people doing  the study w ill be ab le to see the  inform ation collected.
6 .W h a t a re  th e  p o te n tia l  benefits?
The study will no t b ring  any  im m ediate benefits to  you. H ow ever it is hoped that the study will 
help us to understand  the  things that cause obesity  and heart disease. W e think that the study  m ay 
also help you because i f  your chance o f  blood  vessel d isease later on  is h igher than  norm al you can 
be advised on how  to reduce the risk for the  future.
7. Do I h av e  to  ta k e  p a r t?
T h is  s tu d y  is v o lu n ta ry  w h ich  m ean s th a t  it is v o u r  cho ice  to  ta k e  p a r t  a n d  vou sh o u ld  only  rin 
so if  vou w a n t to . I f  you decide not to  take part now  o r later this w ill not affect your m edical care 
in any w ay.
8. W h o  d o  I sp e a k  to  i f  a  p ro b le m  a r ise s?
I f  you have any  com plain ts about the w a y  in w hich  th is research project has been, o r  is being  
conducted, please, in the  first instance, discuss them  w ith  the  researcher. I f  the problem s are not 
sorted out, o r you w ish to  com m ent in an y  o ther w ay, p lease contact the C hairm an o f  the Research 
Ethics C om m ittee, by  post v ia the R esearch  and D evelopm ent O ffice, Institute o f  C hild  H ealth,  
 o r if, u rgent, by  telephone on and the 
com m ittee adm inistration will pu t you in  contact w ith  him .
10. D eta ils  o f  bow  to c o n ta c t th e  R e se a rc h e rs
P lease contact either;
 R ecruitm ent Nurse,
S irinuch C hom tho, S tudy C o-ord inator, Institu te o f  C hild  H ealth , London, 
D r Jonathan W ells, Researcher, Institu te o f  C hild  H ealth, London,  
D r M ary Few trell, Principal Investigator, Institu te o f  C hild H ealth, London,  
Thank you for reading this information sheet
Institute of Child Health -  UCL
^  and G reat O rm ond  S tree t H osp ita l fo r C hildren NHS Trust
Version 4 5.5.05
P A R E N T ’S IN F O R M A T IO N  S H E E T
E a r ly  D iet a n d  L a te r  B ody C om p o sitio n  a n d  B lood V essel F u n c tio n
___________ is be in g  inv ited  to  take part in a  research study. B efore you decide w hether
he/she should take part o r not, it is im portant to understand w hy the research  is being done 
and w hat it w ill involve. P lease take tim e to read  the fo llow ing  inform ation carefully  and 
discuss it w ith  o thers i f  you  w ish. A sk us i f  there is anything that is no t c lear o r  i f  you w ould  
like m ore inform ation. T hank you for reading  this.
1. T h e  a im  o f  th e  s tu d y .
T he aim  o f  this project is to find out w hether the type o f  m ilk received b y  a  baby, o r the 
pattern o f  grow th, especially  in  the first year o f  life, has any  effect on: 1) body com position 
(how  m uch fat, m uscle and  bone you have) and 2) how  blood vessels w ork later in life.
2. W h y  is th e  s tu d y  b ein g  d o n e?
M any scientists now  believe that the type o f  m ilk you receive as a  baby , the size you are at 
b irth  and  how  you grow  in the first year have an  influence on  your b ody  com position  later in 
life and on  w he ther or no t you get heart and blood vessel d isease. W e have asked your child 
to take part in th is study  because they  previously took  part in a  study  looking  at different 
types o f  infant feeding  and so  w e have good records o f  your ch ild ’s early  m ilk  intake, grow th 
and body  com position.
3. H ow  is th e  s tu d y  b ein g  d o n e?
If  your child  decides to  take part, w e w ould like h im /her to  spend a day  a t our special clinic 
in L ondon w here the study  has been arranged. I f  this is no t possib le for an y  reason, w e 
w ould am ange to  conduct a  m ore lim ited version o f  the study  at hom e. In  th is case, w e w ould 
not b e  ab le to perform  the tests m arked  w ith an asterisk. B efore the s tudy  w e w ill send you a 
conta iner so that your ch ild  can  p rovide a sam ple o f  the first urine passed  on the day  o f  the 
appointm ent. I f  your ch ild  agrees to have a blood test, w e w ould like h im /her not to  have 
anyth ing  to eat o r drink (except w ater) on the m orning o f  the appoin tm ent or, i f  it’s going to 
be a long  jo u rn ey , 4 hours before com ing to London. Breakfast, lunch and o ther 
refreshm ents w ill be availab le throughout the day and all travelling exp en ses will be 
refunded for both you and your child.
A t the clin ic/v isit w e w ill ask you do the following:
a) A fter the s tudy  has been  explained to you (and w e have answ ered all your questions) 
w e w ould  like you to sign a consent form. This w ill g ive us perm ission to include 
your ch ild  in the study  and to use the inform ation collected p reviously  in the infant 
study  to answ er o u r research  questions.
To m easure your ch ild ’s body com position (how  m uch fat, m uscle and bone they  have) we 
will ask  your child  to:
b) Lie on a bed  w ith  a m achine above it (D X A ), that m easures your ch ild ’s bones using 
very  low dose X -rays (m uch less than a d ay ’s background radiation). This will also 
take a p icture o f  h is/her skeleton, w hich you can  keep. D X A  scans will no t be 
perform ed i f  there is any  possib ility  o f  pregnancy*.
c) Sit inside a cham ber (w ith a w indow ) ca lled  a B odpod for a few minutes. This 
cham ber m easures body volum e. Y our child  w ill need to  w ear a  sw im m ing costum e 
(please b ring  one w ith  you) and a sw im m ing cap (w hich w e w ill provide)*.
d) D rink a  sm all am ount o f  w ater that contains som e special w ater called deuterium. 
This w ater is en tire ly  safe; it is no t radioactive and occurs naturally . W e w ill ask 
your child to  give a  sam ple o f  saliva before and after the drink.
e) M easure your ch ild ’s height and w eight, w aist, arm , head, hip and ca lf 
circum ferences, and skinfolds (by  pressing  the fat gently  on the arm , shoulder and 
abdom en). C hildren  w ill not b e  asked to undress com pletely. Pads w ill be attached to 
the hands and feet. A n electrical signal w ill b e  m easured  to  determ ine the am ount o f  
w ater and m uscle in the body. This m easurem ent is com plete ly  painless and harm less 
and  has been  done thousands o f  tim es before (even  in  sm all babies).
f) M easure the strength  o f  the bones in  your ch ild ’s w rist and  low er leg using an 
ultrasound m achine. T he m easurem ents take a few  m inutes, are com pletely painless 
and  do not use x-rays*.
For the blood vesse ls part o f  the study w e w ill ask your ch ild  to:
g) Rest on a bed for 10 m inutes and then  m easure h is/her blood  pressure and heart rate. 
W e will then  look  at the m ain blood vessel in  the righ t arm  and  m easure its w idth 
(using  an u ltrasound scanner w hich  is the sam e as the scan  used  to  look at unborn 
babies) and  how  fast the  pulse travels dow n the arm  (w hich  is no t in  any w ay painful 
o r unpleasant). A  tight c u f f  w ill be inflated around the low er arm  for 5 m inutes, and 
then  released (there m ay be som e ting ling  in  the fingers before the cu ff  is released). 
T he change in b lood  vessel size will b e  m easured. T his m easurem ent has been done 
in over 5000 people, including children as young as 5 years o f  age and is painless and 
harm less. W e w ill also m easure the size o f  the m ain  arte ry  in the neck, using the 
sam e scanner*.
h) I f  you and your ch ild  agree, w e w ould like to  take a b lood  sam ple to  m easure the level 
o f  a  num ber o f  substances thought to affect the chances o f  b lood  vessel disease in 
adults, including cholestero l. W e w ill also m easure how  fast bone is being m ade. W e 
w ill also look for genes that affect how  m uch fat/lean and bone tissue that you have 
and genes that affec t heart disease. T he genetic tests are on ly  for research  purposes 
and are unlikely  to be have im plications for your ch ild ’s health  personally. The 
sam ple w ill be regarded as a  gift and m ay  be stored at the Institu te o f  Child Health and 
m easurem ents m ay  not be done until a later date. T h e  sam p les  w ill be id en tified  b y  a 
n u m b e r  on ly  a n d  all in fo rm a tio n  co llec ted  w ill b e  c o m p le te ly  co n fid e n tia l. You 
w ill be asked to g ive us your consent to  tell your fam ily  docto r (G P) that your ch ild  is 
tak ing  part in  th is study. I f  any  o f  the resu lts are abnorm al they  w ill be sent to the GP 
and you w ill receive a letter advising  you to  contact the G P. C h ild re n  can  tak e  p a r t  
in  th e  s tu d y  w ith o u t h av iu g  a b lood  te s t if  th ey  w a n t.
i) To assess physical fitness, your child will be asked to step  on and  o ff  a low bench for 
3-5 m inutes and their heart rate m easured.
j)  C hildren w ill be asked to assess their stage o f  puberty (physical m aturity) using 
pictures as a gu ide and to  fill in a  questionnaire about certain  factors that could affect 
blood vessel function (such as sm oking and alcohol consum ption). A  room  w here 
they  can  do  this in  private will be provided for all children (w ho will be asked to put 
their com pleted  questionnaire into an envelope and then seal the envelope). The 
inform ation collec ted  w ill be strictly  confidential and not know n to the people doing 
the m easurem ents, 
k) W e w ill ask you and your child  som e questions about their diet.
I) W e w ill ask  your ch ild  to w ear a sm all instrum ent on h is/her belt (for 4 days) that 
detects m ovem ent and so m easures physical activity. Y ou can chose w hen you do this 
test, and the  equipm ent can be returned to us b y  post.
All o f  the things w e  have asked your ch ild  to  do w ill take about 5 hours over the day you are 
at the centre. T here w ill b e  lots o f  breaks, including stops for lunch and refreshm ents. I f  w e 
v isit you at hom e to conduc t the study, the tests w ould take about 1 hour.
4 . A re  th e re  an y  risk s  a n d  d isco m fo rts?
N o risk to  your ch ild  can  be foreseen. T he c u f f  around the arm  for the scan p rocedure m ay 
cause m inor d iscom fort b u t is w ell tolerated (the scan has been done in  ch ildren  as young as 
5 years o f  age). A lthough local anaesthetic cream  w ill be used to num b the skin for blood 
tak ing  there still m ay  be som e discom fort o r bruising. T he R esearch E th ics C om m ittee o f  the 
Institute o f  C hild  H ealth , has given its approval for the study.
5. W h o  w ill h av e  access to  th e  c a se /re se a rch  re c o rd s?
O nly the researchers and  a representa tive o f  the R esearch  E thics C om m ittee w ill have access 
to  the data collected du ring  this study.
6. W h a t a r e  th e  a r ra n g e m e n ts  fo r  c o m p e n sa tio n ?
T his research has been  approved  by  an independent Research E th ics C om m ittee w ho believe 
that it is o f  m inim al risk to  your child . H ow ever, research can carry  unforeseen  risks and w e 
w ant you to  be in form ed o f  your rights in the unlikely event that an y  harm  should  occur as a 
result o f  taking part in th is study.
This research is covered  b y  a no -fau lt com pensation  schem e w hich  m ay apply  in  the event o f  
any significant harm  resu lting  to  your ch ild  from  involvem ent in  the study. U nder this 
schem e it w ould  no t be necessary  fo r you to  prove fault. You also have the right to  claim  
dam ages in  a court o f  law. This w ould  require you to prove fault o n  the part o f  the 
H ospital/Institute and /o r any m anufacturer involved.
7. W h a t a re  th e  p o te n tia l  b en e fits?
T he study  w ill no t b ring  any  im m ediate benefits to your child. H ow ever, it is hoped that this 
study w ill further o u r understanding  o f  the factors that cause obesity  and heart d isease (and 
so be o f  benefit in  finding w ays to  lessen the risk o f  heart disease). W e believe that the 
inform ation collec ted  cou ld  also be beneficial to your child in  that i f  their risk o f  blood 
vessel d isease in later life  is h igher than average (eg  due to a  high cholestero l level or high 
blood pressure) you  can be advised o n  how  to reduce the risk for the future.
8. Does m y ch ild  h av e  to  ta k e  p a r t?
I f  you do  decide to  take part you w ill be given this inform ation sheet to  keep and asked to 
sign tw o consent form s, on e  for you and  one for o u r records. I f  you decide, now  or at a  later
stage that you do not w ish  to  partic ipate in this research  pro jec t, that is entirely  your right 
and w ill no t in any w ay pre judice any  present o r future treatm ent.
9. Who do I speak to if a problem arises?
If  you have any com plain ts about the w ay in w hich th is research  pro jec t has been, or is being 
conducted, please, in the first instance, discuss them  w ith  the researcher. I f  the problem s are 
not resolved, o r you w ish  to com m ent in any o ther w ay, p lease  contact the Chairm an o f  the 
R esearch  E thics C om m ittee, b y  post v ia the R esearch and D evelopm ent Office, Institute o f  
C hild  Health,  o r  if, u rgent, by  telephone on  
 and the com m ittee adm inistration w ill pu t you in  contact w ith  him .
10. Details of how to contact the Researchers
P lease contact either;
R ecruitm ent N urse,
Sirinuch C hom tho, S tudy  C o-ordinator, Institu te o f  C hild  H ealth ,  
D r Jonathan W ells, R esearcher, Institute o f  C hild  H ealth ,  
or
D r M ary Few trell, P rincipal Investigator, Institu te o f  C hild  H ealth ,  
Thank -  you for reading this information sheet
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and G reat O rm ond S treet H o sp ita l fo r  C h ild r e n  N H S  Trust  
U N IV E R S IT Y  C O LLEG E L O N D O N
C en tre  N u m b er::
S tudy  N um ber:
P a tien t Identification N um ber for this trial:
ASSENT FORM
Title of Project: Early diet and later Body Composition and Blood Vessel Function
Please initial box
1 . I h a v e  re a d  a n d  u nderstand  th e  information sh e e t  d a t e d ..................................
( v e rs io n  } for th e  ab o v e  s tudy  a n d  h a v e  h a d  th e  c h a n c e  to a sk  questions.
2 . I u n d e rs tan d  that taking part is vo luntary an d  tha t I c a n  w ithdraw
a t a n y  tim e, w ithout giving any  rea so n , an d  w ithout m y m edical c a re  o r legal rights being affected.
3 . 1 a g re e  to  m y G P  being told tha t I am  taking p art In th is  stu d y  an d  a lso  being 
told o f an y  resu lts that m ay  require further te s ts
3. I a g re e  to  ta k e  part in the  ab o v e  stu d y .'
N am e  of young perso n  D ate  S ignature
S ignature
1 for patient; 1 for re sea rch e r; 1 to b e  kept with hospital no tes 
version 1 14 .05.04
Institute o f Child Health
and G reat O rm on d  S treet H o sp ita l for C h ild ren  N H S  Trust  
U N IV E R S IT Y  COLLEGE, L O N D O N
C en tre  N um ber::
S tudy  N um ber:
P a tien t Identification N um ber for this trial:
CONSENT FORM
Title of Project: Early diet and later Body Composition and Blood Vessel Function
Please initial box
1. I confirm  th a t I h ave  re a d  a n d  u nderstand  th e  information sh e e t d a t e d     □
(v e rs io n  } for th e  ab o v e  stu d y  an d  h a v e  h a d  th e  opportunity to a sk  questions.
2 . I u n d e rs tan d  th a t my child’s  participation is voluntary an d  tha t I am  free to  w ithdraw 
a t an y  tim e, w ithout giving an y  rea so n , without m y child’s  m edical ca re  o r legal rights being affected.
3 . i a g re e  to  m y child’s  G P  being notified of h is/her participation In this study  an d  a lso  being 
notified o f a n y  re su lts  tha t m ay  require further investigation
3 . I a g re e  to  m y c h i ld .....................................v ..................................taking part in th e  ab o v e  study.
N am e  of P aren t/G uard ian  D ate S igna tu re
N am e  of P e rso n  taking co n sen t D ate S igna tu re
(if different from  re sea rc h e r)
S igna tu re
□
s□
□
1 for patient; 1 for re sea rch e r; 1 to b e  kept with hosp ita l no tes
Institute o f Child Health
and G reat O rm on d  Street H o sp ita l fo r  C h ild ren  N H S  Trust 
U N IV E R S IT Y  CO LLEG E L O N D O N
C en tre  N u m b er::
S tudy  N um ber:
P a tien t Identification N um ber for this trial:
A SSEN T FORM  FO R  A BLOOD TEST 
T itle  o f  P ro je c t:  E arly  d ie t a n d  la te r  B o d y  C o m p o s itio n  a n d  B lo o d  V e sse l F u n c tio n
T hank  you for ag ree ing  to h ave  a  blood te s l. As you know  from  the  Information sheet, 
tak e  so m e  b lood to  look at factors th a t affect b o n e  health  a n d  th e  risk of obesity  and  h eart d isea se . To do 
this, w e  would like to tak e  a  small am o u n t o f blood using  a  local a n aes th e tic  c ream  to num b the  skin and  
s to p  th e  te s t  from  being painful. Before w e c a n  d o  this w e  n e e d  your perm ission  after you have  read  the  
following:
P le a s e  in itia l b o x
1. I confirm  tha t I have  read  a n d  un d e rstan d  th e  inform ation sh e e t  d a t e d ................................... Q
( v e rs io n  ) for th e  ab o v e  study , h av e  h a d  the  c h a n c e  to  a sk  qu estio n s and  been
g iven a  copy  o f the  information sh e e t  to keep .
2 . I a g re e  to  give a  sam ple of blood for re se a rc h  in this p ro ject. I un d erstan d  how  the  sam ple  0
will b e  co llected , tha t giving a  sam p le  for th is re se a rc h  is voluntary an d  tha t I am  free  to w ithdraw my 
a pprova l for th e  u se  of this sam p le  a t a n y  tim e  w ithout giving a  rea so n , an d  without my m edical or 
legal rights being affected. I consider th e  risk o f harm  in giving th e  sam p le  is very small.
3. I u n d e rs tan d  th a t m y doctor (G P) a n d  I will b e  told if th e  re su lts  of an y  0  
m edical te s ts  d o n e  now  or a s  part o f th e  re se a rc h  a re  Im portant for m y health .
(M ost of th e s e  te s ts  a re  for re sea rch  p u rp o se s  only an d  will no t m e a su re  anything that 
d irectly ap p lie s  to  you)
4. I u n d e rs tan d  tha t re sea rch  using th e  sam p le  m ay include g en e tic  re sea rch  to | j
investigate  g en e tic  influences on d ise a se , bu t th e  re su lts  o f th e se  te s ts  a re
unlikely to  h av e  any  m eaning  for m y ow n health
5. I u n d e rs tan d  tha t the blood sam ple  will b e  s to red  an d  so m e  te s ts  m ay  b e  conducted  a t a  0
la te r da te . I un d erstan d  tha t future re se a rc h  using  th e  s am p le  m ay  include genetic  research .
N am e  o f young pe rso n  D ate  S ignature
R e se a rc h e r  D ate  S ignature
always
1 for patient; 1 for re sea rch e r ; 1 to  b e  kept with hospital no tes 
version I 14.05..04
Institute o f Child Health
and G reat O rm on d  S treet H o sp ita l for C h ild ren  N H S  Trust 
U N IV E R S IT Y  C O LL EG E L O N D O N
C en tre  N u m b er::
S tudy  N um ber:
P a tien t Identification N um ber for this trial:
CONSENT FORM FO R  A BLOOD TEST 
T itle  o f  P ro je c t:  Early  d ie t  a n d  la te r  B o d y  C o m p o s itio n  a n d  B lood  V esse l F u n c tio n
always
T hank you for ag ree in g  for your child to  h av e  a  blood te st. A s you know from the  information sh e e t, we 
would like to  ta k e  so m e  blood to look a t factors that affect bo n e  health  an d  th e  risk of obesity  an d  heart 
d is e a se . T o  do  this, w e would like to  tak e  a  sm all am o u n t o f blood using a  local a n aes th e tic  c ream  to 
num b th e  skin a n d  s top  th e  te s t  from being  painful. B efore  w e  can  do  this w e  n e e d  your perm ission  after 
you h av e  re a d  th e  following:
P le a s e  in itia l b o x
1. I confirm  tha t I h av e  read  a n d  und erstan d  th e  information sh e e t d a t e d ..................................  0
(v e rs io n  ) for th e  ab o v e  study , h a v e  h ad  th e  opportunity  to  a sk  questions a n d  b een
given a  copy  o f th e  information sh e e t  to  keep .
2 . I a g re e  to  m y c h ild ................................................................giving a  sam ple  of blood for re sea rch  0
in th is pro ject. I u n d e rs tan d  how  th e  sam p le  will b e  collected , th a t giving a  sam p le  for this 
re se a rc h  is voluntary an d  tha t I am  free  to  w ithdraw  m y approval for the u se  of this sam ple
a t an y  tim e w ithout giving a  rea so n , a n d  w ithout m y m edical o r legal rights being  affected.
I c o n s id e r th e  risk of harm  in donating  th e  s am p le  is negligible.
3. I u n d e rs tan d  th a t m y child 's doctor (G P) a n d  I will b e  inform ed if the  resu lts o f any  0
m edical te s ts  d o n e  now  or a s  part of th e  re se a rc h  a re  im portant for h is/her health.
(M ost of th e s e  te s ts  a re  for re sea rch  p u rp o ses  only a n d  will no t m easu re  anything that 
directly ap p lie s  to  your child)
4. I u n d e rs tan d  th a t re se a rc h  using the  sam p le  m ay  include gene tic  re sea rch  aim ed  a t 0
investigating  th e  gene tic  in fluences o n  d ise a se , bu t th e  resu lts of th e se  investigations a re  
unlikely to  h a v e  a n y  implications for m y ch ild 's  ow n hea lth
5. I u n d e rs tan d  th a t th e  sam p le  will b e  s to red  an d  so m e  te s ts  m ay b e  conducted  a t a  0
la te r d a te . I u n d e rs tan d  th a t future re se a rc h  using  th e  sam p le  m ay include gene tic  research .
N am e of P aren t/G u a rd ian  D ate  S ignature
N am e o f P e rso n  taking co n sen t D ate  S ignature
(if different from  re sea rc h e r)
S ignature
1 for patient; 1 for re sea rch e r; 1 to b e  kept with hospital no tes 
version 1 12.03.04
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Appendix E
Additional data analyses for Chapter 5
Table 10-6 Age range of weight measurements at different period in infancy#
n
E xact age o f  
m easurem ent
range
At 3 weeks 149 3.09 ±  0.49 2 .0 1 - 4 .2 9
At 6 w eeks 172 6.06 ± 0 .61 4.43 -  7.57
At 12 w eeks 173 12.15 ± 0 .9 5 1 0 .0 0 -1 6 .2 9
At 6  months 161 5.94 ±  0.36 5.09 -  6.97
At 12 months 136 11.98 ± 0 .7 7 9 .9 9 -1 3 .9 0
# Data shown as mean ±  SD
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Table 10-7 Partial correlation coefficients (r) controlled for sex and current age 
a) Relationship between A weight SDS at different periods and potential confounders
ASDS0-3wk ASDS3-6wk ASDS6-12wk ASDS 3-6mo ASDS6-12mo
Puberty -0.14 -0.13 0.11 0.06 0.06
Physical activity 0.07 0.05 -0.03 -0.10 -0.12
Social class -0.002 -0.09 -0.03 0.23? -0.03
M aternal height 0.12 0.1.7* -0.01 0.07 -0.10
Paternal height 0.08 0.11 -0.02 0.09 0.04
M aternal BMI -0.04 0.004 0.08 0.09 0.17
Paternal BMI 0.07 0.01 0.09 0.21* -0.02
b) Relationship between body composition outcomes and potential confounders
FMI SDS FFMI SDS TrunkFMlSDS WCSDS Triceps SDS Subsc SDS
Puberty 0.001 0.2? 0.05 0.06 -0.03 -0.02
Physical activity -0.28? 0.04 -0.2? -0.12 -0.2? -0.29?
Social class 0.18? 0.08 0.1? 0.12 0.09 0.14
Maternal height -o .i r -0.07 -0.13 -0.03 -0,20? -0.18?
Paternal height -0.08 -0.12 -0.07 <0.001 -0.04 -0.05
Maternal BMI 0.40? 0.32f 0.40? 0.3? 0.3f 0.39?
Paternal BMI 0.33? 0.28? 0.35? 0.31c 0.2? 0.2?
& A ll variables which were not normally distributed (Maternal BMI, Paternal BMI) were natural log 
transformed before analysis; ap < 0.05, bp <0.01, cp<0.001
Puberty coded as: 1 = prepubertal, 2 =  pubertal, 3 =  postpubertal, Physical activity was coded as: 2= much 
less or less active than peers, 3= same as peers, 4=  more active than peers, 5= much more active than peers, 
Social class range from 1 which is the highest to > 4 which is the lower social class
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Table 10-8 Regression of current body size and composition on weight SDS change at different infancy periods&
Aweight SDS 0-3wk Aweight SDS 3-6wk Aweight SDS 6-12wk Aweight SDS 3-6mo Aweight SDS 6-12mo
Later BC B SE P r2 B SE P r2 B SE P r2 B SE P r2 B SE P r2
Wt SDS 0.21 0.17 0.21 0.62 0.28 0.03 0.037 0.53 0.20 0.009 0.046 0.66 0.16 <0.001 0.103 0.18 0.18 0.31
Ht SDS 0.20 0.13 0.13 0.29 0.21 0.17 0.23 0.15 0.13 0.39 0.13 0.003 0.064 0.20 0.13 0.14
BMI SDS 0.14 0.19 0.45 0.64 0.30 0.04 0.033 0.57 0.22 0.01 0.044 0.62 0.18 0.001 0.077 0.10 0.19 0.62
FMI SDS 0.12 0.15 0.41 0.49 0.24 0.04 0.031 0.44 0.17 0.01 0.042 0.45 0.15 0.002 0.065 0.05 0.16 0.73
FFMI SDS 0.12 0.15 0.45 0.24 0.25 0.35 0.24 0.18 0.20 0.35 0.15 0.02 0.037 0.14 0.16 0.37
Triceps SDS 0.14 0.15 0.34 0.75 0.23 0.001 0.076 0.37 0.17 0.03 0.031 0.39 0.14 0.006 0.053 -.15 0.15 0.32
Subscapular SDS 0.10 0.16 0.52 0.65 0.26 0.01 0.047 0.31 0.19 0.10 0.34 0.16 0.04 0.032 0.09 0.17 0.60
WCSDS* 0.28 0.17 0.11 0.63 0.28 0.03 0.038 0.23 0.21 0.29 0.50 0.17 0.004 0.064 -.05 0.18 0.78
WCS 0.02 0.02 0.33 0.03 0.03 0.27 0.02 0.02 0.22 0.04 0.02 0.02 0.039 -.001 0.02 0.95
WC“ 0.01 0.01 0.66 -.01 0.02 0.53 <0.001 0.01 0.99 0.002 0.01 0.83 0.01 0.01 0.64
TrunkFMISDS 0.12 0.15 0.42 0.65 0.25 0.01 0.051 0.47 0.18 0.009 0.046 0.50 0.15 0.001 0.075 0.07 0.16 0.66
TrunkFMISDS” -.04 0.09 0.66 0.18 0.15 0.24 0.27 0.11 0.01 0.044 0.11 0.07 0.11 0.15 0.09 0.11
& From multiple regression analysis, each row represents a different model with body size and BC in the left hand column as a dependent variable; AweightSDS  
was an independent variable; birthweight SD S, gender, puberty, physical activity, social class, ethnicity, and parental height were covariates; B = the coefficient 
o f  AweightSDS i.e. the change in current body size or body com position per early AweightSDS (w eight SDS change between 2 time points), SE = standard error, 
highlighted p value indicate significant at p<0.05, r2 =  coefficient o f  determination (calculated from partial r o f  A w eight SD S)
# n=144, 134, 142, 136, and 116 for AweightSDS 0-3w k, AweightSDS 3-6w k, Aweight SDS 6-12w k, AweightSDS 3-6m o, and AweightSDS 6-12m o, respectively  
since the database for w aist SDS was available only up to the age o f  17.
WC was natural log transformed and presented in loge scale. For the m odel with WC, current age was also adjusted for.
$ Adjusted for current height (m ), WC was natural log  transformed and presented in loge scale. For the m odel with WC, current age was also adjusted for.
00 Adjusted for both current height (m ) and total FM (loge scale)
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Table 10-9 Regression of current body size and composition on weight SDS change at different infancy periods with
jp
interpolation of weight SDS at 6 wk, 12 wk, 6 mo, and 12 mo.
Aweight SDS 3-6wk (n=147) Aweight SDS 6-12wk (n=178) Aweight SDS 3-6mo (n—178) Aweight SDS 6-12mo (n=178)
Later BC B SE P r2 B SE P r2 B SE P r2 B SE P r2
Wt SDS 0.21 0.17 0.23 0.46 0.18 0.01 0.037 0.61 0.15 <0.001 0.089 0.36 0.15 0.02 0.030
Ht SDS 0.21 0.15 0.17 0.25 0.15 0.11 0.40 0.13 0002 0.052 0.27 0.13 0.04 0.024
BMI SDS 0.17 0.20 0.39 0.43 0.20 0,03 0.026 0.51 0.17 0.003 0.050 0.26 0.17 0.13
FMI SDS 0.12 0.16 0.47 0.32 0.16 0,05 0.023 0.39 0.14 0.005 0.045 0.18 0.14 0.20
FFMI SDS 0.19 0.16 0.24 0.07 0.16 0.69 0.25 0.14 0.08 0.16 0.14 0.27
Triceps SDS 0.22 0.15 0.15 0.32 0.15 0.04 0.025 0.31 0.13 0.02 0.030 0.03 0.14 0.83
Subscapular SDS 0.14 0.17 0.43 0.26 0.17 0.14 0.31 0.15 0.04 0.023 0.26 0.15 0.09
WC SDS# 0.23 0.17 0.19 0.22 0.18 0.23 0.47 0.15 0.003 0.056 0.13 0.16 0.42
WCS 0.01 0.02 0.56 0.02 0.02 0.31 0.03 0.01 0.82 0.01 0.01 0.37
WC" 0.003 0.01 0.76 -.011 0.01 0.26 0.01 0.01 0.51 0.004 0.01 0.61
TrunkFMISDS 0.14 0.16 0.37 0.37 0.16 0.02 0.029 0.43 0.14 0.002 0.052 0.21 0.14 0.13
TrunkFMISDS" 0.07 0.07 0.31 0.07 0.07 021 0.13 0.06 0.03 0.028 0.12 0.06 0.04 0.025
& From multiple regression analysis, each row represents a different model with body size and BC in the left hand column as a dependent variable; Aweight SDS  
was an independent variable; birthweight SD S and gender were covariates
n=142, 160, 160, and 160 for Aweight SDS 3-6w k, Aweight SD S 6-12w k, Aweight SDS 3-6m o, and Aweight SDS 6-12m o, respectively since the database for 
waist SDS was available only up to the age o f  17
s Adjusted for current height (m ), WC was natural log  transformed and presented in loge scale. For the model with WC, current age was also adjusted for.
00
Adjusted for both current height (m ) and total FM (loge scale)
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Table 10-10 Regression of current body size and composition on weight SDS change at two different infancy periods in boys
and girls&
Boys Girls
Aweight SDS 6-12 wk (n=69) Aweight SDS 3-6 mo (n=65) Aweight SDS 6-12 wk (n-88) Aweight SDS 3-6 mo (n=85)
Later BC B SE P r2 B SE P r2 B SE P r2 B SE P r2
Wt SDS 0.58 0.26 0.03 0.070 1.09 0.28 <0.001 0.196 0.54 0.31 0.09 0.50 0.18 0.007 0.086
Ht SDS 0.19 0.22 0.40 0.61 0.25 0.02 0.091 0.31 0.29 0.23 0.36 0.17 0.03 0.054
BMI SDS 0.68 0.30 0.03 0.073 1.03 0.33 0.003 0.135 0.49 0.34 0.16 0.41 0.20 0.04 0.050
FMI SDS 0.49 0.24 0.05 0.059 0.68 0.27 0.02 0.089 0.43 0.29 0.14 0.39 0.17 0 02 0.065
FFMI SDS 0.26 0.23 0.27 0.61 0.26 0.02 0.085 0.07 0.31 0.81 0.15 0.18 0.41
Triceps SDS 0.52 0.24 0.03 0.067 0.60 0.28 0.03 0.070 0.41 0.26 0.12 0.31 0.15 0.05 0.047
Subscapular SDS 0.43 0.26 0.11 0.56 0.30 0.06 0.34 0.31 0.27 0.29 0.18 0.11
WCSDS# 0.49 0.26 0.07 0.87 0.29 0.004 0.136 0.11 0.33 0.74 0.37 0.19 0.06
w c $ 0.03 0.02 0.26 0.05 0.03 0.08 0.02 0.03 0.61 0.04 0.02 0.05 0.048
WC” -.01 0.01 0.73 -.003 0.02 0.87 -0.02 0.02 0.23 0.003 0.01 0.79
TrunkFMISDS 0.57 0.24 0.02 0.080 0.83 0.27 0.003 0.133 0.39 0.29 0.19 0.37 0.17 0.03 0.056
TrunkFMISDS” 0.18 0.09 0.06 0.21 0.11 0.06 0.001 0.11 0.99 0.06 0.07 0.34
& From multiple regression analysis, each row represents a different m odel with body size and BC in the left hand column as a dependent variable; Aweight SDS  
was an independent variable; birth SDS was covariates
# n=63 and 60 for Aweight SD S 6-12w k, Aweight SD S 3-6m o, respectively for boys; n=79 and 76 for Aweight SD S 6-12w k, Aweight SDS 3-6m o, respectively  
for girls since the database for w aist SDS was available only up to the age o f  17.
$
Adjusted for current height (m ), WC was natural log transformed and presented in loge scale. For the m odel with WC, current age was also adjusted for.
0 0
Adjusted for both current height (m ) and total FM (loge scale)
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